commission staff working document on the … · (b) modifications of the national plan for 2011 the...

1

COMMISSION STAFF WORKING DOCUMENT

on the implementation of national residue monitoring plans in the Member States in 2011 (Council Directive 96/23/EC)

The aim of this document is to communicate to the European Parliament and to the Council of the European Union a summary of the Member States' findings and actions taken as a consequence of the non-compliant results found in food of animal origin through the implementation of Council Directive 96/23/EC on measures to monitor certain substances and residues thereof in live animals and animal products during 2011.

(1) Introduction Council Directive 96/23/EC1 on measures to monitor certain substances and residues thereof in live animals and animal products requires Member States to adopt and implement a national residue monitoring plan for specific groups of residues. Member States must assign the task of co-ordinating the implementation of the controls to a central public department or body. This department is responsible for drawing up the national plan, co-ordinating the activities of the central and regional departments responsible for monitoring the various residues, collecting the data and sending the results of the surveys undertaken to the Commission each year.

The Directive lays down specific sampling levels and frequencies, as well as the groups of substances to be monitored for each food commodity. Commission Decision 97/747/EC2 lays down additional rules for milk, eggs, honey, rabbits and game.

National monitoring plans should be targeted: samples should be taken with the aim of detecting illegal treatment or controlling compliance with the maximum residue limits (MRLs) for veterinary medicinal products set out in Table I in the Annex to Commission Regulation (EU) No 37/20103, the maximum levels for pesticides set out in Regulation (EC) No 396/20054 or the maximum levels laid down in relevant legislation on contaminants. This means that in the national plan the Member States target the groups of animals/gender/age combinations where the probability of finding residues is the highest. This approach is different from random sampling, where the objective is to gather statistically significant data, for instance to evaluate consumer exposure to a specific substance.

Member States must forward annually to the Commission the national monitoring plans, together with the results of their residue monitoring for the previous year, by 31 March at the latest. The Directive lays down a procedure by which the plans are approved on a yearly basis. This procedure involves the Member States.

1 OJ L 125, 29.4.1996, p. 10-24. 2 OJ L 303, 6.11.1997, p. 12-15. 3 OJ L 15, 20.1.2010, p. 1. 4 OJ L 70, 16.3.2005, p. 1-16.

2

(2) Results As laid down in Article 8 of Directive 96/23/EC, the Commission has to report to the Member States, within the Standing Committee on the Food Chain and Animal Health, the outcome of the checks carried out, in particular on the implementation of the national plans and on the development of the situation in the various regions of the Community. To this end, the Commission has summarised the results of the national residue monitoring plans for the year 2011. Trends within the European Union are also indicated by comparison with previous reports. These aspects were presented to the Member States in the Standing Committee on the Food Chain and Animal Health – section toxicological safety held on 26 November 2012.

Part II/III of this document is a compilation and analysis of data of the results obtained in the Member States in 2011. This compilation and analysis of data is broken down by food commodities (bovines, pigs, sheep and goats, horses, poultry, rabbit, farmed game, wild game, aquaculture, milk, eggs and honey) and groups of substances (hormones, corticosteroids, beta-agonists, prohibited substances, antibacterials, other veterinary medicinal products, “other” substances and contaminants).

At the request of the European Commission, the European Food Safety Authority (EFSA) produces a technical report (“Report for 2011 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products”) in the framework of Article 31 of Regulation (EC) No 178/20025. This technical report serves as the basis for the part II/III of this document.

(3) Actions taken as a consequence of non-compliant results In accordance with Article 8 of Directive 96/23/EC, the Member States were requested, as a follow-up, to provide information on actions taken at regional and national level. The objective is to provide an overview of actions taken as a consequence of non-compliant6 results for residues of non-authorised substances or when the maximum residue limits (MRLs) established in EU legislation are exceeded.

In order to collect information on actions taken as a consequence of non-compliant results, the Commission sent a questionnaire to the Member States. These actions could be divided into the following three groups: sampling as suspect, modifications of the national plans for 2009 and other actions.

(a) Sampling as suspect

Suspect samples are defined as:

(1) samples taken as a consequence of non-compliant results on samples taken in accordance with the monitoring plan (Article 5 of Directive 96/23/EC);

5 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying

down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. OJ L 31/1, 1.2.2002, p. 1-24.

6 Non-compliant results correspond to the presence of a prohibited substance or to the presence of an authorised substance above the maximum level allowed in the legislation.

3

(2) samples taken as a consequence of possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale throughout the food and feed production chain (Article 11 of Directive 96/23/EC);

(3) samples taken where the veterinarian suspects or has evidence of illegal treatment or non-compliance with the withdrawal period for an authorised veterinary medicinal product (Article 24 of Directive 96/23/EC).

In summary, this means that the term “suspect sample” applies to a sample taken as a consequence of:

– non-compliant results and/or

– suspicion of an illegal treatment at any stage of the food chain and/or

– suspicion of non-compliance with the withdrawal period for an authorised veterinary medicinal product.

(b) Modifications of the national plan for 2011

The national residue monitoring plan aims at detecting illegal treatment of food-producing animals, controlling compliance with the maximum residue limits for veterinary medicinal products, the maximum residue levels for pesticides and the maximum levels for contaminants. Non-compliant results for a specific substance/group of substances or a specific food commodity should result in intensified controls for this substance/group or food commodity in the plan for the following year.

(c) Other actions taken as a consequence of non-compliant results

Article 16 and Articles 22-28 of Directive 96/23/EC prescribe a series of actions (other than modifications of the residue monitoring plan) to be taken in the case of non-compliant results or infringements:

• To carry out investigations in the farm of origin, such as verification of records and additional sampling

• To hold animals in the farm as a consequence of positive findings

• To slaughter animals in case of confirmation of illegal treatment and to send them to a high risk processing plant

• To intensify the controls in the farms where non-compliant results were found

• To impound carcasses at the slaughterhouse when non-compliant results have been found

• To declare the carcasses or products of animal origin unfit for human consumption.

The changes introduced by some Member States for the 2011 plan together with the responses of the Member States in relation to this type of actions are summarised in Part III/III of this document.

4

Report for 2011 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products7

European Food Safety Authority (EFSA), Parma, Italy

SUMMARY

The presence of unauthorised substances, residues of veterinary medicinal products or chemical contaminants in food may pose a risk factor for public health. The EU legislative framework defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Maximum limits for residues of veterinary medicinal products in food-producing animals and animal products are established in Regulation (EU) No 37/20108. Maximum limits for the presence of certain contaminants in animal products are laid down in Commission Regulation (EC) 1881/20069. Council Directive 96/23/EC10 lays down measures to monitor certain substances and residues thereof, mainly veterinary medicinal products, in live animals and animal products. Additionally, Commission Decision 97/747/EC11 lays down levels and frequencies of sampling for certain animal products. The present report summarises the monitoring data from 2011 on the presence of residues of veterinary medicinal products and certain substances in live animals and animal products in the European Union (EU). Data were collected in aggregated form in a database managed by the European Commission (EC).

In the framework of Article 31 of Regulation EC 178/200212, the European Commission asked the European Food Safety Authority (EFSA) to produce an annual compilation of the monitoring results obtained under the provision of Council Directive 96/23. Animal categories and animal products covered in the monitoring are: bovines, pigs, sheep and goats, horses, poultry, rabbit, farmed game, wild game, aquaculture, milk, eggs and honey.

Data collected in aggregated form do not allow for an in-depth analysis. The limitations described in the previous EFSA reports (EFSA, 2010a; EFSA, 2010b; EFSA, 2011; EFSA, 2012) were still applicable in the present analysis. Therefore, the recommendations made with regard to the collection of data in the EFSA format similar to pesticides and contaminants data remain valid.

7 On request from the European Commission, Question No EFSA-Q-2012-00559, issued on 3 December 2012. 8 Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their

classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15/1, 20.1.2010, p. 1-72. 9 Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in

foodstuffs. OJ L 364/5, 20.12.2006, p. 5 – 24. 10 Council Directive 96/23/EC on measures to monitor certain substances and residues thereof in live animals and animal

products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC. OJ L 125, 23/05/1996, p. 10 – 32.

11 Commission Decision 97/747/EC fixing the levels and frequencies of sampling provided for by Council Directive 96/23/EC for the monitoring of certain substances and residues thereof in certain animal products. OJ L 303, 6.11.1997, p. 12–15.

12 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. OJ L 31/1, 1.2.2002, p. 1-24.

5

Altogether, 742,902 samples were reported by the 27 EU Member States in the framework of the residue monitoring in 2011. They included 415,909 targeted samples and 23,236 suspect samples reported under Council Directive 96/23/EC, 299,428 samples collected in the framework of other programmes developed under the national legislation and 4,329 samples checked at import. Considering all animal species and product categories included in the 2011 monitoring plans, 779 substances13 were listed to be checked for. The frequency of analyses for a certain substance is highly variable depending on the targeted animal/product category. The data analysis presented in this report was focused on the targeted samples reported under Council Directive 96/23/EC. Samples collected through other sampling strategies (suspect, import or ‘other’) do not follow a designed monitoring plan, thus results on those samples were not pooled together with the results on targeted samples.

With regard to the minimum requirements for sampling frequency laid down in Council Directive 96/23/EC and in Commission Decision 97/747/EC, they were fulfilled by the vast majority of EU Member States.

Overall, 1,178 samples or 0.28 % of the 415,909 targeted samples were non-compliant in 2011. Similar to the previous four years, there were no non-compliant samples for stilbenes and derivatives (A1). For antithyroid agents (A2), there were 0.63 % non-compliant samples, all for thiouracil, most likely due to feeding diets rich in cruciferous plants. In the group of steroids (A3), there were 0.11 % non-compliant samples in all animal and product categories but only about half of them were non-compliant for anabolic steroids. The others were non-compliant for corticosteroids reported in the group A3. The non-compliant results for anabolic steroids (n = 32) were found in bovines (n = 17), pigs (n = 6), poultry (n = 6) and aquaculture (n = 3). For 80 % of the non-compliant results on anabolic steroids, Member States indicated that the source was most likely the endogenous production. Non-compliant results for corticosteroids were reported in group A3 (n = 29) and in B2f (n = 10). All but one of non-compliant results for corticosteroids (A3 and B2f) were reported in bovines (n = 38). In the group of resorcyclic acid lactones (A4), 0.08 % of the samples were non-compliant for zearalenone and derivatives. For beta-agonists (A5), there were 0.03 % non-compliant samples. Prohibited substances were found in 0.04 % of samples. Substances identified were chloramphenicol (n = 12), nitrofurans (n = 15) and nitroimidazoles (n = 2).

For antibacterials (B1), 0.19 % of the samples analysed under the Directive 96/23 monitoring were non-compliant. The highest frequency of non-compliant samples for antibacterials was found in honey (1.0 %).

In the group B2 (other veterinary drugs), the highest proportion of non-compliant samples was found for anticoccidials (0.26 %; B2b). Across animal species and product categories, the non-compliant samples for anticoccidials accounted for 0.22 % in poultry, 0.06 % in pigs, 0.12 % in sheep and goats, 1.1 % in rabbit meat, 2.5 % in farmed game and 0.72 % in eggs. An important decrease has been observed in the frequency of non-compliant samples for 13 The number of substances included in the monitoring plan might be slightly different from the true number

of substances analysed. Due to the structure of the data collection, it was not possible to extract the exact number of substances analysed.

6

anticoccidials in poultry (0.22 % in 2011 compared to 0.96 % in 2010 and 2.05 % in 2009). Instances of non-compliance for anthelmintics (B2a) were reported in bovines (0.1 %), sheep and goats (0.21 %), poultry (0.03 %) and milk (0.18 %). There was one non-compliant sample for pyrethroids (B2c) and one for sedatives (B2d). For non-steroidal anti-inflammatory drugs (B2e), non-compliant samples were found in bovines (0.15 %), pigs (0.02 %), horses (0.66 %), poultry (0.34 %) and milk (0.09 %). Non-compliant samples for “other pharmacologically active substances” (B2f) were reported in bovines (0.1 %), sheep and goats (0.18 %), poultry (0.14 %) and rabbit (1.9 %).

Similar to previous years, in the group B3 (other substances and environmental contaminants), the chemical elements (B3c) had the highest overall percentage of non-compliant samples (3.4 %). Cadmium, lead, mercury and copper were the most frequent elements identified. Instances of non-compliance for organochlorine compounds (B3a) and organophosphorus compounds (B3b) were much lower: 0.17 % and 0.03 %, respectively. For mycotoxins (B3d), there were non-compliant samples for zearalenone and derivatives, ochratoxin A, aflatoxin B1 and aflatoxin M1 in milk. Important to highlight that by a relatively constant sampling frequency over time, the number of non-compliant milk samples for aflatoxin M1 (n = 13) was higher compared to the period 2008 to 2010 (n = 4 to 7). Prevalence of dyes (B3e) in aquaculture samples remained relatively high in 2011 (1.8 %), a value similar to those reported in the previous years. Substances found were malachite green, leuco malachite green, crystal violet and leuco crystal violet.

A comparison of the data from the period 2007 to 2011 highlighted that the overall frequency of non-compliant samples in 2011 was slightly lower compared to the previous four years (0.32 % – 0.34 %). For several substance groups, there were no notable variations in the frequency of non-compliant samples in 2011 compared to previous years but a decrease was observed for steroids, resorcyclic acid lactones, prohibited substances, antimicrobials, anthelmintics and anticoccidials. The decrease in the frequency of non-compliant samples for anticoccidials is most likely the result of the awareness and the measures that followed the implementation of the Commission Directive 2009/8/EC14 setting up maximum levels of unavoidable carry-over of coccidiostats in non-target feed. In contrast, the proportion of non-compliant samples for chemical elements (mainly metals) was similar to 2010 but higher compared to the period 2007 to 2009. This development is explained by the application since 2010 of a stricter legal basis in the evaluation of compliance for mercury and copper.

The national sampling plans and the pattern of substances analysed were likely not the same over the years and the prescribing patterns of veterinary medicines vary between species. Therefore, the outcome of the data analysis at EU level may not reflect accurately the residue situation in each individual EU Member State and for each species or product category.

14 Commission Directive 2009/8/EC of 10 February 2009 amending Annex I to Directive 2002/32/EC of the

European Parliament and of the Council as regards maximum levels of unavoidable carry-over of coccidiostats or histomonostats in non-target feed. OJ L 40/19, 11.2.2009, p. 19-25.

7

TABLE OF CONTENTS Summary ................................................................................................................................ 1

Table of contents ................................................................................................................. 4

Background as provided by the European Commission ....................................... 6

Terms of reference as provided by the European Commission......................... 6

Analysis of residue monitoring data............................................................................. 7

1. Introduction ............................................................................................................. 7

2. Objectives................................................................................................................. 9

3. Materials and Methods ...................................................................................... 10

3.1. Materials.................................................................................................................. 10

3.2. Methods ................................................................................................................... 11

4. Results ..................................................................................................................... 11

4.1. EU overall assessment ...................................................................................... 11

4.1.1. Hormones ............................................................................................................... 13

4.1.2. Corticosteroids...................................................................................................... 14

4.1.3. Beta-agonists ........................................................................................................ 15

4.1.4. Prohibited substances ........................................................................................ 15

4.1.5. Antibacterials ........................................................................................................ 16

4.1.6. Other veterinary drugs...................................................................................... 17

4.1.7. Other substances and environmental contaminants ............................. 19

4.1.8. Multi-year comparison ....................................................................................... 21

4.2. Bovines .................................................................................................................... 24

4.3. Pigs............................................................................................................................ 26

4.4. Sheep and goats .................................................................................................. 28

4.5. Horses ...................................................................................................................... 31

4.6. Poultry...................................................................................................................... 32

4.7. Aquaculture............................................................................................................ 34

4.8. Milk............................................................................................................................ 37

4.9. Eggs .......................................................................................................................... 39

4.10. Rabbit meat ........................................................................................................... 41

4.11. Farmed game ........................................................................................................ 43

4.12. Wild game .............................................................................................................. 45

4.13. Honey ....................................................................................................................... 47

8

4.14. Suspect, import and other samples ............................................................. 49

Conclusions .......................................................................................................................... 52

References............................................................................................................................ 55

Appendices ........................................................................................................................... 56

A. List of non-compliant results: targeted sampling 2011................................ 56

B. List of non-compliant results: suspect sampling ............................................. 68

C. List of non-compliant results: import sampling ............................................... 74

D. List of non-compliant results: other sampling ................................................. 75

E. Annex I to Directive 96/23/EC................................................................................ 78

Abbreviations ...................................................................................................................... 80

9

BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION Council Directive 96/23/EC requires Member States to adopt and implement a national residue monitoring plan for specific groups of residues. The Directive lays down sampling levels and frequency, as well as the group of substances to be monitored for each category of live animals or animal products. Member States must submit to the Commission, by no later than 31 March of each year, the national monitoring plans together with the monitoring results for the previous year. According to Article 8.4 of the aforementioned Directive, each year or whenever it deems it necessary, the Commission shall report to the Member States on the outcome of the surveys. According to Article 8.5, the Commission sends to the European Parliament and the Council a Communication on the results and actions taken at regional, national or Community level. The Communication is drafted on the basis of a summary report which includes the main results reported by the Member States as the outcome of the implementation of national residue plans. Summary reports have been published since 1998. Since 2001, the Commission has published the annual Communication to the Parliament and the Council (http://ec.europa.eu/food/food/chemicalsafety/residues/control_en.htm).

TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION In the framework of Article 31 of Regulation EC No 178/2002, the European Commission asked EFSA to prepare an annual compilation (report) of the results of residue monitoring in live animals and animal products in the Member States. EFSA shall present its report to the Member States in the Standing Committee of the Food Chain and Animal Health (SCFCAH). Together with the comments from the Member States and the answers to the questionnaires on actions taken as a consequence of non-compliant results, the Commission will use EFSA’s report for the drafting of the Annual Report and the Communication to the European Parliament and the European Council.

Data used in the report were collected from Member States under Directive 96/23/EC and stored in the Commission’s residue application. DG for Health & Consumers (DG SANCO) is in charge of the overall coordination of the residue data collection from Member States; it performs a preliminary format check and examines the data for inconsistencies, omissions or misreporting. It also requests that, where appropriate, the Member States check and update data that have been uploaded onto the application. When DG SANCO considers that data provided are in line with the requirements of Directive 96/23/EC, EFSA starts to produce its contribution.

http://ec.europa.eu/food/food/chemicalsafety/residues/control_en.htm

10

ANALYSIS OF RESIDUE MONITORING DATA

Introduction

The presence of unauthorised substances, residues of veterinary medicinal products or chemical contaminants in food may pose a risk factor for public health. The EU legislative framework defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain.

Council Directive 96/23/EC on measures to monitor certain substances and residues thereof in live animals and animal products requires Member States to adopt and implement a national residue monitoring plan for the groups of residues detailed in its Annex I in accordance with the sampling rules referred to in Annex IV. The Directive lays down sampling levels and frequency for bovines, pigs, sheep and goats, equine animals, poultry and aquaculture, as well as the groups of substances to be monitored for each food commodity. Commission Decision 97/747/EC lays down rules for levels and frequencies of sampling for milk, eggs, honey, rabbit meat and game.

Member States should forward to the European Commission the results of their residue monitoring by 31 March of each year at the latest. National residue control plans should be targeted to take the following minimum criteria into account: species, gender, age, fattening system, all available background information and all evidence of misuse or abuse of substances. Additionally, suspect samples may also be taken as part of the residue control.

The requirements for the analytical methods to be applied in the testing of official samples and the common criteria for the interpretation of analytical results are laid down in Commission Decision 2002/657/EC15 of 12 August 2002 implementing Council Directive 96/23/EC.

Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.

Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the monitoring plan, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.

15 Commission Decision 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. OJ L 221/8, 17.8.2002, p. 1-29.

11

Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.

Unauthorised substances or products mean substances or products prohibited under European Union legislation.

Illegal treatment refers to the use of unauthorised substances or products or the use of substances or products authorised under EU legislation for purposes or under conditions other than those laid down in EU legislation or, where appropriate, in the various national legislation.

Withdrawal period represents the period necessary between the last administration of the veterinary medicinal product to animals under normal conditions of use and the production of foodstuffs from such animals, in order to ensure that such foodstuffs do not contain residues in quantities in excess of the maximum limits laid down in EU legislation.

Non-compliant result: since the entry into force of Decision 2005/657/EC, the term for analytical results exceeding the permitted limits (in previous reports termed “positives”) is “non-compliant”. The result of an analysis shall be considered non-compliant if the decision limit of the confirmatory method for the analyte is exceeded.

Non-compliant sample: is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.

Maximum residue limit means the maximum concentration of residue resulting from the use of a veterinary medicinal product, which may be accepted by the Community to be legally permitted or recognised as acceptable in or on a food. For veterinary medicinal products, maximum residue limits (MRLs) are established according to the procedures laid down in Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 200916. Pharmacologically active substances and their classification regarding maximum residue limits are set out in Commission Regulation (EU) No 37/2010 of 22 December 2009. In addition, Commission Directive No 2009/8/EC lays down maximum levels of unavoidable carry-over of coccidiostats or histomonostats in nontarget feed and Commission Regulation (EC) No 124/200917 lays down maximum levels for the presence of coccidiostats or histomonostats in food resulting from the unavoidable carry-over of these substances in non-target feed. 16 Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council. OJ L 152/11, 16.6.2009, p. 1-12. 17 Commission Regulation (EC) No 124/2009 of 10 February 2009 setting maximum levels for the presence of

coccidiostats or histomonostats in food resulting from the unavoidable carry-over of these substances in non-target feed. OJ L 40/7, 11.2.2009, p. 7-11.

12

For pesticides, MRLs are laid down in Regulation (EC) No 396/200518. Some substances (e.g. carbamates, pyrethroids, organophosphorus compounds) are recognised both as veterinary medicinal products and pesticides and therefore they might have different MRLs in the corresponding legislation.

Maximum levels for contaminants are laid down in Commission Regulation (EC) No 1881/200619. For contaminants where no EU maximum levels had been fixed at the time when data included in this report were collected, national tolerance levels were applied.

Minimum Required Performance Limits (MRPLs). According to the Annex to Commission Decision 2002/657/EC, MRPL means the minimum content of an analyte in a sample which has to be detected and confirmed. It is intended to harmonise the analytical performance of methods for substances for which no permitted limit has been established.

MRPLs for chloramphenicol, nitrofurans metabolites and medroxyprogesterone acetate were established by Commission Decision 2003/181/EC and for malachite and leuco malachite green were established by Commission Decision 2004/25/EC20.

Objectives

The present report summarises the monitoring data from 2011 submitted by the Member States to the European Commission. Data analysis was mainly focused on data submitted under Directive 96/23/EC and aimed to provide an overview on:

• Production volume and number of samples collected in each Member State. These data were used to check whether the Member States had fulfilled the minimum requirements on sampling frequency as stated in Directive 96/23/EC and Commission Decision 97/747/EC.

• Number of samples analysed in each animal species or food commodity for substance groups and subgroups as defined in Annex I to Directive 96/23/EC (see Appendix E).

• Summary of non-compliant results per animal species or food commodity and substance group.

• Identification of main substances contributing to non-compliant results within a group.

• EU overall distribution of non-compliant samples in the substance groups. 18 Regulation (EC) 396/2005 of the European Parliament and of the Council on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L 70/1, 16.3.2005, p. 1-16. 19 Commission Regulation (EC) 1881/2006 setting maximum levels for certain contaminants in foodstuffs. OJ L 364/5, 20.12.2006. 20 Commission Decision 2004/25/EC of 22 December 2003 amending Decision 2002/657/EC as regards the

setting of minimum required performance limits (MRPLs) for certain residues in food of animal origin. OJ, L6, 10.1.2004, 38-39.

13

Materials and Methods

Materials

Data used in this report have been collected from Member States under Directive 96/23/EC and stored in DG SANCO’s residue database. The samples included in the monitoring were taken from the production process of animals and primary products of animal origin (live animals, their excrements, body fluids and tissues, animal products, animal feed and drinking water).

The DG for Health and Consumers (DG SANCO) is in charge of the overall coordination of the residue data collection from Member States (see “Terms of reference”). Each Member State assigns the coordination of the national monitoring plan to a central public department or body which is also in charge of the data collection at national level (Directive 96/23/EC Art. 4). The respective institution is also in charge of the aggregation of the data received from the various central and regional departments. DG SANCO verifies whether or not the transmitted results are in line with the established monitoring plan and indicates misreporting. In case of misreporting, the Member States in question are asked to update their data.

Aggregate data are transmitted to the Commission at the following level of detail:

• Animal category and animal products: bovines, pigs, sheep and goats, horses, poultry, rabbit, farmed game, wild game, aquaculture, milk, eggs and honey.

• Production volume expressed in number of animals for bovines, pigs, sheep and goats, and horses, and in tonnes for poultry, rabbit, farmed game, wild game, aquaculture, milk, eggs and honey.

• Sampling strategy: targeted, suspect, import and ‘others’.

• Number of samples analysed for each substance group as defined in Annex I to Directive 96/23/EC.

• Number of non-compliant results within each substance group or subgroup and within each animal category or animal product. Non-compliant results are listed by the substance identified. Additional information about the non-compliant samples is given in a separate document (Questionnaires) provided by the Member States. This information is not included in the database.

In this context, it is important to note that the number of non-compliant samples is not necessarily the same as the number of non-compliant results. One sample can be non-compliant for more than one substance and therefore the sum of non-compliant results might be higher than the sum of non-compliant samples. The information on sample identification, sample matrix and the corresponding results was not available in the database and thus it was impossible to perform a more elaborate statistical analysis at the matrix level (e.g. meat, liver, blood, etc.) and to identify the samples non-compliant for more substances (multi-residues samples).

14

Since information on the number of total analyses performed for an individual substance was only transmitted by the Member States which reported at least one non-compliant result for the respective substance, it was not possible to extract the full spectrum of substances analysed within one group or subgroup.

Methods

For the data analysis, the database and the data extraction tools available in DG SANCO’s residue application were used. Making use of those tools it was possible to extract the production volume reported by the Member States and the number of samples analysed for each animal species or animal product category and for each substance group or subgroup. To check whether the minimum required sampling frequencies had been fulfilled, the number of samples collected in 2011 was referred to the production of 2010. The number of non-compliant samples could be extracted at the group or subgroup level. At the substance level, only Member States which found at least one non-compliant result reported the total number of samples analysed for that substance. The shortcomings mentioned in 3.1 represented considerable limitations in performing a more elaborate statistical analysis.

Results

The structure and the data analysis performed in the present report follows the one of the 2010 report:

• The EU overall assessment includes all animal/animal product categories and is presented for each main substance group.

• Assessment of samples analysed, non-compliant samples and non-compliant results are presented for each animal/animal product category separately.

• Suspect samples are evaluated separately from the targeted samples.

• Results which were not reported under the Council Directive 96/23/EC (import and ‘others’) are not included in the overall assessment but treated separately. Non-compliant results for the individual substances in each animal/animal product category are listed in Appendix A (targeted samples), Appendix B (suspect samples), Appendix C (import samples) and Annex D (‘other’ samples).

EU overall assessment

The aim of this assessment was to give an overview of the total number of samples analysed for the individual substance groups and to summarise the non-compliant samples for the major substance groups at EU level. Further details on the non-compliant samples found in each animal/product category are presented in chapters 4.2 to 4.13.

In 2011, 742,902 samples were reported by the 27 Member States for analysis of substances and residues covered by Directive 96/23/EC. Out of this, 415,909

15

were targeted samples collected in conformity with the specification of the National Residue Control Plans (NRCPs) for 2011. Additionally, 23,236 suspect samples were reported as follow-up of non-compliant targeted samples or suspicion of illegal treatment or non-compliance with the withdrawal period. Apart from the data submitted in accordance to NRCPs, Member States reported in total 299,428 samples collected in the framework of other programmes developed under the national legislation. Only a relatively limited number of data (n = 4,329) was reported for samples checked at import. This is because the control of samples at import is more linked to the third country monitoring than to the residue monitoring in EU; thus Member States report those results to the European Commission ((EC) using other tools e.g. the Trade Control and Expert System (TRACES) and the Rapid Alert System for Food and Feed (RASFF).

In total, the 2011 monitoring plan covered 779 substances21 to be checked for in all animal species and product categories. The list of substances included in the National Residue Control Plans is adjusted every year by the Member States under the coordination of the EC taking into consideration several factors such as the prescribing patterns of veterinary medicines and the emerging or recurrent issues concerning certain substances.

Of the total of targeted samples, 45 % were analysed for substances having an anabolic effect and unauthorised substances (group A) and 61 % for veterinary drugs and contaminants (group B)22. Of the 415,909 targeted samples, 1,178 were non-compliant (0.28 %) (1,268 non-compliant results). The percentage of non-compliant samples calculated from the total number of samples analysed for substances in that category was: 0.09 % for substances having an anabolic effect and unauthorized substances (A), 0.19 % for antibacterials (B1), 0.12 % for the “other veterinary drugs” (B2) and 1.5 % for “other substances and environmental contaminants” (B3) (Table 1, Figure 1).

Number of targeted samples analysed, non-compliant samples and non-compliant results in all species and product categories.

Samples analysed Non-compliant samples Non-compliant results

Substance group (a)

n(b) % n(c) % n(d)

A 186,152 45 174 0.09 185A1 23,575 5.7 0 0.00 0A2 10,155 2.4 64 0.63 64A3 46,378 11 53 0.11 61A4 21,288 5.1 18 0.08 19A5 42,541 10 12 0.03 12A6 73,258 18 27 0.04 29

B 251,643 61 1,004 0.40 1,083B1 124,895 30 242 0.19 249B2 90,744 22 106 0.12 109

B2a 25,900 6.2 21 0.08 23

B2b 20,768 5.0 54 0.2 54

21 The number of substances included in the plan might be slightly different from the true number of

substances analysed. Due to the structure of the data collection, it was not possible to extract the exact number of substances analysed.

22 Some samples were analysed for substances in both groups therefore the sum of percentages is higher than 100.

16

B2c 8,826 2.1 1 0.01 1B2d 9,673 2.3 1 0.01 1B2e 15,213 3.7 17 0.11 18B2f 16,837 4.0 12 0.07 12

B3 44,594 11 656 1.5 725B3a 16,992 4.1 29 0.17 39B3b 7,534 9.6 2 0.03 2B3c 16,506 4.0 564 3.4 602B3d 6,440 1.5 26 0.40 44B3e 1,932 0.46 34 1.8 37B3f 2,604 0.63 1 0.04 1

Total 415,909 100 1,178 0.28 1,268(a): as detailed in Appendix E; (b): number of samples analysed for one or more substances of the respective group; (c): number of non-compliant samples for one or more substances in the respective group; (d): number of non-compliant results; one sample can be non-compliant for more substances therefore the number of non-compliant results can be higher than the number of non-compliant samples of the same group.

Percentage of non-compliant samples in each substance group.

17

Hormones

Directive 96/22/EC prohibits the use of hormones in food producing animals except for well-defined therapeutic and zootechnical purposes and under strict veterinary control.

This group includes also synthetic, hormonally active substances such as stilbenes and their derivatives (A1), antithyroid agents (A2) and steroids (A3). Resorcyclic acid lactones (A4) are hormonally active as well and potentially used for growth promoting purposes, but their presence in animals and products of animal origin could also be linked to the ingestion of feed contaminated with fungi belonging to the genus Fusarium.

Of all the targeted samples analysed for the category “hormones” in all animal/product categories (101,396 samples) there were 135 non-compliant samples (0.13 %) (144 non-compliant results).

The number of targeted samples analysed for stilbenes and derivatives (A1) in all animal/product categories together was 23,575. Similar to the previous years, no non-compliant sample was reported for this group.

Antithyroid agents (A2) were analysed in 10,155 targeted samples of which 64 samples were non-compliant (0.63 %) (64 non-compliant results). All non-compliant samples in the group A2 were for thiouracil. They were found in bovines (n = 50; 0.9 %), pigs (n = 5; 0.16 %) and sheep and goats (n = 9; 3.7 %). Residues of thiouracil resulted most probably from feeding diets rich in cruciferous plants. Pinel et al. (2006) demonstrated that urinary excretion of thiouracil in adult bovines fed with cruciferous plants can give erroneous indications of the possible illegal use of thyrostats in meat production animals.

For steroids (A3), of the 46,378 samples analysed in all animal species and product categories, 53 were non-compliant (0.11 %) (61 non-compliant results). Overall, there were 32 non-compliant results for anabolic steroids and 29 non-compliant results for corticosteroids reported in the group A3. The non-compliant samples were found in bovines (n = 39; 0.13 %), pigs (n = 6; 0.06 %), poultry (n = 6; 0.13 %) and aquaculture (n = 2; 0.57 %). For 26 results of anabolic steroids (80 %), Member States indicated that the source was most likely the endogenous production as reported in previous studies (Clouet et al., 1997; Samuels et al., 1998). No evidence of illegal use was found for other 5 non-compliant results for anabolic steroids.

For resorcyclic acid lactones (A4), of 21,288 samples analysed in all animal species and product categories, 18 were found non-compliant (0.08 %) (19 non-compliant results). All non-compliant samples were in bovines.

Corticosteroids

There are several substances (e.g. dexamethasone, betamethasone and prednisone) legally used in the therapy of food producing animals in the EU. The legal utilisation of corticosteroids, as for any other veterinary medicine, is strictly regulated in the EU, with withdrawal periods given between treatment and slaughtering. Due to their growth promoting effects (increase of appetite and weight gain) corticosteroids might be used in cocktails with other illegal

18

substances in animal feeding. Thus, some Member States include these substances in group A3 (steroids), whereas others allocate them to the group B2f (other pharmacologically active substances). The Member States that include all corticosteroids in group A3 claim that in this way they have more legal action power against illegal use.

Of the total of 39 non-compliant results for corticosteroids in all species (targeted samples), 29 were reported in group A3 and 10 in group B2f. All but one of the 39 non-compliant results were reported in bovines. Italy reported 29 of them. Substances identified were dexamethasone (n = 24), prednisolone (n = 9) and prednisone (n = 6) (Table 2). Important to note that recent studies suggest that prednisolone could be produced endogenously by animals, especially by those found in a state of stress (Pompa et al., 2011; Fidani et al., 2012).

Overview on corticosteroids non-compliant results.

Substance Substance group (a)

Species Number of non-compliant results

Member States reporting non-compliant results

Dexamethasone A3 bovine 16 IT B2f bovine 8 DE, ES, PL

Prednisolone A3 bovine 7 IT B2f bovine 1 BE B2f sheep/goats 1 BE Prednisone A3 bovine 6 IT

(a): as detailed in Appendix E.

Beta-agonists

Beta-agonists (A5) are used therapeutically in human and animal medicine for specific effects on smooth muscle. When misused at higher doses, they can also act as growth promoters by stimulating the increase of the muscular mass and reducing the adipose tissue. Directive 96/22/EC23 prohibits the use of beta-agonists in food producing animals except for well-defined therapeutic purposes and under strict veterinary control. In 2011, 42,541 targeted samples were analysed for beta-agonists and 12 non-compliant samples (0.03 %) were reported (in bovines: eight for clenbuterol, one for clencyclohexerol and two for isoxsuprine; in poultry one for isoxsuprine).

Prohibited substances

This group (A6) includes substances listed in Commission Regulation (EU) No 37/2010 under prohibited substances for which MRLs cannot be established. These substances are not allowed to be administered to food-producing animals. Examples of substances belonging to this group are chloramphenicol, nitrofurans and nitroimidazoles.

23 Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stock farming of certain

substances having a hormonal or thyrostatic action and of beta-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC. OJ, L 125, 29.5.1996, 3-9.

19

In the framework of the 2011 residue monitoring, 73,258 targeted samples were analysed for prohibited substances and 27 samples (0.04 %) were non-compliant (29 non-compliant results). Altogether, there were 12 non-compliant results for chloramphenicol, 15 for nitrofurans and two for nitroimidazoles (Table 3). The distribution of the non-compliant results by individual substances and Member States is presented in Appendix A.

Overview on the non-compliant results for prohibited substances.

Substance Species Number of non-compliant

results

Member States reporting non-

compliant results Chloramphenicol bovine 3 CZ, DE, FR pigs 1 DE poultry 3 CZ, FR, HU aquaculture 1 IT milk 1 ES rabbit 2 FR, IT honey 1 SE Nitrofurans SEM (semicarbazide) bovine 4 IE, IT, PL sheep/goats 4 IE AOZ (3-amino-2-oxazolidone) honey 1 LV AMOZ (5-methylmorpholino-3-amino-2-oxazolidone) bovines 3 IT farmed 1 BE Nitrofurazone pigs 1 ES poultry 1 NL Nitroimidazoles Metronidazole bovines 2 DE

Antibacterials

The group of antibacterials (B1) includes antibiotics (e.g. beta-lactams, tetracyclines, macrolides, aminoglycosides) but also sulphonamides and quinolones.

The total number of analyses carried out in 2011 for antimicrobials in targeted samples was 124,895, of which 242 (0.19 %) were non-compliant (249 non-compliant results) (Table 1). The highest frequency of non-compliant samples for antibacterials was observed in honey (1.0 %) (Figure 2).

It is important to mention that in some Member States there are specific control programmes which use microbiological tests (inhibitor tests). In some cases, a positive result in a microbiological test is sufficient to reject the sample. This may mean that no confirmation by a physico-chemical method is carried out and thus there is no conclusive identification of the substance concerned. In other cases, a positive result in the screening test is confirmed by means of an immunochemical or physico-chemical test and it is then possible to identify the substance and establish whether its concentration is above the MRL or not.

20

Number of targeted samples analysed and percentage of non-compliant samples for antibacterials (B1) in animal/product categories.

In Germany, for instance, there are two different strategies. One is to fulfil the requirements of Directive 96/23/EC. The second strategy is based on national law and means that at least 2 % of all commercially slaughtered calves and 0.5 % of all other commercially slaughtered hoofed animals must be officially sampled and analysed for residues of antimicrobials using inhibitor tests. To finally assess compliance with MRLs, all positive or suspicious results obtained with the inhibitor tests must be confirmed using chemical instrument analyses, as it is also the case with the screening results of tests performed pursuant to Directive 96/23/EC. In 2011, 288,786 samples were analysed in Germany under this scheme (28,163 for bovines, 257,443 for pigs, 2,938 for sheep and goats, 130 for horses, 38 for poultry, 47 for aquaculture, 10 for farmed game and 17 for rabbit meat) giving rise to 709 positive inhibitor tests (162 in bovines, 536 in pigs, six in sheep and goats, three in horses, one in poultry and one in aquaculture). A similar monitoring programme for residues of antibiotic exists in the Netherlands. The control program concerns suspect animals and therefore those results are included in the data on suspect samples (section 4.14).

Other veterinary drugs

The group “other veterinary drugs” (B2) includes a variety of veterinary medicinal products classified according to their pharmacological action in:

• Anthelmintics (B2a) • Anticoccidials (B2b) • Carbamates and pyrethroids (B2c) • Sedatives (B2d) • Non-steroidal anti-inflammatory drugs (NSAIDs) (B2e) and • Other pharmacologically active substances (B2f)

21

In the 2011 monitoring, 90,778 targeted samples were analysed for substances in the group B2 and 106 samples (0.12 %) were non-compliant. The total number of targeted samples analysed for each subgroup in the group B2 and the percentage of non-compliant samples is presented in Figure 3. It is important to note that the frequency of analyses for substances in the B2 subgroups follows a different pattern in each species, depending on their animal specific therapeutic application. For example, in bovines, the anthelmintics, NSAIDs and other pharmacologically active substances (corticosteroids are largely represented in this subgroup) were more frequently analysed than anticoccidials or sedatives. Conversely, in poultry, anticoccidials was the largest subgroup. An overview of the number of samples analysed and the percentage of non-compliant samples for the B2 subgroups in the specific animal/product category is presented in Table 4.

Number of targeted samples analysed within the group “other veterinary drugs” (B2) and the percentage of non-compliant samples.

Regarding the number of samples analysed in each B2 subgroup the highest proportion of non-compliant samples was found for anticoccidials (0.26 %; B2b): 0.22 % in poultry, 0.06 % in pigs, 0.12 % in sheep and goats, 1.1 % in rabbit, 2.5 % in farmed game and 0.72 % in eggs. An important decrease has been observed for the frequency of non-compliant samples for anticoccidials in poultry in 2011 (0.22 % compared to 0.96 % in 2010 and 2.05 % in 2009).

Non-compliant samples for anthelmintics (B2a) were reported in bovines (0.1 %), sheep and goats (0.21 %), poultry (0.03 %) and milk (0.18 %).

There was one non-compliant sample for pyrethroids (B2c) and one for sedatives (B2d).

For non-steroidal anti-inflammatory drugs (B2e), non-compliant samples were reported in bovines (0.15 %), pigs (0.02 %), horses (0.66 %), poultry (0.34 %) and milk (0.09 %).

22

Number of targeted samples analysed for B2 subgroups in different animal categories and the frequency of non-compliant samples (percentage from the total number of samples analysed in each animal category).

Group B2a B2b B2c B2d B2e B2f

n % nc n % nc n % nc n % nc n % nc n % nc

Bovines 4,973 0.10 1,863 0 1,633 0 2,199 0 4,824 0.15 7,849 0.11

Pigs 8,363 0 6,423 0.06 2,626 0 6,688 0.01 5,172 0.02 6,300 0

Sheep/goats 2,800 0.21 846 0.12 1,120 0.09 556 0 441 0 542 0.18

Horses 191 0 61 0 81 0 136 0 456 0.66 170 0

Poultry 3,096 0.03 7,186 0.22 1,632 0 32 0 883 0.34 717 0.14

Aquaculture 690 0 45 0 288 0 8 0 0 0 104 0

Milk 4,985 0.18 375 0 245 0 36 0 3,285 0.09 677 0

Eggs 305 0 3,480 0.72 201 0 7 0 17 0 113 0

Rabbit 175 0 272 1.1 109 0 3 0 66 0 54 1.85

Farmed game 260 0 202 2.5 136 0 7 0 67 0 7 0

Wild game 54 0 5 0 91 0 1 0 2 0 0 0

Honey 8 0 10 0 664 0 0 0 0 0 304 0

n: Number of samples analysed; % nc: Percentage of non-compliant samples.

Non-compliant samples for “other pharmacologically active substances” (B2f) were reported in bovines (0.1 %), sheep and goats (0.18 %), poultry (0.14 %) and rabbits (1.9 %). More details on the number of samples analysed and the non-compliant samples found in each category are given in sections 4.2 to 4.13 and in Appendix A.

Other substances and environmental contaminants

The group “other substances and environmental contaminants" (B3) includes the following subcategories:

• Organochlorine compounds including PCBs (B3a) • Organophosphorus compounds (B3b) • Chemical elements (B3c) • Mycotoxins (B3d) • Dyes (B3e) and • Others (B3f)

In the 2011 residues monitoring, 44,594 samples were analysed for substances in group B3 of which 656 samples were non-compliant (1.5 %) (725 non-compliant results). The total number of targeted samples analysed for each subgroup in group B3 and the percentage of non-compliant samples is presented in Figure 4. Similar to group B2, the frequency of analyses for certain B3 subgroups is highly variable with the targeted animal/product category. While chemical contaminants (B3c) are analysed in all animal/product categories, dyes (B3e) are analysed only in aquaculture products. An overview of the number of samples analysed and the percentage of non-compliant samples for the B3 subgroups in the specific animal group and animal product category is presented in Table 5.

23

The highest percentage of non-compliant samples was found, in almost all species, in the subgroup B3c "chemical elements" (3.4 %). Similar to previous years, cadmium, lead, mercury and copper were the chemical elements frequently identified as responsible for non-compliance.

Instances of non-compliance for organochlorine compounds (B3a) and organophosphorus compounds (B3b) were lower: 0.17 % and 0.03 %, respectively.

For mycotoxins (B3d), there were non-compliant samples for zearalenone and derivatives in bovines (n = 1) and in pigs (n = 8), ochratoxin A in pigs (n = 2), aflatoxin B1 in horses (n = 1) and in milk (n = 1), and aflatoxin M1 in milk (n = 14).

Dyes (B3e) were reported in aquaculture (34 non-compliant samples; 1.8 %). Substances found were malachite green, leuco malachite green, crystal violet and leuco crystal violet. In the subgroup “others” (B3f), only one non-compliant sample was reported in wild game for Cesium-137.

More details on the number of samples analysed and non-compliant samples in each category are given in the sections 4.2 to 4.13 and in Appendix A.

Number of samples analysed within the group “other substances and environmental contaminants” (B3) and the percentage of non-compliant samples.

24

Number of targeted samples analysed for B3 subgroups in different animal and product categories and the frequency of non-compliant samples (percentage from the total number of samples analysed in each animal/product category).

Group B3a B3b B3c B3d B3e B3f

n % nc n %

ncn %

ncn % nc n %

nc n %

nc

Bovines 2,739 0 1,564 0.06 2,840 3.8 1,128 0.09 0 0 391 0

Pigs 4,391 0.09 2,305 0.04 4,324 3.8 1,891 0.53 0 0 933 0

Sheep/goats 997 0 1,031 0 1,074 3.5 228 0 0 0 32 0

Horses 136 0 86 0 696 3.6 60 1.7 0 0 6 0

Poultry 2,680 0.07 605 0 1,978 0.2 753 0 0 0 229 0

Aquaculture 784 0.26 70 0 867 0 223 0 1,932 1.8 175 0

Milk 1,975 0.05 877 0 1,339 0.1 2,013 0.70 0 0 226 0

Eggs 1,784 0.45 214 0 177 0 7 0 0 0 180 0

Rabbit 188 0.53 20 0 196 0 36 0 0 0 10 0

Farmed game 222 0 49 0 320 5.3 43 0 0 0 45 0

Wild game 385 2.1 57 0 2,175 9.0 10 0 0 0 205 0

Honey 711 0.42 656 0 520 2.3 48 0 0 0 172 0n: Number of samples analysed; % nc: Percentage of non-compliant samples.

Multi-year comparison

It is important to note that this analysis is based on data that were partially aggregated. In addition, the number of samples analysed for each substance and animal/product category was not necessarily the same over the five years. Therefore this analysis should be regarded as having a certain degree of uncertainty. The purpose of this exercise was to check whether major variations of the proportion of non-compliant samples occurred at substance group level in the EU. When such variations are noted, a more in-depth analysis of the monitoring plans per species, country and pattern of substances analysed has to be carried out in order to identify the trigger for the differences observed and in consequence to take corrective measures.

An overall picture covering the period 2007 - 2011 (EU 27) is presented in Figure 5. The percentage of overall non-compliant samples in 2011 (0.28 %) was slightly lower compared to the previous four years (0.32 % - 0.34 %).

25

Percentage of non-compliant samples reported in relation to the total number of targeted samples analysed for the respective group in 2007, 2008, 2009, 2010 and 2011 (substance groups are detailed in Appendix E).

Among hormones and prohibited substances (group A) the proportion of non-compliant samples was the lowest in 2011 (0.09 %). However, between 2007 and 2010 the percentage of non-compliant samples in this group accounted for less than 0.2 %. There was no non-compliant sample for stilbenes (A1) in the five years included in the analysis and only a very limited number of non-compliant samples for beta-agonists (A5) (0.005 % - 0.03 %). The percentage of non-compliant samples for antithyroid agents (A2) was slightly higher in 2011 (0.63 %) compared to 2007 - 2010 (0.41 %- 0.47 %). For steroids (A3), the percentage of non-compliant samples was lower in 2011 compared to 2007 - 2010 (0.11 % compared to 0.19 % - 0.39 %). With regard to steroids, it is important to note that some Member States reported corticosteroids in this group (see chapter 4.1.1.1) and thus they have been included in this calculation. The percentage of non-compliant samples reported in 2011 for resorcyclic acid lactones (A4) was similar to the one reported in 2010 (0.08 % - 0.09 %) but lower compared to 2007 - 2009 (0.17 % - 0.23 %). For prohibited substances (A6), the proportion of non-compliant samples remained at very low level over the five years (0.04 % - 0.09 %).

26

In the group of antibacterials (B1), the percentage of non-compliant samples was the lowest in 2011 (0.19 %) compared to the previous four years (0.21 % - 0.29 %).

In the group B2 (other veterinary drugs), the highest percentage of non-compliant samples over the five years was observed for anticoccidials (B2b) (0.26 % - 1.6 %). However, since 2009 an important decrease in the frequency of non-compliant samples for anticoccidials has been recorded. The most notable effect was present in poultry where the frequency of non-compliant samples dropped from 2.05 % in 2009, to 0.96 % in 2010 and to 0.22 % in 2011. This development is most likely the result of the awareness raised by and the measures taken after Commission Directive 2009/8/EC laying down maximum levels of unavoidable carry-over of coccidiostats in non-target feed entered into force.

Proportion of non-compliant samples for anthelmintics (B2a) increased slightly from 0.05 % in 2007 to 0.18 % in 2010, but in 2011 it decreased to 0.08 %. In the groups of non-steroidal anti-inflammatory drugs (B2e) the proportion of non-compliant samples remained relatively constant (around 0.1 % - 0.2 %). For “other pharmacologically active substances" (B2f), the percentage of non-compliant samples decreased from 0.17 % - 0.22 % in the period 2007 – 2010 to 0.07 % in 2011. Non-compliant samples for carbamates and pyrethroids (B2c) were found in only a few isolated cases. Similarly, there was only one non-compliant sample for sedatives (B2d) since 2008.

In the group of “other substances and environmental contaminants” (B3), the percentage of non-compliant samples increased from 1 % in 2007 – 2009 to 1.5 % in 2010 and 2011. The increase was mainly due to the higher proportion of non-compliant samples for chemical elements (B3c) where the non-compliant samples accounted for around 2 % in 2007 and 2008 and for 3.6 % in 2010 and 3.4 % in 2011. This evolution is mainly explained by the practice introduced since 2009 with regard to the legal basis applied for compliance checking for mercury and copper. Commission Regulation (EC) No 1881/2006 specifies maximum limits for mercury only in aquaculture and does not specify any maximum limits for copper in food. Since 2009, the maximum limits laid down in Commission Regulation (EC) No 149/200824 amending Regulation (EC) No 396/2005 are applied to evaluate the compliance for copper and mercury (excepting aquaculture) which led to a substantial higher proportion of non-compliant samples for the two chemical elements. For example, in 2007 and 2008 only 30 and 47 non-compliant samples, respectively, were reported for mercury in all species and product categories whereas in 2010 and 2011 their number reached 269 and 218, respectively. Similarly, no non-compliant sample

24 Commission Regulation (EC) No 149/2008 of 29 January 2008 amending Regulation (EC) No 396/2005 of the

European Parliament and of the Council by establishing Annexes II, III and IV setting maximum residue levels for products covered by Annex I thereto. OJ L 58/1, 1.3.2008, p. 1-398.

27

was reported for copper in 2007, 2008 and 2009 but after applying the new legal provision in 2010 and 2011 there were 73 and, respectively, 67 non-compliant samples for copper.

Non-compliant samples in the groups of organochlorine compounds (B3a), mycotoxins (B3d) and “other substances” (B3f) represented about 0.1 % - 0.5 % of the total number of samples analysed in each year. For organophosphorus compounds (B3b), the number of non-compliant samples remained very low over the five years (zero to three samples per year). The proportion of non-compliant samples for dyes (B3e) remained relatively constant over the five years (1.5 – 2.2 %).

Taking into account the limitations mentioned at the beginning of this section, it appears that the frequency of non-compliant samples for steroids (A3), resorcyclic acid lactones (A4), prohibited substances (A6), antibacterials (B1) and anticoccidials (B2b) was lower in 2011 compared to the previous years whereas the proportion of non-compliant samples for chemical elements (B3c; mainly metals) was similar to 2010 and higher compared to 2007, 2008 and 2009. For the other substance groups, apparently there were no notable variations over the five years (see also EC, 2007; EFSA, 2010b; EFSA, 2011; EFSA, 2012).

Bovines

Council Directive 96/23/EC requires that the minimum number of bovine animals to be controlled each year for all kinds of residues and substances is 0.4 % of the bovine animals slaughtered the previous year. The minimum requirements for the number of samples were fulfilled in 2011 for the EU overall, and by the vast majority of the Member States (Table 6). Only Greece did not achieve the minimum required. The percentage of targeted samples taken in each Member State for the reported production of bovines is presented in Table 7.

Production of bovines and number of targeted samples over 2007-2011.

Year Production (animals)

Targeted samples

% Animals tested(a)

Minimum 96/23/EC

2007 (EU 27) 27,087,367 129,201 0.47 2008 (EU 27) 26,898,702 122,648 0.48 2009 (EU 27) 26,677,946 127,897 0.48 0.42010 (EU 27) 26,267,917 128,130 0.48 2011 (EU 27) 26,566,593 126,540 0.48

(a): in relation to the production of the previous year.

The distribution of samples analysed, non-compliant samples and non-compliant results in bovines are presented in Table 8. Of the 126,540 samples analysed in this category 330 (0.26 %) were non-compliant (353 non-compliant results). The non-compliant samples were reported by 18 Member States.

Production volume and number of targeted samples collected in bovines.

28

Country Production 2010

(animals)

Number of

samples 2011

Animals tested

(%)


(animals)

Number of

samples 2011

Animals tested

(%)

Austria 702,333 3,955 0.56 Latvia 97,151 389 0.40Belgium 799,256 4,675 0.58 Lithuania 178,705 955 0.53Bulgaria 17,324 172 0.99 Luxemburg 25,803 106 0.41Cyprus 16,442 739 4.49 Malta 5,691 64 1.12Czech Republic 279,164 1,392 0.50 Netherlands 2,042,000 14,898 0.73Denmark 496,500 1,998 0.40 Poland 1,612,417 6,622 0.41Estonia 46,934 189 0.40 Portugal 446,082 1,883 0.42Finland 267,828 1,272 0.47 Romania 140,319 547 0.39France 4,961,750 20,160 0.41 Slovakia 69,717 297 0.43Germany 3,775,142 14,652 0.39 Slovenia 117,242 525 0.45Greece 242,858 785 0.32 Spain 2,326,661 10,762 0.46Hungary 101,409 553 0.55 Sweden 425,967 2029 0.48Ireland 1,714,465 7,955 0.46 United 2,517,513 11,423 0.45Italy 2,841,244 17,543 0.62 Total (EU 26,267,9 126,540 0.48

No non-compliant samples were reported for the group A1. In the group A2, three Member States reported a total of 50 non-compliant samples, all for thiouracil. In the group A3, five Member States reported a total of 39 non-compliant samples (46 non-compliant results) of which nine for 17-beta testosteron, four for boldenone-alpha and 35 for corticosteroids. Together with the results for corticosteroids reported in the group B2f, there were 38 non-compliant samples for corticosteroids in bovine animals. In the group A4, two Member States reported 18 non-compliant samples (19 non-compliant results) for alpha and beta-zearalanol. Beta-agonists (A5) determined 11 non-compliances (eight for clenbuterol, two for isoxsuprine and one for clencyclohexerol). Prohibited substances (A6) were found in eight samples. Substances identified were: chloramphenicol, semicarbazide and AMOZ.

For antibacterials (B1), 11 Member States reported a total of 74 non-compliant samples (77 non-compliant results). Among the substances identified, oxytetracycline was the most frequent one (20 non-compliant samples).

In the group B2, non-compliant samples were reported for ivermectin, (n = 4; B2a), triclabendazole (n = 1; B2a), non-steroidal (n = 7; B2e) and steroidal (n = 9; B2f) anti-inflammatory drugs.

29

Number of samples analysed, non-compliant samples and non-compliant results in bovines.

Samples analysed Non-compliant samples Non-compliant results

Substance group (a)

n(b) % n(c) % n(d)

A 78,206 62 126 0.16 136A1 11,980 9.5 0 0 0A2 5,539 4.4 50 0.90 50A3 29,201 23 39 0.13 46A4 11,311 8.9 18 0.16 19A5 22,944 18 11 0.05 11A6 15,390 12 8 0.05 10

B 53,283 42 204 0.38 217B1 24,562 19 74 0.30 77B2 22,439 18 21 0.09 22

B2a 4,973 3.9 5 0.10 5B2b 1,863 1.5 0 0 0B2c 1,633 1.3 0 0 0B2d 2,199 1.7 0 0 0B2e 4,824 3.8 7 0.15 8B2f 7,849 6.2 9 0.11 9

B3 6,973 5.5 109 1.56 118B3a 2,739 2.2 0 0 0B3b 1,564 1.2 1 0.06 1B3c 2,840 2.2 107 3.8 114B3d 1,128 0.9 1 0.09 3B3e 0 0 0 0 0B3f 391 0.31 0 0 0

Total 126,540 100 330 0.26 353(a): as detailed in Appendix E; (b): number of samples analysed for one or more substances of the respective group; (c): number of non-compliant samples for one or more substances in the respective group; (d): number of non-compliant results; one sample can be non-compliant for more substances therefore the number of non-compliant results can be higher than the number of non-compliant samples of the same group.

In the group B3, there was one non-compliant sample for chlorpyrifos (B3b), 107 non-compliant samples for heavy metals (B3c) and one non-compliant sample for zearalenone and derivatives. Within the 107 samples non-compliant for heavy metals (114 non-compliant results) there were 52 non-compliant results for cadmium, 32 for mercury, 29 for copper and one for lead.

A detailed presentation on the specific substances identified and the number of non-compliant results reported by each Member State is given in Appendix A.

Pigs

Council Directive 96/23/EC requires that the minimum number of pigs that have to be controlled each year for all kinds of residues and substances is 0.05 % of the pigs slaughtered the previous year. The minimum requirements for the number of samples to be taken were fulfilled in 2011 for the EU overall, and by the vast majority of the Member States (Table 9). Only Greece did not achieve

30

the minimum required. The percentage of targeted samples taken in each Member State for the reported pig production is presented in Table 10.

The distribution of samples analysed, non-compliant samples and non-compliant results in pigs are presented in Table 11. Of the 133,255 samples analysed in this category, 268 (0.2 %) were non-compliant (309 non-compliant results). The non-compliant samples were reported by 19 Member States.

Production of pigs and number of targeted samples over 2007-2011.


Targeted samples

% Animals tested(a)

Minimum 96/23/EC

2007 (EU 27) 241,501,638 144,378 0.06 2008 (EU 27) 244,965,996 137,281 0.06 2009 (EU 27) 242,260,526 138,137 0.06 0.052010 (EU 27) 245,149,546 136,792 0.06 2011 (EU 27) 249,082,904 133,255 0.05


There were no non-compliant samples in the group A1. In the group A2, three Member States reported a total of five non-compliant samples, all for thiouracil. In the group A3, two Member States reported six non-compliant samples (four for nandrolone and two for 18-beta-nortestosteron). Prohibited substances (A6) were found in two samples: one for chloramphenicol and one for nitrofurazone.

Production volume and number of targeted samples collected in pigs.


(animals)

Number of

samples 2011

Animals tested

(%)


(animals)

Number of

samples 2011

Animals tested

(%)

Austria 5,577,579 3,365 0.06 Latvia 316,415 173 0.05Belgium 11,677,88 6,162 0.05 Lithuania 721,075 609 0.08Bulgaria 497,577 439 0.09 Luxemburg 134,417 77 0.06Cyprus 734,064 3,703 0.50 Malta 85,228 68 0.08Czech Republic 3,190,806 1,893 0.06 Netherlands 13,920,00 8,375 0.06Denmark 20,228,16 10,360 0.05 Poland 19,710,69 10,314 0.05Estonia 407,710 204 0.05 Portugal 4,629,297 2,484 0.05Finland 2,328,048 1,406 0.06 Romania 2,976,071 1,352 0.05France 24,907,76 12,710 0.05 Slovakia 938,141 448 0.05Germany 57,765,44 29,115 0.05 Slovenia 292,325 171 0.06Greece 1,804,625 732 0.04 Spain 39,645,66 19,625 0.05Hungary 4,614,263 2,351 0.05 Sweden 2,946,350 1,583 0.05Ireland 2,586,303 2,640 0.10 United 8,919,870 4,513 0.05Italy 13,593,77 8,383 0.06 Total (EU 245,149, 133,255 0.05

For antibacterials (B1), 18 Member States reported a total of 69 non-compliant samples (70 non-compliant results). The most frequent substances reported were: doxycycline (n = 10), dihydrostreptomycin (n = 9) and oxytetracycline (n = 9).

In the group B2, five Member States reported six non-compliant samples. They were distributed as follows: four for anticoccidials (B2a), one for sedatives (B2d)

31

and one for NSAIDs (B2e). There were no non-compliant samples for the groups B2a, B2c and B2f.

In the group B3, there were 180 non-compliant samples (220 non-compliant results). The non-compliant results were distributed as follows: four for organochlorine compounds (B3a), one for organophosphorus compounds (B3b), 189 for heavy metals (B3c) and 24 for zearalenone and alpha and beta zearalenol and two for ochratoxin A (B3d). Of the 189 non-compliant results for heavy metals, 124 were reported by one Member State as non-compliant for mercury.

The specific substances identified and the number of non-compliant results reported by each Member State are presented in Appendix A.

Number of targeted samples analysed, non-compliant samples and non-compliant results in pigs.

Samples analysed Non-compliant samples

Non-compliant results

Substance group (a)

n(b) % n(c) % n(d)

A 54,476 41 13 0.02 13A1 7,626 5.7 0 0 0A2 3,188 2.4 5 0.16 5A3 10,623 8.0 6 0.06 6A4 6,083 4.6 0 0 0A5 11,621 8.7 0 0 0A6 23,788 18 2 0.01 2

B 88,934 67 255 0.29 296B1 46,507 35 69 0.15 70B2 33,251 25 6 0.02 6

B2a 8,363 6.3 0 0 0B2b 6,423 4.8 4 0.06 4B2c 2,626 2.0 0 0 0B2d 6,688 5.0 1 0.01 1B2e 5,172 3.9 1 0.02 1B2f 6,300 4.7 0 0 0

B3 11,235 8.4 180 1.6 220B3a 4,391 3.3 4 0.09 4B3b 2,305 1.7 1 0.04 1B3c 4,324 3.2 165 3.8 189B3d 1,891 1.4 10 0.53 26B3e 0 0 0 0 0B3f 933 0.7 0 0 0


Sheep and goats

Council Directive 96/23/EC requires that the minimum number of sheep and goats that have to be controlled each year for all kinds of residues and substances is 0.05 % of the sheep and goats slaughtered the previous year. The

32

minimum requirements for the number of samples were fulfilled in 2011 for the EU overall (Table 12), and by the vast majority of the Member States (Table 13). Greece and Romania did not achieve the minimum sampling frequency for sheep and goats.

Production of sheep and goats and number of targeted samples over 2007-2011.


Targeted samples

% Animals tested(a)

Minimum 96/23/EC

2007 (EU 27) 40,935,665 26,599 0.06 2008 (EU 27) 41,435,268 24,320 0.06 2009 (EU 27) 39,584,954 26,265 0.06 0.052010 (EU 27) 36,121,283 23,894 0.06 2011 (EU 27) 37,217,484 23,112 0.06


Of the 23,112 samples analysed in this category 97 (0.42 %) were non-compliant (100 non-compliant results). The non-compliant samples were reported by 15 Member States. There were no non-compliant samples for the group A1, A3, A4 and A5. In the group A2, two Member States reported nine non-compliant samples, all for thiouracil. In the group A6, one Member State reported four non-compliant samples for semicarbazide.

Production volume and number of targeted samples collected in sheep and goats.


(animals)

Number of

samples 2011

Animals tested

(%)


(animals)

Number of

samples 2011

Animals tested

(%)

Austria 127,354 376 0.30 Latvia 9,317 19 0.20Belgium 141,214 245 0.17 Lithuania 4,990 18 0.36Bulgaria 176,021 114 0.06 Luxemburg 4,602 14 0.30Cyprus 253,330 1,212 0.48 Malta 3,959 18 0.45Czech Republic 11,074 58 0.52 Netherlands 702,500 400 0.06Denmark 87,965 49 0.06 Poland 22,503 100 0.44Estonia 5,846 3 0.05 Portugal 1,077,000 544 0.05Finland 33,555 44 0.13 Romania 403,131 90 0.02France 4,585,34 2,572 0.06 Slovakia 117,664 97 0.08Germany 985,027 566 0.06 Slovenia 9,616 33 0.34Greece 1,329,06 600 0.04 Spain 8,381,543 5,671 0.07Hungary 15,363 73 0.48 Sweden 254,630 119 0.05Ireland 2,463,57 1,898 0.08 United 14,285,06 7,204 0.05Italy 630,029 975 0.15 Total (EU 36,121,2 23,112 0.06

The distribution of samples analysed, non-compliant samples and non-compliant results in sheep and goats is presented in Table 14.

33

Number of targeted samples analysed, non-compliant samples and non-compliant results in sheep and goats.



Substance group (a)

n(b) % n(c) % n(d)

A 4,964 21 13 0.26 13A1 400 1.7 0 0 0A2 246 1.1 9 3.7 9A3 1,141 4.9 0 0 0A4 447 1.9 0 0 0A5 1,301 5.6 0 0 0A6 1,925 8.3 4 0.21 4

B 18,508 80 84 0.45 87B1 9,303 40 37 0.40 39B2 6,250 27 9 0.14 10

B2a 2,800 12 6 0.21 7B2b 846 3.7 1 0.12 1B2c 1,120 4.8 1 0.09 1B2d 556 2.4 0 0 0B2e 441 1.9 0 0 0B2f 542 2.3 1 0.18 1

B3 3,031 13 38 1.25 38B3a 997 4.3 0 0 0B3b 1,031 4.5 0 0 0B3c 1,074 4.6 38 3.5 38B3d 228 1.0 0 0 0B3e 0 0 0 0 0B3f 32 0.14 0 0 0


For antibacterials (B1), seven Member States reported a total of 37 non-compliant samples (39 non-compliant results). Sulfamides were the most frequent substances reported (n = 22).

In the group B2, three Member States reported nine non-compliant samples (10 non-compliant results: seven for anthelmintics (B2a), one for anticoccidials (B2b), one for pyrethroids (B2c) and one for corticosteroids (B2f)). There were no non-compliant samples in the groups B2d and B2e.

In the group B3, there were 38 non-compliant samples (38 non-compliant results), all from the subgroup B3c – heavy metals: 26 for cadmium, seven for mercury and five for lead.


34

Horses

For horses, Council Directive 96/23/EC requires that the number of samples is to be determined by each Member State in relation to the identified problem. The number of targeted samples taken in 2011 at EU level was similar to previous years (Table 15). The percentage of targeted samples taken in each Member State for the reported horse production is presented in Table 16. Estonia, Greece, Luxembourg and Slovakia did not report horse production and thus no samples have been taken.

Production of horses and number of targeted samples over 2007-2011.


Targeted samples

% Animals tested(a) Minimum 96/23/EC

2007 (EU 27) 312,969 3,115 1.162008 (EU 27) 386,302 2,545 0.812009 (EU 27) 264,538 3,000 0.78 Not specified2010 (EU 27) 258,362 3,094 1.172011 (EU 27) 249,403 3,309 1.28


The distribution of samples analysed, non-compliant samples and non-compliant results in horses is presented in Table 16.

Production volume and number of targeted samples collected for horses.


(animals)

Number of

samples 2011

Animals tested

(%)


(animals)

Number of

samples 2011

Animals tested

(%)

Austria 947 67 7.1 Latvia 400 22 5.5Belgium 12,000 336 2.8 Lithuania 2,250 18 0.8Bulgaria 214 40 19 Luxemburg 0 0 NACyprus 6,800 0 0 Malta 173 1 0.58Czech 336 23 6.9 Netherlands 2,083 99 4.8Denmark 1,872 45 2.4 Poland 45,152 371 0.82Estonia 0 0 NA Portugal 907 57 6.3Finland 1,179 51 4.3 Romania 27,520 51 0.19France 15,468 384 2.5 Slovakia 0 0 NAGermany 8,937 119 1.3 Slovenia 1,578 32 2.0Greece 0 0 NA Spain 29,638 279 0.94Hungary 394 39 9.9 Sweden 3,940 234 5.9Ireland 7,449 288 3.9 United 5,062 102 2.0Italy 84,063 651 0.77 Total (EU 258,362 3,309 1.28

NA: not applicable

Of the 3,309 samples analysed in this category 29 samples (0.88 %) were non-compliant (36 non-compliant results). The non-compliant samples were reported by 10 Member States. No non-compliant sample was reported for the groups A and B1.

In the group B2, two Member States reported three non-compliant samples for NSAIDs (B2e).

35

In the group B3, there were 26 non-compliant samples giving 33 non-compliant results: 32 for heavy metals (25 for cadmium, six for mercury and one for lead) and one for aflatoxin B1.


Number of targeted samples analysed, non-compliant samples and non-compliant results in horses.



Substance group (a)

n(b) % n(c) % n(d)

A 769 23 0 0 0A1 70 2.1 0 0 0A2 42 1.3 0 0 0A3 160 4.8 0 0 0A4 77 2.3 0 0 0A5 192 5.8 0 0 0A6 260 7.9 0 0 0

B 2,583 78 29 1.1 36B1 583 18 0 0 0B2 1,073 32 3 0.28 3

B2a 191 5.8 0 0 0B2b 61 1.8 0 0 0B2c 81 2.4 0 0 0B2d 136 4.1 0 0 0B2e 456 14 3 0.66 3B2f 170 5.1 0 0 0

B3 946 29 26 2.8 33B3a 136 4.1 0 0 0B3b 86 2.6 0 0 0B3c 696 21 25 3.6 32B3d 60 1.8 1 1.7 1B3e 0 0 0 0 0B3f 6 0.18 0 0 0


Poultry

According to Directive 96/23/EC, the minimum number of samples for each category of poultry must be one per 200 t of annual production, with a minimum of 100 samples for each group of substances where annual production in the category concerned is over 5,000 t. The minimum requirement of one sample analysed per 200 t production was achieved for the EU overall (Table 18).

Percentage of targeted samples taken in each Member State for the reported production of poultry is given in Table 19. Member States which did not achieve this requirement were Greece and Slovakia. Luxembourg did not report poultry production for 2010 and in consequence no samples were taken in 2011. The

36

distribution of samples analysed, non-compliant samples and non-compliant results in poultry are presented in Table 20.

Production of poultry and number of targeted samples over 2007-2011.

Year Production (t) Targeted samples

% Samples tested/ 200 t tested(a)

Minimum 96/23/EC

2007 (EU 27) 10,912,500 62,101 1.15 2008 (EU 27) 12,421,566 60,406 1.11 2009 (EU 27) 11,383,434 61,989 1.00 1/200 t2010 (EU 27) 11,804,262 61,259 1.08 2011 (EU 27) 12,417,108 65,942 1.12


Production volume and number of targeted samples collected for poultry.

Country Production 2010 (t)

Number of

samples 2011

Samples tested/

200 t


Number of

samples 2011

Samples tested/

200 t

Austria 102,812 857 1.7 Latvia 23,200 200 1.7Belgium 382,045 2,321 1.2 Lithuania 61,810 310 1.0Bulgaria 74,204 521 1.4 Luxemburg 0 0 NACyprus 22,346 1,481 13 Malta 4,398 215 9.8Czech Republic 176,275 889 1.0 Netherlands 800,505 4,357 1.1Denmark 155,619 810 1.0 Poland 1,236,608 6,335 1.0Estonia 12,966 200 3.1 Portugal 290,302 1,877 1.3Finland 94,248 622 1.3 Romania 344,096 1,575 0.9France 1,652,235 8,321 1.0 Slovakia 75,751 237 0.6Germany 1,353,468 8,367 1.2 Slovenia 53,266 328 1.2Greece 186,581 449 0.5 Spain 1,281,454 6,884 1.1Hungary 476,245 3,167 1.3 Sweden 119,080 605 1.0Ireland 143,280 1,091 1.5 United 1,484,168 7,580 1.0Italy 1,197,300 6,343 1.1 Total (EU 11,804,2 65,942 1.12

NA: not applicable

Of the 65,942 samples analysed in this category 52 (0.08 %) were non-compliant (54 non-compliant results). The non-compliant samples were reported by 16 Member States. No non-compliant samples were reported in the groups A1, A2 and A4. In the group A3, one Member State reported six non-compliant samples for 17-beta-estradiol. In A5, one non-compliant sample was reported for isoxsuprine. Prohibited substances (A6) were reported by five Member States. They included chloramphenicol (n = 3), metronidazole (n = 2) and nitrofurazone (n = 1).

For antibacterials (B1), six Member States reported a total of 13 non-compliant samples (14 non-compliant results). Similar to previous year, the most frequent substance reported was doxycycline (n = 7).

In the group B2, the highest number of non-compliant samples reported was for anticoccidials (B2b): 16 samples from six Member States. The number of non-compliant samples for anticoccidials was much lower compared to 2010 where 13 Member States reported 73 non-compliant samples. Other non-compliant results

37

reported in the group B2 were for anthelmintics (B2a) (n = 1), non-steroidal anti-inflammatory drugs (B2e) (n = 3) and other pharmacologically active substances (B2f) (n = 1). No non-compliant samples were reported in the groups B2c and B2d.

In the group B3, there were three non-compliant samples for heavy metals (B3c).


Number of targeted samples analysed, non-compliant samples and non-compliant results in poultry.



Substance group (a)

n(b) % n(c) % n(d)

A 32,843 50 13 0.04 13A1 3,141 4.8 0 0 0A2 1,067 1.6 0 0 0A3 4,670 7.1 6 0.13 6A4 3,155 4.8 0 0 0A5 5,954 9.0 1 0.02 1A6 18,251 28 6 0.03 6

B 35,719 54 39 0.11 41B1 17,987 27 13 0.07 14B2 13,274 20 21 0.16 21

B2a 3,096 4.7 1 0.03 1B2b 7,186 11 16 0.22 16B2c 1,632 2.5 0 0 0B2d 32 0.05 0 0 0B2e 883 1.3 3 0.34 3B2f 717 1.1 1 0.14 1

B3 5,252 8.0 5 0.10 6B3a 2,680 4.1 2 0.07 3B3b 605 0.92 0 0 0B3c 1,978 3.0 3 0.15 3B3d 753 1.1 0 0 0B3e 0 0 0 0 0B3f 229 0.3 0 0 0


Aquaculture

Directive 96/23/EC specifies that the minimum number of samples to be collected each year must be at least one per 100 t of annual production. The minimum requirements for the number of samples to be taken were fulfilled in 2011 for the EU overall (Table 21) and by the vast majority of Member States. The production volume and the number of samples analysed in each Member State are given in Table 22. Only Greece did not analyse at least one sample/100

38

t of production. Luxembourg did not report aquaculture production and consequently no samples were taken.

The distribution of samples analysed, non-compliant samples and non-compliant results in aquaculture are presented in Table 23.

Production of aquaculture and number of targeted samples over 2007-2011.


% Samples tested/ 100 t(a)

Minimum 96/23/EC

2007 (EU 27) 602,555 9,257 1.5 2008 (EU 27) 644,875 8,751 1.4 2009 (EU 27) 627,109 8,606 1.3 1/100 t2010 (EU 27) 622,032 8,668 1.4 2011 (EU 27) 655,772 8,241 1.3

(a): related to the production of the previous year.

Of the 8,241 samples analysed for aquaculture 45 samples (0.55 %) were non-compliant (49 non-compliant results). The non-compliant samples were reported by 10 Member States. In the group A, there were three non-compliant samples for boldenone (A3) and one for chloramphenicol (A6). There were no non-compliant samples for the groups A1, A2, A4 and A5. For antibacterials (B1), five Member States reported six non-compliant samples.

Production volume and number of targeted samples collected for aquaculture.


Number of

samples 2011

Samples tested/

100 t


Number of

samples 2011

Samples tested/

100 t

Austria 2,919 222 7.6 Latvia 502 12 2.4Belgium 3,000 166 5.5 Lithuania 3,216 41 1.3Bulgaria 4,013 373 9.3 Luxemburg 0 0 NACyprus 4,070 463 11.4 Malta 2,900 29 1.0Czech 20,100 275 1.4 Netherlands 7,000 99 1.4Denmark 36,000 363 1.0 Poland 34,000 604 1.8Estonia 655 15 2.3 Portugal 4,074 42 1.0Finland 13,627 182 1.3 Romania 5,249 71 1.4France 42,104 742 1.8 Slovakia 686 37 5.4Germany 36,772 550 1.5 Slovenia 1,307 27 2.1Greece 98,504 657 0.7 Spain 49,911 554 1.1Hungary 9,685 163 1.7 Sweden 10,000 106 1.1Ireland 13,584 140 1.0 United 152,554 1,527 1.0Italy 65,600 781 1.2 Total (EU 27) 622,032 8,241 1.3

NA: not applicable.

39

Number of targeted samples analysed, non-compliant samples and non-compliant results in aquaculture.



Substance group (a)

n(b) % n(c) % n(d)

A 2,304 28 3 0.13 4A1 229 2.8 0 0 0A2 2 0.0 0 0 0A3 349 4.2 2 0.57 3A4 87 1.1 0 0 0A5 87 1.1 0 0 0A6 1,677 20 1 0.06 1

B 6,177 75 42 0.68 45B1 1,730 21 6 0.35 6B2 951 12 0 0 0

B2a 690 8.4 0 0 0B2b 45 0.5 0 0 0B2c 288 3.5 0 0 0B2d 8 0.1 0 0 0B2e 0 0 0 0 0B2f 104 1.3 0 0 0

B3 3,774 46 36 0.95 39B3a 784 9.5 2 0.26 2B3b 70 0.8 0 0 0B3c 867 11 0 0 0B3d 223 2.7 0 0 0B3e 1,932 23 34 1.8 37B3f 175 2.1 0 0 0


There were no non-compliant samples in any of the B2 subgroups. No monitoring is required for substances in the groups B2d (sedatives) and B2e (non-steroidal anti-inflammatory drugs) in aquaculture (Annex II to Council Directive 96/23/EC).

In the group B3, 36 samples proved to be non-compliant (39 non-compliant results). The non-compliant results were distributed as follows: two for PCBs (B3a) and 37 for dyes (malachite green, leuco-malachite green, crystal violet and leuco-crystal violet (B3d). It is evident that with 1.8 % non-compliant samples in group B3e, residues of dyes are the most frequently found residues in aquaculture.


40

Milk

Commission Decision 97/747/EC lays down that the annual number of samples taken should be one per 15,000 t of annual milk production, with a minimum of 300 samples. The minimum requirements for the number of samples to be taken were fulfilled in 2011 by all Member States (Table 24). The production volume and the number of samples analysed in each Member State are given in Table 25.

Production of milk and number of targeted samples over 2007-2011.


Samples tested/ 15 000 t (a)

Minimum 96/23/EC

2007 (EU 27) 142,461,705 51,571 5.3 2008 (EU 27) 145,006,173 53,333 5.6 2009 (EU 27) 141,669,974 54,063 5.6 1/15 000 t2010 (EU 27) 144,705,166 30,372 3.2 2011 (EU 27) 143,022,677 29,592 3.1


The distribution of samples analysed, non-compliant samples and non-compliant results in milk and the number of Member States reporting non-compliant results is presented in Table 26.

Of the 29,592 milk samples analysed 43 (0.15 %) were non-compliant (44 non-compliant results). The non-compliant samples were reported by 14 Member States. In the group A, there was only one non-compliant sample for chloramphenicol (A6). According to Annex II to Council Directive 96/23/EC there is no requirement for residue monitoring of the substances in groups A1, A2, A3, A4 and A5 in milk.

For antibacterials (B1), six Member States reported a total of 14 non-compliant samples (14 non-compliant results) of which eight were found by applying inhibitor tests, two for benzylpenicillin, two for tetracycline, one for doxycyclin and one for cefoperazon.

In the group B2, there were nine non-compliant samples (10 non-compliant results) for anthelmintics (B2a) and three for non-steroidal anti-inflammatory drugs (B2e). In the group B3, there were 16 non-compliant samples (16 non-compliant results) distributed as follows: one for organochlorine compounds (B3a), one for heavy metals (B3c), one for aflatoxin B1 and 13 for aflatoxin M1 (B3d). The 14 non-compliant results for aflatoxin B1 or M1 were reported by four Member States.

More information on the specific substances identified and the number of non-compliant results reported by each Member State is given in Appendix A.

Production volume and number of targeted samples collected for milk.


Number of

samples 2011

Samplestested/

15 000 t


Number of

samples 2011

Samples tested/

15 000 t

41

Austria 3,256,926 342 1.6 Latvia 831,500 723 13Belgium 3,070,000 642 3.1 Lithuania 1,278,130 1,157 14Bulgaria 454,253 1107 37 Luxemburg 281,000 305 16Cyprus 151,000 4244 422 Malta 44,862 520 174Czech Republic 2,620,000 396 2.3 Netherlands 11,635,000 1,455 1.9Denmark 4,500,000 307 1.0 Poland 12,083,000 2,649 3.3Estonia 671,000 300 6.7 Portugal 2,021,686 1,075 8.0Finland 2,268,200 308 2.0 Romania 1,015,416 298 4France 24,416,252 1960 1.2 Slovakia 957,327 392 6.1Germany 28,248,005 1837 1.0 Slovenia 428,806 335 12Greece 1,890,649 786 6.2 Spain 7,164,233 1201 2.5Hungary 1,169,142 626 8.0 Sweden 2,863,000 300 1.6Ireland 5,038,465 1211 3.6 United 15,441,553 3,245 3.2Italy 10,905,761 1871 2.6 Total (EU 144,705,16 29,592 3.1

Number of targeted samples analysed, non-compliant samples and non-compliant results in milk.



Substance group (a)

n(b) % n(c) % n(d)

A 6,672 23 1 0.01 1A1 0 0 0 0 0A2 0 0 0 0 0A3 64 0.22 0 0 0A4 0 0 0 0 0A5 154 0.5 0 0 0A6 6,707 22.7 1 0.01 1

B 25,343 86 42 0.17 43B1 15,471 52 14 0.09 14B2 7,215 24 12 0.17 13

B2a 4,985 17 9 0.18 10B2b 375 1.3 0 0 0B2c 245 0.83 0 0 0B2d 36 0.12 0 0 0B2e 3,285 11 3 0.09 3B2f 677 2.3 0 0 0

B3 5,916 20 16 0.27 16B3a 1,975 6.7 1 0.05 1B3b 877 3.0 0 0 0B3c 1,339 4.5 1 0.07 1B3d 2,013 6.8 14 0.70 14B3e 0 0 0 0 0B3f 226 0.8 0 0 0


Eggs

The number of samples to be taken each year must be at least equal to one per 1,000 t of annual egg production, with a minimum of 200 samples. This

42

requirement was fulfilled at the EU level (Table 27) and by all Member States (Table 28).

The distribution of samples analysed, non-compliant samples and non-compliant results in eggs is presented in Table 29.

Of the 12,248 egg samples analysed, 38 (0.31 %) were non-compliant (41 non-compliant results). The non-compliant samples were reported by 12 Member States.

Directive 96/23/EC, Annex II requires Member States to monitor in the group A only the residues of prohibited substances (A6). Although 3,451 samples were analysed for one ore more substances in this group (3,489 analyses), no non-compliant sample was reported.

Production of eggs and number of targeted samples over 2007-2011.

Year Production (t)

Targeted samples

Samples tested/1000 t (a)

Minimum 96/23/EC

2007 (EU 27) 6,114,369 13,685 2.32008 (EU 27) 6,021,476 10,859 1.82009 (EU 27) 6,137,732 13,031 2.2 1/1000 t2010 (EU 27) 6,101,039 12,715 2.12011 (EU 27) 6,136,691 12,248 2.0


For antibacterials (B1), five non-compliant samples were reported by three Member States. Substances found were: enrofloxacin (n = 2), flumequine (n = 2) and doxycycline (n = 1).

In the group B2, 25 non-compliant samples were found (25 non-compliant results) for anticoccidials (B2b) representing 0.72 % of the total samples analysed for this substance group.

In the group B3, eight non-compliant samples (11 non-compliant results) were reported for dioxins and PCBs (B3a) by three Member States.

43

Production volume and number of targeted samples collected for eggs.


Number of

samples 2011

Samples tested/1000 t


Number of

samples 2011

Samples tested/1000 t

Austria 91,911 221 2.4 Latvia 40,884 480 12Belgium 153,600 252 1.6 Lithuania 48,675 200 4.1Bulgaria 26,909 434 16.1 Luxemburg 1,300 200 154Cyprus 7,313 423 58 Malta 3,553 203 57Czech 123,563 256 2.1 Netherlands 607,200 1,233 2.0Denmark 56,005 204 3.6 Poland 510,000 702 1.4Estonia 10,916 200 18 Portugal 88,975 483 5.4Finland 61,500 200 3.3 Romania 84,650 159 2France 963,200 984 1.0 Slovakia 59,000 203 3.4Germany 627,294 673 1.1 Slovenia 25,221 215 8.5Greece 99,800 122 1.2 Spain 823,276 927 1.1Hungary 85,223 308 3.6 Sweden 112,800 200 1.8Ireland 37,370 283 7.6 United 526,601 1273 2.4Italy 824,300 1,210 1.5 Total (EU 27) 6,101,03 12,248 2.0

More details on the specific substances identified and the number of non-compliant results reported by each Member State are given in Appendix A.

Number of targeted samples analysed, non-compliant samples and non-compliant results in eggs.



Substance group (a)

n(b) % n(c) % n(d)

A 3,451 28 0 0 0A1 0 0 0 0 0A2 0 0 0 0 0A3 0 0 0 0 0A4 0 0 0 0 0A5 0 0 0 0 0A6 3,489 29 0 0 0

B 9,704 79 38 0.39 41B1 4,304 35 5 0.12 5B2 4,072 33 25 0.61 25

B2a 305 2.5 0 0 0B2b 3,480 28 25 0.72 25B2c 201 1.6 0 0 0B2d 7 0.06 0 0 0B2e 17 0.14 0 0 0B2f 113 0.92 0 0 0

B3 2,161 18 8 0.37 11B3a 1,784 15 8 0.45 11B3b 214 1.7 0 0 0

B3c 177 1.4 0 0 0

44

B3d 7 0.06 0 0 0B3e 0 0 0 0 0B3f 180 1.5 0 0 0


Rabbit meat

The number of samples to be taken each year must be equal to 10 per 300 t of annual production (dead weight) for the first 3,000 t, plus one sample for each additional 300 t. The rate between the total targeted samples reported and the minimum number of samples that should be collected for the reported production, as specified in Commission Decision 97/147/EC, was calculated.

Production of rabbit meat and number of targeted samples over 2007-2011.


2007 (EU 27) 189,932 4,4802008 (EU 27) 187,389 3,6252009 (EU 27) 199,655 3,6912010 (EU 27) 172,353 3,8852011 (EU 27) 176,315 3,737

To calculate the total number of samples that should be collected, two different equations were applied depending on the production volume, as follows:

a) For countries with production above 3000 t Total samples required = {(10/300x3000) + [(Production reported in tonnes -3000) x (1/300)]}

b) For countries with production below 3000 t Total samples required = Production reported in t x (10/300)

Countries with a rate equal to one or above completely fulfilled the requirements for sampling frequency. Countries with a value below one did not.

Production volume and number of targeted samples broken down by Member States are presented in Table 31. Greece and Slovakia did not achieve the minimum sampling frequency requirement. Austria, Denmark, Estonia, Finland, Ireland, Romania and Sweden did not report rabbit meat production for the year 2010 and in consequence no rabbit meat samples were taken in 2011.

The distribution of samples analysed, non-compliant samples and non-compliant results in rabbit meat are presented in Table 32.

45

Production volume and number of targeted samples collected for rabbit meat.


Number of

samples 2011

Samples tested/

required


Number of

samples 2011

Samples tested/

required

Austria 0 0 NA Latvia 7 21 90Belgium 4,355 169 1.6 Lithuania 58 13 7Bulgaria 18 90 150 Luxemburg 8 10 38Cyprus 214 498 70 Malta 300 21 2.0Czech Republic 1,133 42 1.1 Netherlands 32 32 30Denmark 0 0 NA Poland 2,304 133 1.7Estonia 0 0 NA Portugal 7,452 124 1.1Finland 0 0 NA Romania 0 0 NAFrance 48,478 820 3.3 Slovakia 1,367 14 0.3Germany 371 36 2.9 Slovenia 25 18 22Greece 3,570 60 0.6 Spain 61,082 1,092 3.7Hungary 5,631 144 1.3 Sweden 0 0 NAIreland 0 0 NA United 9 7 23Italy 35,939 393 1.9 Total (EU 172,353 3,737 NA

NA: not applicable.

Of the 3,737 samples analysed for rabbits, nine (0.24 %) were non-compliant (nine non-compliant results). The non-compliant samples were reported by six Member States.

In the group A, only two non-compliant samples were reported for chloramphenicol (A6).

In the group B, there were two non-compliant samples for antibacterials (B1), three non-compliant results for anticoccidials (B2b), one for “other pharmacologically active substances” (B2f), and one for organochlorine compounds (B3a).


46

Number of targeted samples analysed, non-compliant samples and non-compliant results in rabbit meat.



Substance group (a)

n(b) % n(c) % n(d)

A 1,074 29 2 0.19 2A1 74 2.0 0 0 0A2 35 0.94 0 0 0A3 91 2.4 0 0 0A4 67 1.8 0 0 0A5 153 4.1 0 0 0A6 714 19 2 0.28 2

B 2,709 72 7 0.26 7B1 1,712 46 2 0.12 2B2 660 18 4 0.61 4

B2a 175 4.7 0 0 0B2b 272 7.3 3 1.1 3B2c 109 2.9 0 0 0B2d 3 0.08 0 0 0B2e 66 1.8 0 0 0B2f 54 1.4 1 1.8 1

B3 375 10 1 0.27 1B3a 188 5.0 1 0.53 1B3b 20 0.5 0 0 0B3c 196 5.2 0 0 0B3d 36 1.0 0 0 0B3e 0 0 0 0 0B3f 10 0.3 0 0 0


Farmed game

European Commission Decision 97/747/EC requires the number of samples to be taken each year in the Member States to be at least 100. The minimum number of samples was set as a provisional rule to be reviewed in light of the information provided by the Member States on their production figures. For farmed game, a total of 2,575 targeted samples were collected in 2011 in the EU (Table 33). Estonia, Luxembourg, Malta, Poland, Slovakia and Slovenia did not report farmed game production in 2010 (Table 34). The distribution of samples analysed, non-compliant samples and non-compliant results in farmed game are presented in Table 35.

47

Production of farmed game and number of targeted samples over 2007-2011.


2007 (EU 27) 40,895 2,2862008 (EU 27) 18,485 1,9592009 (EU 27) 84,482 1,9752010 (EU 27) 25,449 2,1572011 (EU 27) 24,991 2,575

Of the 2,575 samples analysed for farmed game, 23 (0.89 %) were non-compliant (23 non-compliant results). The non-compliant samples were reported by five Member States.

There was only one non-compliant sample in the group A, namely for AMOZ (A6). In the group B, there were 17 non-compliant samples for heavy metals (B3c) and five for anticoccidials (B2b). More details on the specific substances identified and the number of non-compliant results reported by each Member State are given in Appendix A.

Production volume and number of targeted samples collected for farmed game.


Number of samples, 2011


Number of samples, 2011

Austria 297 160 Latvia 26 19Belgium 140 185 Lithuania 24 99Bulgaria 11 166 Luxemburg 0 0Cyprus 65 173 Malta 0 0Czech Republic 96 101 Netherlands 67 128Denmark 89 83 Poland 0 108Estonia 0 0 Portugal 1,212 103Finland 1,972 143 Romania 23 35France 9,598 195 Slovakia 0 0Germany 1,645 100 Slovenia 0 0Greece 140 51 Spain 1,761 82Hungary 29 19 Sweden 2,298 89Ireland 44 136 United 2,403 120Italy 3,509 280 Total (EU 27) 25,449 2,575

48

Number of targeted samples analysed, non-compliant samples and non-compliant results in farmed game.



Substance group (a)

n(b) % n(c) % nd)

A 712 28 1 0.14 1A1 52 2.0 0 0 0A2 35 1.4 0 0 0A3 78 3.0 0 0 0A4 60 2.3 0 0 0A5 135 5.2 0 0 0A6 382 15 1 0.26 1

B 1,874 73 22 1.8 22B1 605 23 0 0 0B2 667 26 5 0.75 5

B2a 260 10 0 0 0B2b 202 7.8 5 2.5 5B2c 136 5.3 0 0 0B2d 7 0.27 0 0 0B2e 67 2.6 0 0 0B2f 7 0.27 0 0 0

B3 616 24 17 2.8 17B3a 222 8.6 0 0 0B3b 49 1.9 0 0 0B3c 320 12 17 5.3 17B3d 43 1.7 0 0 0B3e 0 0 0 0 0B3f 45 1.7 0 0 0


Wild game

European Commission Decision 97/747/EC requires the number of samples to be taken each year in the Member States to be at least 100 samples. Samples must be taken to analyse residues of chemical elements. For wild game, a total of 2,671 targeted samples were collected in 2011 in the EU (Table 36). Cyprus, Malta and Sweden did not report wild game production in 2010 thus no samples were taken in 2011 (Table 37).

49

Production of wild game and number of targeted samples over 2007-2011.

Year Production (t) Targeted samples2007 (EU 27) 270,704 2,3602008 (EU 27) 316,541 2,4432009 (EU 27) 252,328 2,4882010 (EU 27) 147,097 2,3952011 (EU 27) 263,860 2,674

The distribution of samples analysed, non-compliant samples and non-compliant results in wild game are presented in Table 38.

Of the 2,674 samples analysed for wild game, 205 (7.7 %) were non-compliant (211 non-compliant results). The non-compliant samples were reported by 14 Member States. The vast majority of the non-compliant results (n = 196) were reported for heavy metals (B3c) representing 9 % of the total number of samples analysed for elements in this group. Other non-compliant samples (n = 8) were reported for organochlorine compounds including dioxins and PCBs (B3a) and one for Cesium 137 (B3f).

Production volume and number of targeted samples collected for wild game.


Number of samples,

2011


Number of samples,

2011

Austria 8,779 180 Latvia 148 80Belgium 1,566 119 Lithuania 162 101Bulgaria 27 89 Luxemburg 360 100Cyprus 0 0 Malta 0 0Czech Republic 7,625 197 Netherlands 253 107Denmark 226 50 Poland 19,676 210Estonia 462 86 Portugal 57 100Finland 33 81 Romania 1,791 70France 36,312 96 Slovakia 2,864 112Germany 45,340 129 Slovenia 1,247 101Greece 100 10 Spain 10,198 121Hungary 5,897 108 Sweden 0 0Ireland 124 108 United Kingdom 550 109Italy 3,300 104 Total (EU 27) 147,097 2,674


50

Number of targeted samples analysed, non-compliant samples and non-compliant results in wild game.



Substance group (a)

n(b) % n(c) % n(d

A 14 0.52 0 0 0A1 3 0.1 0 0 0A2 1 0.04 0 0 0A3 1 0.04 0 0 0A4 1 0.04 0 0 0A5 0 0 0 0 0A6 8 0.30 0 0 0

B 2,661 99.5 205 7.70 211B1 3 0.11 0 0 0B2 138 5.2 0 0 0

B2a 54 2.0 0 0 0B2b 5 0.2 0 0 0B2c 91 3.4 0 0 0B2d 1 0.04 0 0 0B2e 2 0.1 0 0 0B2f 0 0 0 0 0

B3 2,579 96 205 7.9 211B3a 385 14.4 8 2.1 14B3b 57 2.1 0 0 0B3c 2,175 81.3 196 9 196B3d 10 0.4 0 0 0B3e 0 0 0 0 0B3f 205 7.7 1 0.49 1


Honey

The number of samples to be taken must be at least 10 per 300 t of annual production for the first 3 000 t, plus one sample for each additional 300 t. In order to check the fulfilment of this requirement the same equations were applied as described in chapter 4.10.

Where the rate between the total targeted samples reported and the number of samples to be collected for the reported production is equal to one or higher, Member States completely fulfilled the requirements for sampling frequency. Member States with a value below one did not.

In 2011, 4,684 targeted samples were collected for honey in the EU (Table 39). Production volume and number of targeted samples broken down by Member State are presented in Table 40. Only Sweden did not achieve the minimum sampling frequency requirement.

Production of honey and number of targeted samples over 2007-2011.

51

Year Production (t) Targeted samples2007 (EU 27) 188,945 5,8502008 (EU 27) 158,694 5,2572009 (EU 27) 162,213 4,8262010 (EU 27) 191,501 4,7202011 (EU 27) 215,141 4,684

The distribution of samples analysed, non-compliant samples and non-compliant results in honey are presented in Table 41.

Production volume and number of targeted samples collected for honey.


Number of

samples, 2011

Samples tested/

required


Number of

samples, 2011

Samples tested/

required

Austria 5,500 175 1.6 Latvia 631 21 1.0Belgium 1,500 115 2.3 Lithuania 1,110 39 1.1Bulgaria 12,084 342 2.6 Luxemburg 120 30 7.5Cyprus 590 412 21 Malta 15 15 28.0Czech Republic 6,300 130 1.2 Netherlands 100 28 8.4Denmark 2,500 83 1.0 Poland 12,500 263 2.0Estonia 575 20 1.0 Portugal 6,919 114 1.0Finland 1,700 60 1.1 Romania 11,751 153 1.2France 15,584 438 3.1 Slovakia 1,084 62 1.7Germany 18,150 181 1.2 Slovenia 1,910 73 1.1Greece 16,532 240 1.7 Spain 29,860 713 3.8Hungary 18,337 297 2.0 Sweden 2,596 79 0.9Ireland 250 105 13 United 3,303 148 1.5Italy 20,000 348 2.2 Total (EU 191,501 4,684 NA

NA: not applicable.

52

Number of targeted samples analysed, non-compliant samples and non-compliant results in honey.



Substance group (a)

n(b) % n(c) % n(d)

A 667 14 2 0.30 2A1 0 0 0 0 0A2 0 0 0 0 0A3 0 0 0 0 0A4 0 0 0 0 0A5 0 0 0 0 0A6 667 14 2 0.30 2

B 4,148 89 37 0.89 37B1 2,128 45 22 1.0 22B2 788 17 0 0 0

B2a 8 0.17 0 0 0B2b 10 0.21 0 0 0B2c 664 14 0 0 0B2d 0 0 0 0 0B2e 0 0 0 0 0B2f 304 6.5 0 0 0

B3 1,736 37 15 0.86 15B3a 711 15 3 0.42 3B3b 656 14 0 0 0B3c 520 11 12 2.3 12B3d 48 1.0 0 0 0B3e 0 0 0 0 0B3f 172 3.7 0 0 0


Of the 4,684 samples analysed for honey 39 (0.83 %) were non-compliant (39 non-compliant results). The non-compliant samples were reported by 12 Member States. The majority of the non-compliant results (n = 21) were for antibacterials (B1). Substances found belonged to the class of tetracyclines (n = 15) and sulfonamids (n = 7). Other non-compliant results were reported for organochlorines (B3a) (n = 3) and heavy metals (B3c) (n = 12).


Suspect, import and other samples

In addition to the targeted samples collected in conformity with the specification of the NRCP for 2010, Member States also reported results on samples collected through other sampling strategies than targeted. According to Directive 96/23/EC in case of infringements of maximum residue limits when animals or animal products are placed on the market, intensified checks on the animals and products from the farm and/or establishment in question must be carried out by

53

the competent authorities. Also, in the event of possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product the competent authorities have to apply special measures including repeated sampling in the farm or establishment concerned. Thus, these samples are not representative for the assessment of the residue situation in the Member States and therefore they are reported separately in the residue database as “suspect samples”, as part of the follow-up measure taken in case of infringements.

In 2011, 23,236 suspect samples were reported of which 512 (2.2 %) were non-compliant (625 non-compliant results). It is to note that the number of non-compliant results from suspect sampling reported by a Member State does not accurately reflect the residue situation in that Member State. The suspect samples are taken as follow-up of non-compliance of targeted samples or evidence of possession and use of prohibited substances. In addition, the sampling procedure applied in case of suspicion might be different among Member States. For example, in Belgium, at slaughterhouse each injection site must be sampled together with a sample of muscle which are then analysed by a multi-residue method. This approach results in a higher probability that a suspect sample is found non-compliant for more than one substance. An overview on the number of suspect samples analysed for the different animal species/product categories and the frequency of non-compliant samples is presented in Table 42. Further details on the substances identified and Member States which reported non-compliant results are given in Appendix B.

Apart from the data submitted in accordance to NRCPs, Member States reported a relatively limited number of results on samples checked at import (n = 5,377). As the control of samples at import is more linked to the third country monitoring than to residue monitoring in the EU, Member States report those results to the EC using the Trade Control and Expert System (TRACES) and the Rapid Alert System for Food and Feed (RASFF) tools. Therefore, those data are of limited value and are not representative of the overall situation of residue control at import. An overview on the number of import samples analysed for the different animal species/product categories and the frequency of non-compliant samples is presented in Table 42. Further details on the substances identified and Member States which reported non-compliant results are given in Appendix C.

In total, 299,424 samples were collected in the framework of other monitoring programmes developed under the national legislation. Of that, 288,786 were samples analysed in Germany for antibacterials by means of inhibitor tests (see section 4.1.4). An overview on the number of ‘other’ samples analysed for the different animal species/product categories and the frequency of non-compliant samples is presented in Table 42. Further details on the substances identified and Member States which reported non-compliant results are given in Appendix D.

54

Number of suspect, import and other samples analysed and frequency of non-compliant samples and in all species and product categories.

Group Sampling type Suspect Import Other sampling n nc n nc n ncBovines 16,636 213 576 2 30,679 249Pigs 4,735 143 183 5 259,365 687Sheep/goats 357 8 171 0 2,973 9Horses 51 0 136 0 290 6Poultry 581 59 774 2 1,119 12Aquaculture 107 29 1,954 11 70 1Milk 525 21 18 0 3,766 12Eggs 54 5 17 0 176 5Rabbit 76 10 19 1 129 0Farmed game 1 0 59 0 16 0Wild game 35 12 23 1 10 0Honey 78 11 399 3 831 7Total 23,236 511 4,329 25 299,424 988Percentage non-compliant samples

2.2 0.58 0.33

n: number of samples analysed; nc: number of non-compliant samples.

55

CONCLUSIONS • In 2011, 27 EU Member States reported in the framework of the residue

monitoring the results for 742,902 samples. A total of 415,909 targeted samples and 23,236 suspect samples were reported under Council Directive 96/23/EC. Additionally, 299,428 samples collected in the framework of other programmes developed under the national legislation and 4,329 samples checked at import were reported. The 2011 monitoring plan covered 779 substances to be checked for in all animal species and product categories together.

• The majority of Member States fulfilled the requirements for sampling frequency laid down in Council Directive 96/23/EC and in Commission Decision 97/747/EC.

• There were 1,178 or 0.28 % of non-compliant samples out of the 415,909 targeted samples in 2011.

• Similar to the previous four years there were no non-compliant samples for stilbenes and derivatives (A1).

• For antithyroid agents (A2), there were 0.63 % non-compliant samples, all for thiouracil. Feeding diets rich in cruciferous plants was considered to be the source of non-compliance.

• In the group of steroids (A3), there were 0.11 % non-compliant samples in all animal and product categories but only about half of them were non-compliant for anabolic steroids. The others were non-compliant for corticosteroids reported in the group A3. The non-compliant results for anabolic steroids were found in bovines (n = 17), pigs (n = 6), poultry (n = 6) and aquaculture (n = 3). However, for 80 % of the non-compliant results on anabolic steroids, Member States indicated that the source was most likely the endogenous production. All but one of the non-compliant results for corticosteroids were reported in bovines (n = 38).

• In the group of resorcyclic acid lactones (A4), 0.08 % of the samples were non-compliant for zearalenone and derivatives, mainly as a result of feeding diets contaminated with Fusarium sp.

• For prohibited substances, 0.04 % of samples were non-compliant. Substances identified were chloramphenicol (n = 12), nitrofurans (n = 15) and nitroimidazoles (n = 2).

56

• For antibacterials (B1), 0.19 % of the samples analysed under the Directive 96/23 monitoring were non-compliant. The highest frequency of non-compliant samples for antibacterials was found in honey (1.0 %).

• In the group B2 (other veterinary drugs), the highest proportion of non-compliant samples was found for anticoccidials (0.26 %; B2b). Across animal species and product categories, the non-compliant samples for anticoccidials represented 0.22 % in poultry, 0.06 % in pigs, 0.12 % in sheep and goats, 1.1 % in rabbit meat, 2.5 % in farmed game and 0.72 % in eggs.

• Instances of non-compliance for anthelmintics (B2a) were reported in bovines (0.1 %), sheep and goats (0.21 %), poultry (0.03 %) and milk (0.18 %).

• There was one non-compliant sample for pyrethroids (B2c) and one for sedatives (B2d).

• For non-steroidal anti-inflammatory drugs (B2e), non-compliant samples were found in bovines (0.15 %), pigs (0.02 %), horses (0.66 %), poultry (0.34 %) and milk (0.09 %).

• Non-compliant samples for “other pharmacologically active substances” (B2f) were reported in bovines (0.1 %), sheep and goats (0.18 %), poultry (0.14 %) and rabbit (1.9 %).

• Similar to previous years, in the group B3 (other substances and environmental contaminants), the chemical elements (B3c) had the highest overall percentage of non-compliant samples (3.4 %). Cadmium, lead, mercury and copper were the most frequent elements identified.

• Non-compliance for organochlorine compounds (B3a) and organophosphorus compounds (B3b) was 0.17 % and 0.03 %, respectively.

• For mycotoxins (B3d), there were non-compliant samples for zearalenone and derivatives, ochratoxin A, aflatoxin B1 and aflatoxin M1 in milk. It is important to highlight that by a relatively constant sampling frequency over time, the number of non-compliant milk samples for aflatoxin M1 (n = 14) was higher compared to the period 2008 to 2010 (n = 4 to 7).

• Prevalence of dyes (B3e) in aquaculture samples remained relatively high in 2011 (1.8 %), a value similar to those reported in the previous years. Substances found were malachite green, leuco malachite green, crystal violet and leuco crystal violet.

57

• The overall frequency of non-compliant samples in 2011 (0.28 %) was by about 15 % lower compared to the previous four years (0.32 % – 0.34 %). For several substance groups, there were no notable variations in the frequency of non-compliant samples in 2011 compared to the previous four years but a decrease was observed for steroids, resorcyclic acid lactones, prohibited substances, antimicrobials, anthelmintics and anticoccidials. Non-compliances for anticoccidials decreased most likely as a result of the implementation of Commission Directive 2009/8/EC laying down maximum levels of unavoidable carry-over of coccidiostats in non-target feed. In contrast, the proportion of non-compliant samples for chemical elements (mainly metals) was similar to 2010 but higher compared to the period 2007 - 2009. This development is explained by the application since 2010 of a stricter legal basis in the evaluation of compliance for mercury and copper which resulted in more non-compliant samples.

• The national sampling plans and the pattern of substances analysed were likely not the same over the years and the prescribing patterns of veterinary medicines vary between species. Therefore, the outcome of the multi-year analysis may not reflect accurately the residue situation in each individual EU Member State and for each species or product category over the period considered.

58

REFERENCES

Clouet AS, Le Bizec B, Montrade MP, Monteau F, Andre F, 1997. Identification of endogenous 19-nortestosterone in pregnant ewes by Gas-Chromatography-Mass Spectrometry. Analyst, 122, 471-474.

European Commission (EC), 2007. European Commission Staff Working Document on the implementation of National Residue Monitoring Plans in the Member States in 2007. Available at http://ec.europa.eu/food/food/chemicalsafety/residues/workdoc_2007_en.pdf

European Food Safety Authority (EFSA), 2010a. Report for 2008 on the results from the monitoring of veterinary medicinal product residues and other substances in food of animal origin in the Member States. EFSA Journal 2010; 8:1559. Available online: www.efsa.europa.eu

European Food Safety Authority (EFSA), 2010b. Technical report of EFSA: Evaluation of the data collection performed in the framework of Directive 96/23/EC. Available at http://www.efsa.europa.eu/en/supporting/doc/103e.pdf

European Food Safety Authority (EFSA), 2011. Technical report of EFSA: Report for 2009 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. Supporting Publications 2011:158. Available online: www.efsa.europa.eu

European Food Safety Authority (EFSA), 2012. Technical report of EFSA: Report for 2010 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. Supporting Publications 2012:212. Available online: www.efsa.europa.eu

European Medicines Agency, 2011. Trends in the sales of veterinary antimicrobial agents in nine European countries (2005-2009). Available online: http://www.ema.europa.eu

Fidani M, Pompa G, Mungiguerra F, Casati A, Fracchiolla ML, Arioli F, 2012. Investigation of the presence of endogenous prednisolone in equine urine by high-performance liquid chromatography mass spectrometry and high-resolution mass spectrometry. Rapid Communications in Mass Spectrometry, 26:879-86.

Pinel G, Mathieu S, Cesbron N, Maume D, De Brabander HF, Andre F, Le Bizec B, 2006. Evidence that urinary excretion of thiouracil in adult bovine submitted to a cruciferous diet can give erroneous indications of the possible illegal use of thyrostats in meat production. Food Additives and Contaminants, 23:974-980.

Pompa G, Arioli F, Casati A, Fidani M, Bertocchi L, Dusi G. 2011, Investigation of the origin of prednisolone in cow urine. Steroids, 76:104–110.

Samuels TP, Nedderman A, Seymour MA, Houghton E, 1998. Study of the metabolism of testosterone, nandrolone and estradiol in cattle. Analyst, 123:2401-2404.

http://ec.europa.eu/food/food/chemicalsafety/residues/workdoc_2007_en.pdf

http://www.efsa.europa.eu/

http://www.efsa.europa.eu/en/supporting/doc/103e.pdf

http://www.efsa.europa.eu/

http://www.ema.europa.eu/

59

APPENDICES

A. LIST OF NON-COMPLIANT RESULTS: TARGETED SAMPLING 2011

Category Group Substances MS Number of samples analysed

(a)25

Non-compliant

results

N %Bovines A2 Thiouracil IE 242 11 4.6 NL 401 8 2.0 UK 398 31 7.8 Sub-total for A2 3 50 A3 Boldenone-Alpha NL 1615 4 0.3 Dexamethasone IT 3336 16 0.5 Estradiol-17-Alpha FR 2010 1 0.5 Estradiol-17-Beta LT 17 1 5.9 Nandrolone SK 9 1 11.1 Prednisolone IT 3336 7 0.2 Prednisone IT 3336 6 0.2 Stanozolol IT 53 1 1.9 Testosterone-17-Beta NL 152 9 5.9 Sub-total for A3 5 46

A4 Alpha-Zeralanol (Zeranol) IT 335 1 0.3

UK 161 5 3.1

Beta Zearalanol (Taleranol) IT 628 5 0.8

UK 364 8 2.2 Sub-total for A4 2 19 A5 Clenbuterol FR 1866 1 0.5 IE 510 2 0.4 IT 3317 2 0.6 PT 209 3 1.4 Clencyclohexerol NL 320 1 0.3 Isoxsuprine NL 320 2 0.6 Sub-total for A5 5 11

(a): The number of samples analysed for the individual substances was reported by the Member States only if

there was at least one non-compliant sample for the substance in question. In case that all samples were compliant, the number of samples analysed was not reported. Furthermore, in case of animals controlled at farm and slaughterhouse, the number of samples may include either samples taken at farm or slaughterhouse depending where the non-compliant samples were found. Where non-compliant samples were found at both farm and slaughterhouse, the number of samples represents the sum of samples taken at both sampling points.

60


(a)25

Non-compliant

results

N %

A6 AMOZ (5-methylmorpholino-3-amino-2-oxazolidone) IT 115 3 2.6

Chloramphenicol CZ 167 1 0.6 DE 1649 1 0.6 FR 1628 1 0.6 SEM (semicarbazide) IE 196 1 0.5 IT 115 2 1.7 PL 140 1 0.7 Sub-total for A6 6 10 B1 Amoxycillin HU 5 1 20.0

Benzylpenicillin (Penicillin G) CZ 177 1 0.6

IT 1369 1 0.7 PL 1024 4 0.4 UK 1638 1 0.6 Chlortetracyclin FR 3224 1 0.3 IT 1391 3 0.2 Dihydrostreptomycin FR 2428 1 0.4 LT 140 1 0.7 NL 1917 1 0.5 PL 1024 5 0.5 UK 1638 4 0.2 Doxycycline ES 671 1 0.2 Florfenicol UK 1638 1 0.6 Gentamicin NL 1917 3 0.2 PL 1024 1 0.1 Macrolides FR 2428 2 0.8 Marbofloxacin FR 2626 1 0.4 Neomycin NL 1917 3 0.2 PL 1024 1 0.1 UK 1638 1 0.6 Neospiramycin FR 2428 1 0.4 Oxytetracycline DE 788 1 0.1 FR 3224 13 0.4 IT 1391 4 0.3 LT 140 1 0.7 UK 1638 1 0.6 Penicillin FR 2428 1 0.4 Spiramycin FR 2428 1 0.4 Spiramycin 1 LV 66 1 1.5 Sulfadimethoxine IT 2265 5 0.2 Sulfadimidine IT 2265 1 0.4

61


(a)25

Non-compliant

results

N % Sulfamerazine FR 3174 1 0.3 IT 2265 1 0.4 Sulfathiazole IT 2265 1 0.4 Tetracycline DE 709 1 0.1 FR 3224 3 0.9 Trimethoprim LV 66 1 1.5 Tulathromycin FR 2428 1 0.4 Sub-total for B1 11 77 B2a Ivermectin FR 500 1 0.2 IE 498 2 0.4 UK 736 1 0.1 Triclabendazole IE 498 1 0.2 Sub-total for B2a 3 5 B2e Diclofen (Diclofenac) LT 20 1 5.0 Ibuprofen UK 682 1 0.2 Meloxicam FR 592 1 0.2 Phenylbutazone DE 1312 1 0.8 UK 682 2 0.3 Tolfenamic acid FR 592 2 0.3 Sub-total for B2e 4 8 B2f Dexamethasone DE 750 2 0.3 ES 647 5 0.8 PL 50 1 2.0 Prednisolone BE 498 1 0.2 Sub-total for B2f 4 9 B3b Chlorpyrifos AT 1 1 100.0 Sub-total for B3b 1 1 B3c Cadmium Cd CZ 47 1 2.1 DE 359 16 4.5 ES 221 4 1.8 HU 6 1 16.7 LT 18 1 5.6 NL 150 25 16.7 SE 25 1 4.0 SI 11 1 9.1 UK 107 2 1.9 Copper Cu DE 119 29 24.4 Lead Pb DE 359 1 0.3 Mercury Hg CZ 47 2 4.3 DE 359 30 8.4 Sub-total for B3c 9 114 B3d Zearalenol-alpha HU 28 1 3.6 Zearalenol-beta HU 28 1 3.6

62


(a)25

Non-compliant

results

N %

Zearalenone (Mycotoxin F) HU 28 1 3.6

Sub-total for B3d 1 3 Total in Bovines 18 353 Pigs A2 Thiouracil LT 10 1 10.0 PL 208 1 0.5 UK 70 3 4.3 Sub-total for A2 3 5 A3 17-Beta nortestosteron NL 569 2 0.4 Nandrolone PL 695 4 0.6 Sub-total for A3 2 6 A6 Chloramphenicol DE 183 1 0.6 Nitrofurazone ES 450 1 0.2 Sub-total for A6 2 2 B1 Amoxycillin CZ 377 3 0.8

Benzylpenicillin (Penicillin G) CZ 377 1 0.3

DK 1122 1 0.9 LT 79 1 1.3 PL 3222 3 0.9 Chlortetracyclin PL 3222 1 0.3 Dihydrostreptomycin CZ 377 5 1.3 NL 2506 1 0.4 PL 3222 3 0.9 Doxycycline ES 4078 2 0.5 IT 952 2 0.2 NL 2506 2 0.8 PL 3222 4 0.1 Enrofloxacin ES 3950 3 0.8 HU 62 1 1.6 Inhibitors SK 23 1 4.4 Lincomycin BE 1729 1 0.6 Marbofloxacin ES 3417 1 0.3 FR 2399 1 0.4 Oxytetracycline FR 3050 1 0.3 HU 12 1 8.3 LT 79 1 1.3 NL 2506 4 0.2 PL 3222 2 0.6 Sulfadiazine BE 1841 2 0.1 DE 3921 1 0.3 FR 3499 1 0.3 IE 1493 1 0.7

63


(a)25

Non-compliant

results

N % UK 1609 1 0.6 Sulfadimethoxine FR 3499 1 0.3 IT 1516 5 0.3 PT 679 1 0.2 Sulfadimidine AT 239 1 0.4 CY 100 1 1.0 DE 3926 1 0.3 IE 1493 1 0.7 IT 1516 2 0.1 Sulfamerazine GR 159 1 0.6 Sulfamethazine PT 679 2 0.3 Tetracycline DE 2357 1 0.4 Tylosin, Tylosin A ES 3410 1 0.3 Sub-total for B1 18 70 B2b Maduramicin CY 66 1 1.5 Monensin BE 50 1 2.0 Narasin ES 729 2 0.3 Sub-total for B2b 3 4 B2d Azaperone DE 771 1 0.1 Sub-total for B2d 1 1 B2e Diclofen (Diclofenac) NL 130 1 0.8 Sub-total for B2e 1 1

B3a DDT: Sum DDT, DDE, DDD CZ 93 1 1.1

gamma-HCH (HCH, Lindane) ES 828 3 0.4

Sub-total for B3a 2 4 B3b Diazinon ES 179 1 0.6 Sub-total for B3b 1 1 B3c Cadmium Cd DE 1421 24 1.7 ES 303 1 0.3 Copper Cu DE 354 33 9.3 Lead Pb PL 470 2 0.4 Mercury Hg CZ 77 5 6.5 DE 1419 124 8.7 Sub-total for B3c 4 189 B3d Ochratoxin A FI 44 1 2.3 PL 102 1 1.0 Zearalenol-alpha HU 123 8 6.5 Zearalenol-beta HU 123 8 6.5

Zearalenone (Mycotoxin F) HU 123 8 6.5

Sub-total for B3d 3 26

64


(a)25

Non-compliant

results

N % Total in Pigs 19 309 Sheep/Goats A2 Thiouracil IE 11 1 9.1 UK 72 8 11.1 Sub-total for A2 2 9 A6 SEM (semicarbazide) IE 26 4 15.4 Sub-total for A6 1 4 B1 Chlortetracyclin ES 918 3 0.3 GR 149 1 0.7 Dihydrostreptomycin GR 149 2 1.3 NL 121 2 1.7 Enrofloxacin ES 856 5 0.6 Oxytetracycline CY 52 1 1.9 ES 905 1 0.1 NL 121 2 1.7 Sulfadiazine AT 17 1 5.9 ES 1223 13 1.1 FR 688 1 0.2 PT 143 1 0.7 Sulfadimethoxine FR 688 3 0.4 PT 143 1 0.7 Sulfadoxine PT 143 1 0.7 Sulfaquinoxaline FR 688 1 0.2 Sub-total for B1 7 39 B2a 2-Aminoflubendazole IE 260 1 0.4 Closantel IE 260 3 1.2 Hydroxyflubendazole IE 260 1 0.4 Oxfendazole UK 1338 2 0.2 Sub-total for B2a 2 7 B2b Monensin BE 12 1 8.3 Sub-total for B2b 1 1 B2c Cypermethrin UK 526 1 0.2 Sub-total for B2c 1 1 B2f Prednisolone BE 21 1 4.8 Sub-total for B2f 1 1 B3c Cadmium Cd CZ 3 2 66.7 DE 32 1 3.1 ES 171 3 1.8 GR 114 6 6.1 IT 61 2 3.3 NL 7 2 28 PL 20 7 35 SK 11 1 9.1 UK 56 1 1.8

65


(a)25

Non-compliant

results

N % Lead Pb GR 92 2 2.2 PT 24 1 4.2 UK 56 2 3.6 Mercury Hg DE 32 7 21.9 Sub-total for B3c 10 38

Total in Sheep/Goats 15 100

Horses B2e Oxyphenbutazone Monohydrate CZ 3 1 33.3

Phenylbutazone CZ 3 1 33.3 UK 68 1 1.5 Sub-total for B2e 2 3 B3c Cadmium Cd CZ 1 1 100.0 DE 7 6 85.7 ES 86 5 5.8 HU 1 1 100.0 IT 227 3 1.3 LT 1 1 100.0 PL 157 1 0.6 PT 9 5 55.6 SI 2 2 100.0 Lead Pb ES 86 1 1.2 Mercury Hg DE 7 6 85.7 Sub-total for B3c 9 32 B3d Aflatoxin B1 IT 13 1 7.7 Sub-total for B3d 1 1 Total in Horses 10 36 Poultry A3 Estradiol-17-Beta NL 88 6 6.8 Sub-total for A3 1 6 A5 Isoxsuprine IE 44 1 2.3 Sub-total for A5 1 1 A6 Chloramphenicol CZ 174 1 0.6 FR 928 1 0.1 HU 81 1 1.2 Metronidazole DE 1243 2 0.2 Nitrofurazone NL 419 1 0.2 Sub-total for A6 5 6 B1 Aminoglycosides BG 77 1 1.3 Chlortetracyclin BG 77 1 1.3 Doxycycline DE 1054 1 0.9 ES 730 1 0.1 NL 1147 2 0.2 PL 1295 3 0.2

66


(a)25

Non-compliant

results

N % Enrofloxacin ES 684 1 0.2 PL 1264 1 0.8 Inhibitors DE 14 1 7.1 Oxytetracycline IT 456 1 0.2 Sulfadimethoxine IT 774 1 0.1 Sub-total for B1 6 14 B2a Oxfendazole sulfon UK 342 1 0.3 Sub-total for B2a 1 1 B2b Lasalocid IT 206 1 0.5 PL 675 2 0.3 Maduramicin CY 21 1 4.8 PT 102 1 1.0 UK 772 2 0.3 Monensin PL 642 1 0.2 Nicarbazin ES 377 1 0.3 Robenidine CY 21 3 14.3 PT 102 1 1.0 Salinomycin MT 29 1 3.5 Semduramicin CZ 96 2 2.1 Sub-total for B2b 8 16 B2e Diclofen (Diclofenac) LT 5 1 20.0 Ketoprofen BE 130 1 0.8 Salicylic acid NL 93 1 1.1 Sub-total for B2e 3 3 B2f Metoprolol DE 55 1 1.8 Sub-total for B2f 1 1

B3a gamma-HCH (HCH, Lindane) ES 456 2 0.4

HCB (Hexachlorbenzene) ES 396 1 0.3

Sub-total for B3a 1 3 B3c Cadmium Cd DE 147 1 0.7 Lead Pb IT 199 1 0.5 Mercury Hg DE 147 1 0.7 Sub-total for B3c 2 3 Total in Poultry 16 54 Aquaculture A3 Boldenone FR 60 3 5.0 Sub-total for A3 1 3 A6 Chloramphenicol IT 163 1 0.6 Sub-total for A6 1 1 B1 Doxycycline PL 58 1 1.7 Enrofloxacin EE 3 1 33.3 Flumequine FR 70 1 1.4

67


(a)25

Non-compliant

results

N % Inhibitors DE 44 1 2.3 Oxytetracycline UK 380 1 0.3 Sulfadiazine PL 58 1 1.7 Sub-total for B1 5 6 B3a PCB sum UK 11 2 18.2 Sub-total for B3a 1 2 B3e Cristal Violet FR 249 1 0.4 Cristal Violet-Leuco AT 75 1 1.3 CZ 80 2 2.5 DK 62 1 1.6 FR 249 1 0.4 Malachite Green CZ 80 1 1.3 PL 148 6 4.1 Malachite Green-Leuco AT 75 2 2.7 CZ 80 16 20.0 DE 441 2 0.5 DK 62 1 1.6 FR 249 1 0.4 IT 189 1 0.5 SK 10 1 10.0 Sub-total for B3e 8 37 Total in Aquaculture 10 49 Milk A6 Chloramphenicol ES 314 1 0.3 Sub-total for A6 1 1

B1 Benzylpenicillin (Penicillin G) FI 220 1 0.5

LT 211 1 0.5 Cefoperazon CZ 1 1 100.0 Doxycycline ES 471 1 0.2 Inhibitors CY 2600 8 0.3 Tetracycline PL 1797 2 0.1 Sub-total for B1 6 14 B2a Fenbendazole FR 300 1 0.3 Ivermectin IE 305 1 0.3 UK 169 1 0.6 Levamisole BE 54 1 1.9 Nitroxinil IE 305 1 0.3 UK 178 4 2.3 Triclabendazole BE 54 1 1.9 Sub-total for B2a 4 10 B2e Diclofen (Diclofenac) BE 54 1 1.9 CY 83 1 1.2 DE 1173 1 0.9

68


(a)25

Non-compliant

results

N % Sub-total for B2e 3 3 B3a HCH-Beta FR 80 1 1.3 Sub-total for B3a 1 1 B3c Lead Pb HU 5 1 20.0 Sub-total for B3c 1 1 B3d Aflatoxin B1 CY 62 1 1.6 Aflatoxin M1 FI 227 2 0.9 GR 170 7 4.1 IT 442 4 0.9 Sub-total for B3d 4 14 Total in Milk 14 44 Eggs B1 Doxycycline PL 198 1 0.5 Enrofloxacin LV 140 1 0.7 PL 198 1 0.5 Flumequine BE 65 2 3.1 Sub-total for B1 3 5 B2b Decoquinate PL 102 1 1.0 Diclazuril AT 210 1 0.5 MT 20 1 5.0 PL 102 1 1.0 UK 476 2 0.4 Lasalocid DE 225 1 0.4 FR 156 2 1.3 SI 165 1 0.6 Maduramicin FR 156 2 1.3 MT 20 2 10.0 PL 102 2 2.0 SI 165 3 1.8 Monensin FR 156 1 0.6 IE 46 1 2.2 Narasin AT 210 1 0.5 Salinomycin PL 102 1 1.0 Salinomycin sodium EE 42 1 2.4 Semduramicin FR 156 1 0.6 Sub-total for B2b 9 25 B3a Dioxins IT 74 1 1.4 PCB sum EE 32 4 12.5 WHO-PCDD/F-PCB-TEQ DE 28 3 3.6 WHO-PCDD/F-TEQ DE 109 3 2.8 Sub-total for B3a 3 11 Total in Eggs 12 41 Rabbit A6 Chloramphenicol FR 60 1 1.7 IT 27 1 3.7

69


(a)25

Non-compliant

results

N % Sub-total for A6 2 2 B1 Sulfadimethoxine FR 250 1 0.4 Tulathromycin CZ 1 1 100.0 Sub-total for B1 2 2 B2b Diclazuril CY 6 2 33.3 Robenidine CZ 9 1 11.1 Sub-total for B2b 2 3 B2f Olaquindox PT 7 1 14.3 Sub-total for B2f 1 1

B3a HCB (Hexachlorbenzene) ES 42 1 2.4

Sub-total for B3a 1 1 Total in Rabbit 6 9

Farmed Game

A6 AMOZ (5-methylmorpholino-3-amino-2-oxazolidone)

BE 21 1 4.8

Sub-total for A6 1 1 B2b Diclazuril PT 15 1 6.7 Monensin BE 12 4 33.3 Sub-total for B2b 2 5 B3c Cadmium Cd FI 30 13 43.3 Lead Pb CZ 11 1 9.1 Mercury Hg DE 10 3 30.0 Sub-total for B3c 3 17

Total in Farmed Game 5 23

Wild game B3a DDE, pp'- DE 81 3 3.7

DDT: Sum DDT, DDE, DDD DE 81 4 4.9

HCB (Hexachlorbenzene) DE 80 2 2.5

LU 30 1 3.3 HCH-Alpha LU 30 1 3.3 HCH-Beta LU 30 1 3.3 WHO-PCDD/F-PCB-TEQ CZ 3 1 33.3 WHO-PCDD/F-TEQ CZ 3 1 33.3 Sub-total for B3a 3 14 B3c Cadmium Cd DK 50 1 2.0 ES 96 1 1.0 FI 60 32 53.3 FR 62 2 3.2 GR 7 1 14.3 LU 30 1 3.3

70


(a)25

Non-compliant

results

N % LV 80 36 45.0 Lead Pb AT 122 8 6.6 CZ 105 27 25.7 DK 50 1 2.0 EE 34 1 2.9 ES 96 1 1.0 FI 60 1 1.7 GR 7 1 14.3 LV 80 4 5.0 NL 107 24 22.4 PL 106 7 6.6 PT 50 7 14.0 Mercury Hg DE 98 39 39.8 DK 50 1 2.0 Sub-total for B3c 14 196 B3f Cesium 137 CZ 28 1 3.6 Sub-total for B3f 1 1 Total in Wild game 14 211

Honey A6 AOZ (3-amino-2-oxazolidone) LV 2 1 50.0

Chloramphenicol SE 10 1 10.0 Sub-total for A6 2 2 B1 Chlortetracyclin GR 130 5 3.9 Sulfadimethoxine HU 67 2 3.0 Sulfathiazole LT 5 1 20.0 Sulfonamides PL 129 4 3.1 Tetracycline FR 50 1 2.0 HU 32 6 18.8 IT 61 2 3.3 LT 5 1 20.0 Sub-total for B1 6 22 B3a Dichlorobenzene 1,2 UK 19 2 10.5 Vinclozolin FR 57 1 1.8 Sub-total for B3a 2 3 B3c Copper Cu DE 7 5 71.4 Lead Pb CZ 15 1 6.7 FR 51 1 2.0 IE 10 2 20.0 LV 3 3 100.0 Sub-total for B3c 5 12 Total in Honey 12 39

71


(a)25

Non-compliant

results

N %Total in all categories 1268

B. LIST OF NON-COMPLIANT RESULTS: SUSPECT SAMPLING


(a)26

Non-compliant

results

N % Bovines A3 Dexamethasone IT 659 7 1.1 Prednisolone IT 588 2 0.3 Prednisone IT 588 1 0.2 Sub-total for A3 2 10 A5 Clenbuterol IT 272 5 1.8

Clenbuterol-Hydroxymethyl (NA 1142) IT 272 5 1.8

Clenpenterol (NAB 762, Methylclenbuterol) IT 272 5 1.8

Mabuterol IT 272 5 1.8 Mapenterol IT 272 5 1.8 Ractopamine IT 272 5 1.8 Sub-total for A5 1 30

A6

AMOZ (5-methylmorpholino-3-amino-2-oxazolidone) IT 42 2 4.8

Chloramphenicol CZ 10 5 50.0 SEM (semicarbazide) IT 42 13 31.0 Sub-total for A6 2 20 B1 Amoxycillin IT 107 1 0.9 Ampicillin IT 107 1 0.9 Antibacterials NL 7053 70 1.0

Benzylpenicillin (Penicillin G) AT 482 1 0.2

BE 196 4 2.0



72


(a)26

Non-compliant

results

N % IT 107 2 1.9 Chlortetracyclin AT 47 1 2.1 Ciprofloxacin BE 196 3 1.5 Dicloxacillin IT 107 1 0.9 Dihydrostreptomycin AT 538 2 0.4 BE 196 7 3.6 DE 2 1 50.0 Enrofloxacin BE 196 4 2.0 Inhibitors DE 2 1 50.0 Marbofloxacin IE 3583 1 0.3 UK 33 1 3.0 Neomycin BE 196 1 0.5 Oxytetracycline BE 196 8 4.1 GR 11 1 9.1 IE 3583 3 0.8 IT 108 5 4.6 UK 33 4 12.1 Spectinomycin BE 196 2 1.0 Spiramycin BE 196 1 0.5 Streptomycin BE 196 1 0.5 Sulfadiazine IT 81 2 2.5 UK 33 1 3.0 Sulfadimethoxine BE 196 3 1.5 Sulfadimidine IT 81 2 2.5 Sulfamerazine IT 81 1 1.2 Sulfamethazine IE 3583 1 0.3 Tetracycline BE 196 5 2.6 Tilmicosin BE 196 6 3.1 Trimethoprim BE 196 3 1.5 Tylosin, Tylosin A BE 196 7 3.6 Sub-total for B1 8 158 B2a Clorsulon BE 173 1 0.6 Closantel BE 173 4 2.3 Ivermectin BE 173 4 2.3 Levamisole BE 173 2 1.2 Moxidectin BE 173 2 1.2 Sub-total for B2a 2 13 B2e Antipyrin-4-Methylamino AT 1 1 100.0 Carprofen BE 189 2 1.1 Flunixin BE 189 6 3.2 Meloxicam BE 189 4 2.1

Metamizole (Dipyrone Monohydrate) BE 189 1 0.5

73


(a)26

Non-compliant

results

N % Phenylbutazone BE 189 1 0.5 Tolfenamic acid BE 189 10 5.3 Sub-total for B2e 2 25 B2f Dexamethasone BE 610 1 0.2 Prednisolone BE 380 2 0.5 Sub-total for B2f 1 3 B3c Cadmium Cd DE 23 9 39.1 UK 16 1 6.3 Copper Cu DE 13 4 30.8 Lead Pb DE 14 6 42.9 Mercury Hg DE 17 5 29.4 Sub-total for B3c 2 25 Total in Bovines 10 284 Pigs A6 Chloramphenicol DE 49 28 57.1 Sub-total for A6 1 28 B1 Antibacterials NL 2685 32 1.2

Benzylpenicillin (Penicillin G) BE 79 7 8.9

Beta-lactams MT 371 17 4.6 Ciprofloxacin BE 79 1 1.3 Dihydrostreptomycin BE 79 6 7.6 CZ 12 4 33.3 Enrofloxacin BE 79 2 2.5 Florfenicol BE 79 1 1.3 Marbofloxacin BE 79 1 1.3 Neomycin BE 79 3 3.8 Oxytetracycline BE 79 1 1.3

Penicillin V (Phenoxymethylpenicillin) BE 79 1 1.3

Quinolones MT 371 11 3.0 Spectinomycin BE 79 1 1.3 Spiramycin BE 79 1 1.3 Sulfadiazine BE 79 1 1.3 Sulfadimethoxine BE 79 2 2.5 Sulfadoxine BE 79 1 1.3 Sulfamethoxazole BE 79 1 1.3 Tetracycline BE 79 1 1.3 MT 371 13 3.5 Trimethoprim BE 79 3 3.8 Tylosin, Tylosin A BE 79 2 2.5 Sub-total for B1 5 113 B2a Ivermectin BE 56 1 1.8 Moxidectin BE 56 1 1.8

74


(a)26

Non-compliant

results

N % Sub-total for B2a 1 2 B2d Azaperol BE 56 2 3.6 Azaperone BE 56 2 3.6 Sub-total for B2d 1 4 B2e Flunixin BE 56 11 19.6 Ketoprofen BE 56 2 3.6 Meloxicam BE 56 1 1.8

Metamizole (Dipyrone Monohydrate) BE 56 3 5.4

Tolfenamic acid BE 56 1 1.8 Sub-total for B2e 1 18 B2f Dexamethasone BE 56 3 5.4 Methylprednisolone BE 56 2 3.6 Sub-total for B2f 1 5 B3c Mercury Hg CZ 17 7 41.2 DE 7 1 14.3 Sub-total for B3c 2 8 Total in Pigs 6 178 Sheep/ Goats B1 Sulfadiazine ES 166 4 2.4 Sub-total for B1 1 4 B3c Cadmium Cd CZ 8 4 50.0 Sub-total for B3c 1 4 Total in Sheep/Goats 2 8 Poultry A6 Metronidazole DE 313 54 17.3 Sub-total for A6 1 54 B2b Decoquinate PL 17 1 5.9 Salinomycin MT 17 3 17.7 Sub-total for B2b 2 4 B3a WHO-PCDD/F-PCB-TEQ DE 1 1 100.0 WHO-PCDD/F-TEQ DE 1 1 100.0 Sub-total for B3a 1 2 Total in Poultry 4 60 Aqua- culture B1 Enrofloxacin EE 2 2 100.0 Sub-total for B1 1 2 B3a Endrin AT 1 1 100.0 Sub-total for B3a 1 1 B3e Cristal Violet-Leuco DK 5 4 80.0 Malachite Green PL 13 4 30.8 Malachite Green-Leuco AT 29 6 20.7 CZ 12 6 50.0 DE 18 5 27.8

75


(a)26

Non-compliant

results

N % IT 1 1 100.0 Sub-total for B3e 7 26 Total in Aquaculture 8 29 Milk B1 Ampicillin IT 224 1 0.5 Sub-total for B1 2 1 B2a Nitroxinil UK 9 6 66.7 Sub-total for B2a 1 6 B3a HCH-Alpha IT 27 2 7.4 HCH-Beta IT 27 4 14.8 Sub-total for B3a 1 6 B3d Aflatoxin M1 FI 21 4 19.1 IT 72 5 6.9 Sub-total for B3d 2 9 Total in Milk 4 22 Eggs B2b Maduramicin PL 6 2 33.3 Narasin AT 4 1 25.0 Salinomycin sodium EE 2 1 50.0 Sub-total for B2b 3 4 B3a WHO-PCDD/F-TEQ DE 2 1 50.0 Sub-total for B3a 1 1 Total in Eggs 4 5 Rabbit B2b Robenidine CZ 3 2 66.7 Sub-total for B2b 1 2 B2f Olaquindox PT 22 8 36.4 Sub-total for B2f 1 8 Total in Rabbit 2 10 Wild game B3a WHO-PCDD/F-PCB-TEQ CZ 3 3 100.0 WHO-PCDD/F-TEQ CZ 3 3 100.0 Sub-total for B3a 1 6 B3c Lead Pb AT 15 2 13.3 Sub-total for B3c 1 2 B3f Cesium 137 CZ 11 7 63.6 Sub-total for B3f 1 7 Total in Wild game 2 15 Honey B1 Chlortetracyclin IT 25 3 12.0 Sulfathiazole DE 9 3 33.3 Sulfonamides PL 10 4 40.0 Sub-total for B1 3 10 B3c Lead Pb IE 6 1 16.7 Sub-total for B3c 1 1 Total in Honey 4 11

76


(a)26

Non-compliant

results

N % Total in all categories 622

77

C. LIST OF NON-COMPLIANT RESULTS: IMPORT SAMPLING


(a)27

Non-compliant

results

N % Bovines B2a Ivermectin DE 35 1 2.9 IE 9 1 11 Sub-total for B2a 2 2 Total in Bovines 2 2 Pigs A6 Chloramphenicol DK 43 3 7.0 SEM (semicarbazide) DE 3 2 67 Sub-total for A6 2 5 Total in Pigs 2 5 Poultry B2b Chlopidol IE 10 1 10 Sub-total for B2b 1 1 B3c Mercury Hg DE 31 1 3.2 Sub-total for B3c 1 1 Total in Poultry 2 2

Aquaculture A6 AOZ (3-amino-2-oxazolidone) DE 141 1

0.7

Sub-total for A6 1 1 B2c Permethrin DE 58 1 1.7 Sub-total for B2c 1 1 B3c Arsenic As PL 99 1 1.0 Cadmium Cd DE 181 8 4.4 Mercury Hg DE 182 5 2.8 Sub-total for B3c 2 14 Total in Aquaculture 3 16 Rabbit B3c Mercury Hg DE 7 1 14 Sub-total for B3c 1 1 Total in Rabbit 1 1 Wild game B3c Mercury Hg DE 9 1 11 Sub-total for B3c 1 1 Total in Wild game 1 1 Honey A6 Chloramphenicol EE 2 1 50 Metronidazole BE 31 2 6.5 Sub-total for A6 2 3



78

Total in Honey 2 3 Total in all categories 30

D. LIST OF NON-COMPLIANT RESULTS: OTHER SAMPLING

Category Group

Substances MS Number of samples

analysed(a)

Non-compliant

results N % Bovines A3 Dexamethasone IT 528 8 1.5 Sub-total for A3 1 8 B1 Amoxycillin DE 110 5 4.6

Benzylpenicillin (Penicillin G) DE 120 19

16

IT 183 2 1.1 Chlortetracyclin DE 91 1 1.1 IT 190 1 0.5 Ciprofloxacin DE 74 2 2.7 Dihydrostreptomycin DE 105 6 5.7 Enrofloxacin DE 67 5 7.5 Gentamicin DE 96 13 14 Inhibitors DE 28163 162 0.6 Marbofloxacin DE 90 4 4.4 Neomycin DE 95 6 6.3 Oxytetracycline DE 91 1 1.1 IT 190 2 1.1 Sulfadiazine IT 69 1 1.5 Sulfadimidine IT 69 1 1.5 Sulfadoxine DE 116 2 1.7 Sulfamerazine IT 69 1 1.5 Sulfamethoxypyridazine DE 103 1 1.0 Tetracycline DE 92 2 2.2 Tylosin, Tylosin A DE 93 2 2.2 Sub-total for B1 3 239 B2e Antipyrin-4-Amino DE 18 1 5.6 Antipyrin-4-Methylamino DE 19 2 11 Carprofen DE 5 2 40 Meloxicam DE 22 1 4.6 Sub-total for B2e 1 6 B2f Dexamethasone DE 13 2 15 Sub-total for B2f 1 2 B3a Dioxins IT 16 1 6.3 HCH-Beta IT 48 4 8.3 Sub-total for B3a 1 5 Total in Bovines 3 260 Pigs B1 Amoxycillin DE 217 5 2.3

79

Category Group


analysed(a)

Non-compliant

results N % Ampicillin DE 252 1 0.4

Benzylpenicillin (Penicillin G) DE 253 20

7.9

Chlortetracyclin DE 204 8 3.9 IT 215 1 0.5 Danofloxacin DE 260 1 0.4 Dihydrostreptomycin DE 192 13 6.8 Doxycycline DE 377 29 7.7 Enrofloxacin DE 180 9 5.0 Epi-Tetracycline DE 40 2 5.0 Gentamicin DE 184 3 1.6 Inhibitors DE 257443 536 0.2 Marbofloxacin DE 261 10 3.8 Neomycin DE 1381 1 0.7 Oxytetracycline DE 204 2 1.0 Sulfadiazine DE 303 23 7.6 Sulfadimethoxine DE 303 2 0.7 IT 85 2 2.4 Sulfadimidine DE 303 2 0.7 Tetracycline DE 204 9 4.4 IT 215 1 0.5 Tilmicosin DE 251 1 0.4 Trimethoprim DE 234 21 9.0 Sub-total for B1 3 702 B2a 2-Aminoflubendazole DE 86 1 1.2 Sub-total for B2a 1 1 B2e Antipyrin-4-Amino DE 86 3 3.5 Antipyrin-4-Formylamino DE 6 1 17 Antipyrin-4-Methylamino DE 90 1 1.1 Flunixin-Meglumine DE 86 1 1.2 Phenazone DE 10 2 20 Sub-total for B2e 1 8 Total in Pigs 3 711

Sheep/Goats B1 Benzylpenicillin (Penicillin G) DE 5 1

20

Cefquinom DE 3 1 33 Inhibitors DE 2938 6 0.2 Marbofloxacin DE 4 1 25 Oxytetracycline DE 2 1 50 Sulfadoxine DE 6 1 17 Sulfonamides DE 2 1 50 Trimethoprim DE 4 1 25 Sub-total for B1 1 13 Total in Sheep/Goats 1 13

80

Category Group


analysed(a)

Non-compliant

results N % Horses A5 Clenbuterol BE 50 1 2.0 Sub-total for A5 1 1 B1 Chlortetracyclin DE 2 1 50 Inhibitors DE 130 3 2.3 Oxytetracycline DE 2 1 50 Sub-total for B1 1 5 B2e Acetylsalicylic acid BE 50 1 2.0 Phenylbutazone BE 50 1 2.0 Sub-total for B2e 1 1 B2f Methylprednisolone BE 50 1 2.0 Sub-total for B2f 1 1 Total in Horses 2 9 Poultry B1 Doxycycline IT 161 4 2.5 Flumequine IT 145 1 0.7 Inhibitors DE 38 1 2.6 Sulfadimethoxine IT 81 1 1.2 Sub-total for B1 2 7 B2b Robenidine MT 7 1 14 Sub-total for B2b 1 1 B3a Dioxins IT 15 4 27 Sub-total for B3a 1 4 Total in Poultry 3 12 Aquaculture B1 Inhibitors DE 47 1 2.1 Sub-total for B1 1 1 Milk B3a HCH-Alpha IT 253 1 0.4 HCH-Beta IT 253 2 0.8 Sub-total for B3a 1 3 B3d Aflatoxin M1 IT 2544 9 0.35 Sub-total for B3d 1 9 Total in Milk 2 12 Eggs B3a Dioxins IT 42 5 12 Sub-total for B3a 1 5 Total in Eggs 1 5 Honey B1 Chlortetracyclin IT 190 1 0.53 Sulfamethoxazole IT 172 1 0.58 Tetracycline IT 190 1 0.53 Tylosin, Tylosin A IT 110 1 0.91 Sub-total for B1 1 4 B2c Cypermethrin IT 33 3 9.1 Sub-total for B2c 1 3 Total in Honey 1 7 Total in all categories

1030

81

E. ANNEX I TO DIRECTIVE 96/23/EC

ANNEX I TO DIRECTIVE 96/23/EC

GROUP A – Substances having anabolic effect and unauthorized substances

A.1. Stilbenes, stilbene derivatives, and their salts and esters

A.2. Antithyroid agents

A.3. Steroids

A.4. Resorcyclic acid lactones, including zeranol

A.5. Beta-agonists

A.6. Compounds included in Annex IV to Council Regulation (EEC) N° 2377/90 of 26 June 1990

GROUP B – Veterinary drugs and contaminants

B.1. Antibacterial substances, including sulphonamides, quinolones

B.2. Other veterinary drugs

a) Anthelmintics

b) Anticoccidials

c) Carbamates and pyrethroids

d) Sedatives

e) Non-steroidal anti-inflammatory drugs (NSAIDs)

f) Other pharmacologically active substances

82

B.3. Other substances and environmental contaminants

a) Organochlorine compounds, including PCBs

b) Organophosphorus compounds

c) Chemical elements

d) Mycotoxins

e) Dyes

f) Others

83

ABBREVIATIONS

Country Codes

AT Austria

BE Belgium

BG Bulgaria

CY Cyprus

CZ Czech Republic

DK Denmark

EE Estonia

FI Finland

FR France

DE Germany

GR Greece

HU Hungary

IE Ireland

IT Italy

LV Latvia

LT Lithuania

LU Luxembourg

MT Malta

PL Poland

PT Portugal

RO Romania

SI Slovenia

SK Slovak Republic

84

ES Spain

SE Sweden

NL The Netherlands

UK United Kingdom

85

AT AUSTRIA

Group A substances

Modification of national residue plan Information with regard to the recommendations of the EURL RIKILT

See Plan Data Information of Plan 2012

Information with regard to the recommendations of the EURL Berlin (plan 2010)


Accreditation and validation of Group A substances or forbidden substances according to Council Decision 2002/657/EC


New in the plan 2012 See Plan Data Information of Plan 2012 Due to compliant results over a two or more years period, the number of samples will be decreased


Due to non-compliant results in 2011, the number of samples will be increased


General information See Plan Data Information of Plan 2012

Non-compliant results Follow-up actions Bovines, Pigs, Sheep and Goats, Horses, Poultry, Aquaculture Animals,

Farmed Game, Milk, Eggs and Honey None None

Group B substances

Modification of national residue plan Information with regard to the recommendations of the EURL Berlin (plan 2009)

-

New in the plan 2012 See Plan Data Information of Plan 2012 General information See Plan Data Information of Plan 2012 Due to compliant results over a two or more year period, the


86

number of samples will be decreased Due to non-compliant results in 2011, the number of samples will be increased


Non-compliant results Follow-up actions

Bovines 1 chlortetracycline – 168,7 ppb – muscle – veal calf (suspect sample, slaughterhouse)

The carcase was impounded at the slaughterhouse and declared unfit for human consumption. The carcase was disposed of according to Reg. (EC) No 1069/2009. Investigations on the farm of origin by official veterinarian including verification of records. The farmer is a member of the Animal Health Service; 22 bovine animals and one fattening pig were held on the farm. The veal calf drank from the same milk can as a sick veal calf which was treated with chlortetracycline (the animals were held together in the same box). Verbal instruction to the farmer. The veterinary practitioner`s dispensary of the veterinarian in charge of the farm was checked too.

1 dihydrostreptomycin – > 4.988,0 ppb – kidney – other bovine (breeding bull) (suspect sample, slaughterhouse)

The carcase was impounded at the slaughterhouse and declared unfit for human consumption. The carcase was disposed according to Reg. (EC) No 1069/2009. Investigations on the farm of origin (farm specialised on suckler cows) by official veterinarian including verification of records. The farmer is a member of the Animal Health Service. 63 bovine animals as well as porcine animals, horses and poultry were held on the farm. The documentation of the administration of veterinary medicinal products was insufficient. Intensified supervision/checks for the following 6 months. Administrative proceedings were started against the farmer.

1 penicillin G – 85,7 ppb – kidney – cow (suspect sample, slaughterhouse)

The cow was slaughtered before the end of the withdrawal period, the withdrawal period was not observed. The carcase was impounded at the slaughterhouse and declared unfit for human consumption. The carcase was disposed of according to Reg. (EC) No 1069/2009. The farm (42 bovine

87

animals) was investigated by the official veterinarian. The documentation of the administration of veterinary medicinal products (treatment for mastitis and medically indicated caesarean-section) was correct, but not the calculation of the withdrawal period. The veterinary practitioner's dispensary of the veterinarian in charge of the farm was checked too. Administrative proceedings were started against the farmer. Intensified supervision/checks for the following 6 months;

1 dihydrostreptomycin – 3.119,2 ppb – kidney – cow (suspect sample, slaughterhouse)

The withdrawal period had been observed. The offal was declared unfit for human consumption. The farm (150 milk cows and 72 young cattle) was investigated by the official veterinarian. The documentation of the administration of veterinary medicinal products (treatment for mastitis) was correct. An explanation for the residue found in the kidney could be a reduced metabolism and excretion of VMPs of an ill animal. Information to the office for pharmacovigilance of the AGES

1 methylaminoantipyrin (Metamizole) – 10.817,0 ppb – kidney – other bovine (suspect sample, slaughterhouse)

Investigations on the farm of origin with 158 bovine animals by official veterinarian including verification of records. The farmer is a member of the Animal Health Service. The administration of Metamizole was not recorded. The carcase was impounded at the slaughter-house, declared unfit for human consumption and then disposed of in accordance with Regulation (EC) No 1069/2009. Intensified supervision/checks for the following 6 months. Administrative proceedings were started against the farmer.

1 chlorpyrifos – 0,64 ppm – kidney fat – cow (targeted sample, slaughterhouse)

Chlorpyrifos is an insecticide frequently used worldwide. Investigations on the farm of origin with 69 bovine animals by official veterinarian including verification of records. There was no indication regarding the use of chlorpyrifos. Animals of the farm will be tested again in 2012.

Pigs 1 sulfadimidin – 394.8 ppb – muscle – fattening pig (targeted sample, slaughterhouse)

The farmer is a member of the Animal Health Service, but not authorised to manufacture medicated feeding stuffs.

88

Investigations on the farm of origin (about 270 pigs were kept on the farm) by official veterinarian including verification of records. A Pre-mix for medicated feeding stuffs was administered in violation of the requirements of the SPC. The withdrawal period was not observed. The records did not contain relevant data. The identification of treated animals was inadequate. Administrative proceedings were started against the farmer. Intensified supervision/checks for the following 6 months.

Eggs 1 diclazuril – 2,62 ppb (targeted sample)

The farmer is a member of the Poultry Health Service with a capacity of 8.800 laying hens. As a consequence of the detection of diclazuril in eggs, two follow-up samples were taken; these samples were negative. Investigations on the farm by official veterinarian including verification of records. Sampling of feed in order to check the carry-over. The feed sample was compliant. Administrative proceedings were started against the farmer. No verification of any illegal use of Diclazuril.

1 narasin – 3,71 ppb (targeted sample)

The farmer is a member of the Poultry Health Service with a capacity of 2.500 laying hens. As a consequence of the detection of narasin in eggs, two follow-up samples were taken; one sample was non-compliant (please refer to information below). Investigations on the farm by official veterinarian including verification of records and sampling of feed. The feed sample was compliant. Administrative proceedings were started against the farmer. No verification of any illegal use of narasin.

1 narasin – 3,8 ppb (suspect sample)

One of two follow-up samples taken as a consequence of the detection of Narasin in eggs.

Aquaculture 1 crystalviolet-leuco – <1,2 ppb – muscle – trout (targeted sample)

The farm with 6.400 kg rainbow trout and some other types of trout was investigated by official veterinarian. Verification of the records. Official samples were taken (3 samples). All samples showed a compliant result (please refer to the information below). Intensified checks for the following

89

12 months. No verification of any illegal use of crystalviolet.

Three follow-up samples of above mentioned trout (LCV <1.2 ppb);

1 malachite green – <0,4 ppb and malachite green-leuco – 62,4 ppb – muscle – trout (targeted sample)

The farm was investigated and placed under official control (30/12/2011-07/12/2012) by the Provincial Governor (official veterinarian) in accordance with Article 58 of the Food Safety and Consumer Protection Act; about 22 000 trout were held on the farm as a consequence of the positive finding. Verification of the records. The test results of the sampling of a second location of this farm were negative. Official samples were taken (4 samples). The analyses of one sample showed again a non-compliant result (please refer to information below). On the basis of this result, one of the ponds had been verified as positive. The trout of this pond originated from Germany. RASFF/alert/2012:0126 of 24/01/2012. 2.000 trout were killed and sent to a processing plant of category 1 material as required by Regulation (EC) No. 1069/2009. Water of the pond was drained and it was planned to test the mud on whether it contains dyes or not. Intensified checks for the following 12 months. Official information of the farmer. No verification of the illegal use of malachite green

1 malachite green-leuco – 52,2 ppb – muscle – trout (suspect sample)

One of four follow-up samples of above-mentioned trout (LMG 62.4 ppb)

1 malachite green – <0,4 ppb and malachite green-leuco – 31,3 ppb – muscle – trout (targeted sample)

Since 29/12/2011 the farm is placed under official control by the Provincial Governor (official veterinarian) in accordance with Article 58 of the Food Safety and Consumer Protection Act; about 300 kg trout were held on the farm as a consequence of the positive finding. Four official samples were taken and two of the samples showed again a non-compliant result. Verification of the records. At the time of compilation of the report further investigations are ongoing.

2 malachite green-leuco – 23,6 and 26,2 ppb – muscle – trout (suspect samples)

Two of four follow-up samples of above-mentioned trout (LMG 31,3 ppb)

90

2 malachite green-leuco – 8,6 and 7,0 ppb – muscle – carp (suspect samples)

Since 27/05/2011 the farm is placed under official control by the Provincial Governor (official veterinarian) in accordance with Article 58 of the Food Safety and Consumer Protection Act. It is a catch-and-release fishing farm. At the time of compilation of the report, further investigations are ongoing. Some legal questions remain and have to be clarified.

1 malachite green-leuco – 1,4 ppb – muscle – trout (suspect sample)

The farm was investigated and placed under official control (22/08/2011-08/09/2011) by the Provincial Governor (official veterinarian) in accordance with Article 58 of the Food Safety and Consumer Protection Act. Verification of the records. Two official samples were taken; the samples were compliant. Intensified checks for the following 12 months. No verification of the illegal use of malachite green.

Wild game 6 lead – 0,3 – 0,45 – 0,59 – 1,38 – 4,05 and 5,08 ppm – muscle – deer. 2 lead – 1,8 and 81,3 ppm – muscle – wild boar(targeted samples).

In wild game the detection of lead can be mostly traced back to environmental pollution and sometimes to bullets (to some extent depending on the modern construction of bullets and the type of bullets). The contamination of the meat also depends on the way the bullets penetrate the body of the animals.

1 lead – 146 ppm – muscle – deer. 1 lead – 1,9 ppm – muscle – wild boar (suspect samples).

The samples were taken from wild game in order to verify own checks. The animals were shot in an area, which is used as a military training area. The carcases were declared unfit for human consumption and disposed of according to Reg. (EC) No 1069/2009. It was not possible to verify the reason of the contamination with lead.

91

BE BELGIUM

Group A substances

Modification of national residue plan Until 2012, cows with a carcass weight > 600 kg were considered as suspect to have been treated with anabolic substances: a sample was taken for analysis and the carcass was retained pending the result. From 2012, the carcass weight level for suspicion has been increased to 630 kg. In the same time, new sampling criteria have been set in 2012 RCP :

- 250 samples of urine will be taken from female bovine weighing from 560 to 630 kg, with good conformation, low level of fat

- 100 samples of urine from male bovine, less than 24 months, weight > 600 kg

These samplse will be analysed for A1, A3, A4, A5 and corticosteroids. In 2012 analyses for forbidden substances were added in wild animals due to information related to use of forbidden substances at the time of feeding of wild :

- CAP : 30 large animals and 20 birds - Nitrofurans : 30 large animals and 20 birds - Nitro-imidazoles : 30 large animals and 20 birds

Non-compliant results Follow-up actions 1/ Prednisolone (6,8 ppb) – urine – target sample – slaughterhouse – bovine

Investigation on farm. Samples of animal matrices, feed and material were taken. Fattening animals were put under temporary seizure. All samples were compliant. H-status allocated.

2/ Prednisolone – urine – target sample – slaughterhouse – sheep

Investigation on farm. Check of the VMP register. Interview of the holder.

3/ AMOZ – target sample – slaughterhouse – pigeon


4/ Methylprednisolone – injection site – suspect sample – pig – slaughterhouse

Animal from France. See also group B.

5/ Dexamethasone – injection site – suspect sample – pig –slaughterhouse

Animal from France. See also group B.

6/ Dexamethasone – injection site – suspect sample – pig –slaughterhouse

Animal from France. See also in group B substances.

7/ Dexamethasone – injection site Animal from Spain.

92

– suspect sample – pig –slaughterhouse 8/ Dexamethasone – injection site – suspect sample – slaughterhouse – pig

Animal from the Netherlands. See also group B.

9/ Methylprednisolone – injection site – suspect sample – pig – slaughterhouse

Animal from France. See also 9 in group A.

10/ Dexamethasone – injection site – suspect sample – slaughterhouse – bovine

Carcass destroyed. Investigation on farm. Samples of animal matrices, feed and material were taken. Fattening animals were put under temporary seizure. All samples were compliant. R-status allocated.

11/ Prednisolone – feces – suspect sample – farm – calf

Sample taken in the frame of a follow-up in farm. Samples of animal matrices, feed and material were taken. Fattening animals were put under temporary seizure. All samples were compliant.

12/ Prednisolone (> 5 ppb ppb) – urine – suspect sample - bovine

Sample taken in the frame of a follow-up in farm. Samples of animal matrices, feed and material were taken. Fattening animals were put under temporary seizure. All samples were compliant.

13/ Dexamethasone + dexamethasone isonicotinoate – material – suspect sample – slaughterhouse – pig

In the frame of a follow-up in farm after presence of prednisolone in urine. Samples of animal matrices, feed and material were taken. Fattening animals were put under temporary seizure. All samples were compliant.

Results from official samples taken during monitoring / suspicion in farm or at slaughterhouse level showing presence of some A substances but which could not been considered as non compliant. Results from non-official samples.

In these cases, an investigation on farm was performed, samples of animals, feed and material are taken and fattening animals are put under temporary seizure until the results.

Nortestosterone alpha (3 ppb) – urine – target sample – bovine

It was a cow. Investigation on farm. Samples of animal matrices, feed and material were taken. Fattening animals were put under temporary seizure. All these

93

samples were compliant. A bottle containing dexamethasone but with proof of supply from a vet.

Beta nortestosterone (4.4 ppb) – target sample – urine – slaughterhouse – pig

Investigation on farm. Samples of animal matrices, material and milk were taken. Fattening animals were put under temporary seizure. All these samples were compliant.

Beta nortestosterone (17 ppb) + prednisolone (2 ppb) – target sample – urine – slaughterhouse – pig

Investigation on farm. Samples of animal matrices, material and milk were taken. Fattening animals were put under temporary seizure. All these samples were compliant.

Thiouracyl (6 cases from 11 to 37 ppb) – target sample – urine – farm/slaughterhouse – calf and bovine

Investigation on farm. Samples of animal matrices, material and milk were taken. Fattening animals were put under temporary seizure. All these samples were compliant but in 1 farm a urine sample was positive for thiouracyl (11 ppb).

Prednisolone (13 cases, < 5 ppb) – urine – target sample – slaughterhouse – bovine

Investigation on farm. Samples of animal matrices, material and feed were taken. Fattening animals were put under temporary seizure. All these samples were compliant.

Prednisolone (27 cases, > 2 ppb) – urine – target sample – slaughterhouse – pig

Investigation on farm. Samples of animal matrices, material and feed were taken. Fattening animals were put under temporary seizure. Sampling at slaughterhouse on animals coming from these farms: about 20 % of these samples positive for prednisolone. See also group A 13. In 2012, no more seizure but the holder has to inform Belgian Food Agency when a lot of animals is sent to slaughterhouse in order samples can be taken Other source than treatment under investigation. As natural occurrence has been proved in bovine, no H-status and no movement restriction are applied.

Administrative measures: H status: for 52 weeks, animals from the farm may only be sent to slaughterhouse in Belgium where 10 % of them are analysed at the expense of the farmer. In case of new infringement during this period, another period of 104 weeks is added to the first one. 1 H status was allocated in 2011

94

due to use of corticosteroids.

CRIMINAL PENALTIES: IN ALL CASES OF INFRINGEMENTS RELATING TO GROUP A SUBSTANCES (EXCEPT A6), A PRO JUSTITIA IS SENT TO PROSECUTOR WHO DECIDES WHETHER PROSECUTION OR NOT (LAW 15 JULY 1985 HORMONES1 E.A.).

1 Loi du 15 Juillet 1985 relative à l’utilisation de substances à effet hormonal, à effet anti-hormonal, à effet beta-adrénergique ou à effet stimulateur de production chez les animaux.

Group B substances

Modification of national residue plan In 2012, analyses were added in wild animals due to information related to use of VMPs at the time of feeding of wild: benzimidazoles - 50 large animals. Non-compliant results Follow-up actions

Bovines

Benzylpenicillin (29.302 ppb) – injection site – suspect sample – bovine – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Carcass destroyed.

Sulfadimethoxine (37576 ppb) + trimethoprim (30801 ppb) – injection site – suspect sample – slaughterhouse – bovine

Sulfadimethoxine (276 ppb) + trimethoprim (132 ppb) – muscle – suspect sample – slaughterhouse – bovine


Flunixin + meloxicam – injection site – bovine – suspect sample – slaughterhouse

Meloxicam – muscle – bovine – suspect sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Carcass destroyed. Allocation of a R-status.

Enrofloxacin + ciprofloxacin – injection site – bovine – suspect sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Carcass destroyed. H-status allocated.

95

Enrofloxacin + ciprofloxacin – injection site – bovine – suspect sample – slaughterhouse

Animal from the Netherlands.

Tetracycline (159 ppb) - injection site – suspect sample – bovine – slaughterhouse


Carprofen – injection site – suspect sample – bovine – slaughterhouse

Emergency slaughter. Treatment recorded id FCI.

Benzylpenicillin (244258 ppb) + clorsulon (99 ppb) + dihydrostreptomycin (> 1500 ppb) + ivermectin + streptomycin (1140 ppb) – injection site – bovine – suspect sample – slaughterhouse

Dihydrostreptomycin ( > 1500 ppb) – muscle – bovine – suspect sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Carcass destroyed. R-status allocated.

Tylosin (2010 ppb) – injection site – suspect sample – bovine – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Carcass destroyed. Interview of the veterinarian.



Flunixin + tylosin (3438 ppb) – injection site – suspect sample –bovine – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Interview of the vet. Carcass destroyed. Allocation of R-status.

Tilmicosine (71 ppb) – injection site – bovine – suspect sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Interview of the vet. Carcass destroyed.

Flunixin + Moxidectin – injection site – suspect sample – bovine – slaughterhouse


Dihydrostreptomycin ( > 1500 Investigation on farm. Check of the VMP register. Interview of the holder. Interview

96

ppb) – injection site – suspect sample – bovine – slaughterhouse

of the vet. Carcass destroyed. Allocation of R-status.

Dihydrostreptomycine (1633 ppb) + flunixin + tolfenamic acid – injection site – suspect sample –bovine – slaughterhouse


Metamizol - injection site + muscle – suspect sample – bovine – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Carcass destroyed. Allocation of R-status.

Enrofloxacine (123 ppb) + oxytetracycline (250 ppb) + tolfenamic acid – injection site – suspect sample – bovine –slaughterhouse

Tolfenamic acid – muscle – suspect sample – bovine – slaughterhouse


Tylosin (102 ppb) + spiramycin (84.400 ppb) – injection site – suspect sample – bovine – slaughterhouse


Sulfadimethoxine (219.982 ppb) + trimethoprim (205.480 ppb) – injection site – suspect sample – bovine – slaughterhouse


Tolfenamic acid – injection site – suspect sample – bovine – slaughterhouse


Flunixin – injection site – suspect sample – bovine – slaughterhouse


Tolfenamic acid + dihydrostreptomycin (12.050 ppb) – injection site – suspect sample – bovine – slaughterhouse


Trimethoprim + sulfadimethoxine + dihydrostreptomycin – injection


97

site – suspect sample – bovine –slaughterhouse

Enrofloxacin (> 100 ppb) + ciprofloxacin (76 ppb) – injection site – suspect sample – bovine –slaughterhouse


Closantel – injection site – suspect sample – bovine – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Interview of the vet. Carcass destroyed..

Closantel – injection site – bovine – suspect sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Interview of the veterinarian. Carcass destroyed.

Tilmicosine (63.800 ppb) + meloxicam + ivermectin (290 ppb) – injection site – suspect sample – bovine – slaughterhouse

Tilmicosine (1.450 ppb) + meloxicam – muscle – suspect sample – bovine – slaughterhouse




Tolfenamic acid – injection site – bovine – slaughterhouse


Dihydrostreptomycin (1.896 ppb) + spectinomycin (832 ppb) – injection site – suspect sample – bovine – slaughterhouse


Oxytetracycline (398.564 ppb) + tetracycline (1.820 ppb) – injection site – suspect sample – bovine – slaughterhouse


Oxytetracycline (267 ppb) – injection site – suspect sample – bovine – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Interview of the vet. Carcass destroyed. Allocation of a R-status.

Oxytetracycline (658 ppb) – Investigation on farm. Check of the VMP register. Interview of the holder. Carcass

98

injection sites – suspect sample – bovine – slaughterhouse

destroyed.

Tylosin (2.770 ppb) – injection sites – suspect sample – bovine – slaughterhouse


Flunixin + meloxicam – injection site – suspect sample – bovine –slaughterhouse




Oxytetracycline (235 ppb) – injection site – suspect sample – bovine – slaughterhouse

Oxytetracycline (118.155 ppb) + tetracycline (954 ppb) + tilmicosine (90 ppb) – injection site – suspect sample – bovine – slaughterhouse

Oxytetracycline (261 ppb) – muscle – suspect sample – bovine – slaughterhouse



Investigation on farm. Check of the VMP register. Interview of the holder. Interview of veterinarian. Carcass destroyed.

Ivermectine (1.074 ppb) + tilmicosine (162 ppb) + Closantel – injection site – suspect sample – slaughterhouse

Tilmicosine (520 ppb) + Closantel – muscle – suspect sample – bovine – slaughterhouse


Levamisole – injection site – suspect sample – bovine – slaughterhouse


Spectinomycine (> 900 ppb) – Investigation on farm. Check of the VMP

99

injection site – suspect sample – bovine – slaughterhouse

register. Interview of the holder. Carcass destroyed.

Closantel + ivermectine (> 600 ppb) – injection site – suspect sample – bovine – slaughterhouse

Closantel + ivermectine (> 600 ppb) – muscle – suspect sample – bovine – slaughterhouse


Tilmicosine (71 ppb) – injection site – suspect sample – bovine – slaughterhouse


Carprofen – injection site – suspect sample – bovine – slaughterhouse


Oxytetracycline (1.142 ppb) – injection site – suspect sample – bovine – slaughterhouse


Moxidectine (76 ppb) – injection site – suspect sample – bovine – slaughterhouse

Moxidectine (74 ppb) – muscle – suspect sample – bovine – slaughterhouse






Phenylbutazone + tylosine (713 ppb) – injection site – suspect sample – bovine – slaughterhouse

Phenylbutazone – muscle – suspect sample – bovine – slaughterhouse


100

Benzylpenicilline (462.270 ppb) – injection site – suspect sample – bovine – slaughterhouse


Oxytetracycline (58.528 ppb) + tetracycline (679 pp) – injection site – suspect sample – bovine – slaughterhouse


Neomycin (1.066 ppb) – injection site – suspect sample – bovine – slaughterhouse


Benzylpenicillin – injection site – suspect sample – bovine – slaughterhouse


Dihydrostreptomycin (2.500 ppb) + meloxicam – suspect sample bovine – slaughterhouse

Meloxicam – muscle – suspect sample – bovine – slaughterhouse


Levamisole (40 ppb) – muscle – suspect sample – bovine – slaughterhouse

Levamisole (20 ppb) – muscle – suspect sample – bovine – slaughterhouse




Pigs Lincomycin (3.260 ppb) – kidney – target sample – slaughterhouse Lincomycin (171 ppb) – muscle – target sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. R-status allocated.

Sulfadiazine (> 200 ppb) – kidney – target sample – slaughterhouse Sulfadiazine (>200 ppb) – muscle – target sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. R-status allocated. 193 tonnes still at cutting plan, sampling and analysis, 1 lot non-compliant and destroyed. RASFF.

101

Sulfadiazine (> 200 ppb) – kidney – target sample – slaughterhouse Sulfadiazine (140 ppb) – muscle – target sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. 27 tonnes of products destroyed. R-status allocated.

Monensin (5,6 ppb) – muscle – target sample – slaughterhouse

Investigation on farm. Check of the VMP register. Interview of the holder. Interview of the transporter. Interview of the dealer. Carcass destroyed. Non-compliance regarding trade. Pro-Justitia against the holder, the transporter and the dealer.

Metamizole (> MRL) – injection site – suspect sample – slaughterhouse Metamizole (> MRL)) – muscle – suspect sample – slaughterhouse


Flunixine – injection site – suspect sample – pig – slaughterhouse


Tolfenamic acid – injection site – suspect sample – pig – slaughterhouse

Animal from France.

Sulfadimethoxine (61.371 ppb) + trimethoprim (48.311 ppb) – injection site – suspect sample – pig – slaughterhouse Sulfadimethoxine (345 ppb) – muscle – suspect sample – pig – slaughterhouse


Benzylpenicillin (10.405 ppb) – dihydrostreptomycine (> 1.500 ppb) + florfenicol (> 1.500 ppb) + ketoprofen + tylosin (4.510 ppb) –injection site – suspect sample – pig – slaughterhouse

Animal from France.

Neomycin (> 1.500 ppb ppb)-injection site – suspect sample – pig – slaughterhouse


Penicillin G – injection site – suspect sample – pig – slaughterhouse


Metamizole - injection site – suspect sample – pig – slaughterhouse


102

Metamizole – muscle – suspect sample – pig – slaughterhouse Flunixin + spectinomycin (526 ppb) – injection site – suspect sample – pig – slaughterhouse


Flunixin – injection site – suspect sample – pig – slaughterhouse

Animal from France.

Benzylpenicilline (41.414 ppb) + dihydrostreptomycin (1.477 ppb) + flunixin + Ketoprofen – injection site – suspect sample – pig – slaughterhouse

Animal from France. See also 5 group A.

Dihydrostreptomycin ( > 1.500 ppb) + flunixin – injection site – suspect sample – pig – slaughterhouse


Sulfamethoxazole (10.717 ppb) + trimethoprim ( 4.276 ppb) – injection site – suspect sample – pig – slaughterhouse Sulfamethoxazole (522 ppb) + trimethoprim (103 ppb) – muscle – suspect sample – pig – slaughterhouse


Azaperone (> 100 ppb) – injection site – suspect sample – pig – slaughterhouse


Metamizole – injection site – suspect sample – pig – slaughterhouse


Marbofloxacine ( > 200 ppb) + flunixin – injection site – suspect sample – pig – slaughterhouse

Animal from France. See also 6 in group A substances.

Neomycin (> 1.500 ppb) – injection site – suspect sample –pig – slaughterhouse Neomycin (1.378 ppb) – muscle – suspect sample – pig – slaughterhouse

Animal from France.

Benzylpenicillin (21.935 ppb) + ivermectine + tylosine (735 ppb) – injection site – suspect sample – pig – slaughterhouse

Animal from Poland

Enrofloxacin (109 ppb) + flunixin Animal from Spain.

103

– injection site – suspect sample – pig – slaughterhouse Sulfadoxine (778 ppb) – injection site – suspect sample – pig – slaughterhouse Sulfadoxine (469 ppb) – muscle – suspect sample – pig – slaughterhouse


Oxytetracyclin (129.472 ppb) + tetracycline (3.028 ppb) – injection site – suspect sample – pig – slaughterhouse


Sulfadiazin (127 ppb) – injection site – suspect sample – pig – slaughterhouse


Flunixine + spiramycin (1.380 ppb) - injection site – suspect sample – pig – slaughterhouse

Animal from France.

Dihydrostreptomycin (14.597 ppb) + penicillin (215 ppb) – injection site – suspect sample – pig – slaughterhouse

Animal from Spain.

Dihydrostreptomycin (56.000 ppb) + meloxicam – injection site – suspect sample – pig – slaughterhouse Dihydrostreptomycin (675 ppb) – muscle – suspect sample – pig – slaughterhouse


Benzylpenicillin (42.579 ppb) + neomycin (2.390 ppb) – injection site – suspect sample – pig – slaughterhouse


Benzylpenicilline (56.634 ppb) + dihydrostreptomycine (3.260 ppb) + flunixine – injection site – suspect sample – pig – slaughterhouse

Animal from France.

Azaperol + azaperone (> 120 ppb) + benzylpenicillin (46.980 ppb) + flunixin + moxidectin (> 1.500 ppb) – injection site – suspect sample – pig – slaughterhouse


104

Ciprofloxacin + enrofloxacin + metamizol – injection site – suspect sample – pig –slaughterhouse


Sulfadimethoxine (61.371 ppb) + trimethoprim (48.311 ppb) – injection site – suspect sample – pig – slaughterhouse Sulfadimethoxine (345 ppb) – injection site – suspect sample – pig – slaughterhouse


Flunixin – injection site – suspect sample – pig – slaughterhouse

Animal from France.

Poultry

Ketoprofen (45 ppb) – muscle – broiler – target sample – slaughterhouse


Sheep and goat Monensin (88,1 ppb) – muscle – sheep – target sample – slaughterhouse


Horses Clenbuterol – eye – suspect sample – horse Acetylsalicilic acid + phenylbutazone – injection site – slaughterhouse – suspect sample – horse

Horse euthanized following accident during a local competition (see under). Investigation on farm. Check of VMP register. Interview of the holder. Bottle of VMPs containing clenbuterol, dexamethasone and ACTH (Synacthen) found in stock.

Methylprednisolone – blood – horse

Investigation on a local horse competition. 19 horses sampled; 3 material monster found in cars and vans (syringe, needle, bottle). 2 samples positive: nortestosteronephenylpropionate and dexamethasone. Horses whose passport shown they were intended for slaughtering for human consumption were excluded for that purpose by entry in the passport. 10 of the horses didn’t comply with identification rules. Interview of the owner. Pro Justitia were sent to prosecutor.

Investigation on a local horse competition. 29 horses sampled, all compliant. Material samples taken in cars and vans, some

105

samples were positive for dexamethasone and prednisolone.

As follow-up of these investigations, investigations were performed on 2 premises. In one premises, esters of testosterone, nortestosterone phenylpropionate, betamethasone, betamethasone diproprionate were found in syringes and needles. VMPs containing ACTH were found (Synachten).

Milk Diclofenac – target sample Investigation on farm. Check of VMP

register. Interview of the holder. Levamisole + triclabendazole – cow milk – target sample

Investigation on farm. Check of VMP register. Interview of the holder. Warning to the holder.

Eggs Flumequine (13 ppb) – target sample

Investigation on farm. Check of VMP register. Interview of the holder. 36 kg eggs destroyed.

Farmed game Monensin (8,7 – 84,7 – 31,6 ppb) – deer – muscle – slaughterhouse

Animals from the same holding. Investigation on farm. Check of VMP register. Interview of the holder. Analysis of compound feed on farm : compliant. Analysis of feed used to produce the compound feed at feed mill : presence of monensin < maximum limit for cross-contamination (75 ppb to 336 ppb).

Monensin (244,4ppb) – deer – muscle – slaughterhouse


Administrative measures R status: R-status: for a 8 weeks period the

identification document of the animals of the same species (bovine, pigs) from the herd are marked with a R symbol. In the slaughterhouse, 10 % of these animals are sampled. In case of new infringements during this period, the period will be extended by 26 weeks. The analyses are at the expense of the responsible of the herd. R-status were allocated to bovine farms: 11 (+ 2 due to non-compliant results in 2011). R-status were allocated to pig farms: 11

106

Official reports sent to the legal service for the attribution of administrative penalty: 22. Fines paid: 16. In 4 cases, the report was sent to the prosecutor for follow-up. In all cases, prosecution was given up.

107

BG BULGARIA

Group A substances

Modification of national residue plan No changes

Non-compliant results Follow-up actions None None

Group B substances

Modification of national residue plan

No changes Non-compliant results Follow-up actions

Poultry Chlortetracycline (179.13 mg/kg) and Aminoglycosides (screening method) – targeted sample, in muscles from Mulard ducks – slaughterhouse

Investigation on farm. Interview of the holder. Investigation on slaughterhouse for white meat and object for storage and wholesale. Destruction of Maigret (white meat). As a result from the taken actions, suspect samples were taken. The samples show negative result.

108

CY CYPRUS

Group A substances

Modification of national residue plan Sampling should take place over the entire year (January to December). The tender of Veterinary Services of Cyprus for the interest of accredited laboratories to carry out the laboratory examinations of substances of animal tissues and food of animal origin that are included in the National Residues Plan concerning the year 2013 must be published in the European gazette early in July 2012. Horsemeat: there is no slaughterhouse for horses. Horsemeat is not used for human consumption in Cyprus. Horses exported from Cyprus accompanied by a Passport (Commission Decision 2000/68/EC, Commission Regulation 504/2008/EC) is implemented on the basis of “Genetic improvement of Animals” Laws of 2001 and 2004, Κ.∆.Π. 224/2009, Αρ. 4361, 29.05.2009 in which mentioned all the drugs used for this horse and the withdrawal period. The number of horses (animals) 5.200 which included in the plate of production by species of the database are the total live horses population of Cyprus, not slaughtered animals. Efforts are in progress to arrange NRP tests to be carried out in foreign accredited laboratories in order to cover all the numbers on all substances provided in the programme for the year 2012. We confirm that all methods used by the foreign laboratories to carry out analysis were validated and accredited. This is a basic term included in the Tender. During the evaluation of laboratories responded to the Tender, the evaluation committee checked first if the method used by the laboratory is validated and accredited and for which matrix and if this method is included in the list of the accreditation body. We confirm no any changes of substances analysis in 2012 National Residue Plan. We have minor changes in number of samples. Non-compliant results Follow-up actions None None

Group B substances

Modification of national residue plan NONE

NON-COMPLIANT RESULTS Non-compliant results Follow-up actions

Pigs Sulphadimidine – LCMSMS – sulphadimidine 210 μg/kg – muscle (MRL in muscle 100

Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (11000 Fattening pigs / 1100 sows).

109

μg/kg) Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Others.

Maduramycin – LCMSMS – Maduramycin 7,85 μg/kg – Porcine liver (Regulation 37/2010/EU No MRL, Regulation 124/2009, ML in liver 2 μg/kg)

Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (350 fattening pigs / 126 sows). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Others.

Sheep and goats Oxytetracycline – LCMSMS Oxytetracycline 2.173 μg/kg – muscle (MRL in muscle 100 μg/kg)

Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (169 goats and 200 sheep). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements.

Poultry Maduramycin – LCMSMS – Maduramycin 3,43 μg/kg – Broilers – liver (Regulation 37/2010/EU No MRL Regulation 1831/2003/EC, MRL in liver 800 μg/kg)

Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (404.000 broilers). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Others.

Maduramycin – LCMSMS – Maduramycin 11,5 μg/kg – Broilers – liver (Regulation 37/2010/EU No MRL, Regulation 1831/2003/EC, MRL in liver 800 μg/kg)


Maduramycin – LCMSMS – Maduramycin 4,36 μg/kg – Broilers – liver (Regulation 37/2010/EU No MRL Regulation 1831/2003/EC, MRL in liver 800 μg/kg)


Maduramycin – LCMSMS – Maduramycin 203 μg/kg – Broilers – liver (Regulation 37/2010/EU No MRL, Regulation 1831/2003/EC MRL in liver 800 μg/kg)


Milk Antibiotics – inhibitors (Delvo Case 1: Investigation in the farm of origin.

110

SP test) – Dairy cows farms (3 cases)

Verification of records. Additional sampling. Animals held in the farm (78 cows). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Carcasses and products declared unfit for human consumption (6.056,7 lt. of milk confiscated and destroyed). Administrative measures. Others. Case 2: Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (296 cows). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Carcasses and products declared unfit for human consumption (800 lt. of milk confiscated and destroyed). Administrative measures. Others. Case 3: Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (217 cows). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Carcasses and products declared unfit for human consumption (1.925 lt. of milk confiscated and destroyed). Administrative measures. Others.

Antibiotics – inhibitors (Delvo SP test) – Sheep and Goat farms (5 cases)

Case 1: Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (1841 sheep). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Carcasses and products declared unfit for human consumption (2400 lt of milk confiscated and destroyed). Administrative measures. Others. Case 2: Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (32 sheep and 522 goats). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Carcasses and

111

products declared unfit for human consumption (250 lt. of milk confiscated and destroyed). Administrative measures. Others. Case 3: Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (143 sheep and 53 goats). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Carcasses and products declared unfit for human consumption (100 lt. of milk confiscated and destroyed). Administrative measures. Others. Case 4: Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (120 goats and 16 sheep). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Carcasses and products declared unfit for human consumption (150 lt. of milk confiscated and destroyed). Administrative measures. Others. Case 5: Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (175 goats). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Carcasses and products declared unfit for human consumption (3.647 lt. of milk confiscated and destroyed). Administrative measures. Others.

Diclofenac – LCMSMS – diclofenac 5,56 μg/kg – sheep milk

Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (28 sheep and 4 goats). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Administrative measures. Others.

Aflatoxin M1 – Modified method AOAC 2008.08 (2005) – 0,081 ± 0,016 μg/kg

Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (745 goats and 1252 sheep). Intensified checks on the animals and products

112

from the farm / establishment in the event of repeated infringements. Administrative measures. Others.

Rabbits Diclazuril - LCMSMS – diclazuril 18,03 μg/kg – rabbit – liver (Regulation 37/2010/EU No MRL)

Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (800 parents stock and 2700 fattening). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Others.

Diclazuril – LCMSMS – diclazuril 13,19 μg/kg - rabbit – liver (Regulation 37/2010/EU No MRL)

Investigation in the farm of origin. Verification of records. Additional sampling. Animals held in the farm (50 parents stock). Intensified checks on the animals and products from the farm / establishment in the event of repeated infringements. Others.

113

CZ CZECH REPUBLIC

Group A substances

Modification of national residue plan None

Non-compliant results Follow-up actions 1x 17-alfa-19-nortestosteron: calf-urine (3,4 ppb)

Follow-up investigation was conducted on the farm. Additional tests did not find the use of banned hormonal substances. Increased level of the hormone was probably caused by stress during sampling.

1x 17-beta-19-nortestosteron: fattening pig-urine (35,0 ppb)

Follow-up investigation was conducted on the farm. Hormonal VMP was not used on the farm. Additional sample of urine was taken – compliant. Increased level of the hormone was probably a consequence of stress.

1x CAP: cow-urine (26,0 ppb) Follow-up investigation was conducted on the farm. No evidence of the use of CAP on farm. Five results of follow-up samples (urine) and one sample of bulk milk were non-compliant. Extraordinary veterinary measures were imposed – five positive cows were condemned, all of the other cows were individually tested (154 samples of urine), whole production of milk was daily removed to dunghill, movement of animals was banned until compliant result. All expenses for the examinations were on farmer budget. Individual responsibility was not proved. The fine was imposed.

1x CAP: chicken (broiler)-muscle (0,3 ppb)

Follow-up investigation was conducted on the farm. Additional samples were analysed (2x broiler, 1x water) – compliant. Source of residues was not identified. The fine was imposed.

Group B substances

Modification of national residue plan

Focusing on antibiotic residues in edible tissues of sows and content of heavy metals in tissues of animals.


114

Bovines 2 mercury: cow – kidney (0,0211 and 0,024 ppm)

Follow-up investigation was conducted on the farm and on the slaughterhouse. Additional samples of feed and kidneys were compliant (3 samples).

1x benzylpenicilline: cow – kidney (84,0 ppb)

Follow-up investigation was conducted on the farm and on the slaughterhouse. Use of VMP with benzylpenicilline was not proved. Additional 3 samples (muscle, liver, kidney) were taken– compliant.

1x cadmium: cow – kidney (1,19 ppm)

Follow-up investigation was conducted on the slaughterhouse. Additional 2 samples of cow´s kidney were compliant.

Pigs dihydrostreptomycine: sow – 3.527 ppb (kidney) and 2.027 ppb (liver)

Farm investigation was conducted. Medicine records and storage checked. The sow had been slaughtered 4 days before the end of the withdrawal period. The fine was imposed to the farmer and private vet.

dihydrostreptomycine: sow – 4.342 ppb (kidney) and 1.372 ppb (liver)

Farm investigation was conducted. Medicine records and storage checked. Additional samples (muscle, liver and kidney) from 2 sows were taken – compliant. The fine was imposed.

dihydrostreptomycine: sow – 31.118 ppb (kidney) and 2.795 ppb (liver) and 1x benzylpenicilline in kidney (613 ppb)

Farm investigation was conducted. Medicine records and storage checked. The sow had been slaughtered several days before the end of the withdrawal period. The fine was imposed to the farmer.

2x dihydrostreptomycine: sow – liver (1.361 ppb and 595 ppb)

Farm investigation was conducted. Medicine records and storage checked. Additional samples (muscle, liver and kidney) from 1 sow were taken – compliant. The fine was imposed.

3x amoxicillin: sow – kidney (56,0 – 1.677 and 229 ppb)

Farm investigations were conducted (three different farms). Medicine records and storage checked. The sows had been slaughtered several days before the end of the withdrawal periods. Additional samples (3x muscle, liver, kidney) were taken – compliant. The fines were imposed to the farmers.

1x residue of inhibitory substances: fattening pig – kidney (positive)

Farm investigation was conducted. Medicine records and storage checked. Confirmation of the inhibitory substance was not successful (HPLC MS/MS).

115

1x residue of inhibitory substances: sow – kidney (positive)

Farm investigation was conducted. Medicine records and storage checked. Confirmation of the inhibitory substance was not successful (HPLS MS/MS).

1x DDT sum: fattening pig – muscle (2.102 ppm)

Small pig farm (17 pigs) is situated in adapted historical building. DDT was found out in dust from earlier rough-grind of corn (DDT sum 51.140 ppm). Environment of stable was cleaned and decontaminated.

5x mercury in kidney Follow-up investigations were conducted on the farms and on the slaughterhouses. Additional samples of feed and kidneys were taken.

mercury in kidney 2x: sows – kidney (0,0351 and 0,032 ppm)

Two different farms. In total: 3 additional samples of feed were comliant; 5 additional samples of kidney were compliant.

mercury in kidney 3x: fattening pigs – kidney (0,0254 – 0,039 and 0,028 ppm)

Three different farms. In total: 13 additional samples of feed were compliant; 4 additional samples of kidney were compliant. 8 samples – non-compliant (0,0527 ppm, 0,0223 ppm, 0,0281 ppm, 0,025 ppm, 0,056 ppm, 0,046 ppm, 0,063 ppm, 0,031 ppm). (There is a suspicion that increased concentration of mercury in kidney could be a consequence of the use of thiomersal- containing vaccines (with ethyl Hg).

Poultry 2x semduramicine: chicken – broiler – liver (4,64 and 3,68 ppb)

Farm investigations were conducted. Additional samples (liver) from the subsequent batch were compliant. The most likely cause was considered to be cross-contamination either on the farm or at the feed mill, although the source could not be proved unambiguously. Investigations are conducted in cooperation with Central Institute for Supervising and Testing in Agriculture.

Sheep and Goats 2x cadmium: sheep – kidney (2.526 and 1,33 ppm)

Farm investigations were conducted. One of the farm is situated not far away from area of the former glass factory. Residues of cadmium, lead and arsenic were found in samples of soil, hay, vegetables and door paint (was removed). The investigation is still ongoing.

Horses 1x phenylbutazone Investigations at slaughterhouse and on farm

116

(19,18 ppb) and 1x oxyphenbutazone (57,12 ppb):in the same animal – horse (mare) – muscle

were conducted. There was used VMP which is not authorized (phenylbutazone) for food producing animals. The carcass was condemned. Fines were imposed to the horse owner as well as to his private vet.

1x cadmium – kidney (2,86 ppm)

There was no follow-up investigation. Horse was not intended for human consumption.

1x cadmium – liver (1,46 ppm) There was no follow-up investigation. Horse was not intended for human consumption.

Milk 1x cefoperazon: sheep´s milk (5,5 ppb)

Farm investigation was conducted. Medicine records and storage checked. Used of cefoperazon was not proved (VMP is not authorized for sheep - ATB with restricted indication).

Rabbit 1x tulathromycin: rabbit - muscle (456,0 ppb)

Farm investigation was conducted. Medicine records and storage checked. There was used VMP with tulathromycin not approved for rabbit treatment. Additional samples (muscle) from the subsequent batch were compliant. The fines were imposed to the farmer and private vet.

1 robenidine: rabbit-liver (9,32 ppb)

Farm investigation was conducted. The residue was considered cross-contamination of the feed due to use of robenidine during the fattening together with poor feed practice on farm. Livers from non-compliant batch were condemned. Additional samples (liver) from the subsequent batch were non-compliant too. Livers from non-compliant batch were condemned. The fines were imposed to the farmer and to the feed producer. Aquaculture

14x leuco-malachite green: trout – muscle (0,57 – 29,4 – 20,1 – 0,85 – 1,11 – 0,85 – 1,5 – 1,47 – 0,58 -2,88 – 1,64 and 4,09 ppb)

Farm investigations were conducted. All batches of trout with concentration of sum MG/LMG above 2 ppb were condemned. Subsequent investigation will be conducted on these farms.

1,08 ppb / from PL / 1,24 ppb / from AT / 1x

Communicated through RASFF (2011.1543 and 2011.1568)

Leuco-malachite green: carp - muscle (1,08 ppb)

Farm investigation was conducted. Illegal use of MG was not ascertained. Subsequent investigation will be conducted.

117

1x leuco-malachite green + malachite green: pollan – muscle (vendace) (0,99 and 0,49 ppb)

Farm investigations were conducted. Illegal use of MG was not ascertained. Subsequent investigation will be conducted.

2x leuco-cristalviolet: trout – muscle (3,75 and 5,02 ppb). From SK.

Farm investigations were conducted. Medicine records and storage checked. There was no discovered use of CV. Spawn was purchased from one company from Slovakia. RASFF 2012.0006 Farmed game

1x lead: red deer – muscle (7,57 ppm)

Red deer was legally killed by firearm. Owner of the farm was informed about the problem of lead contamination from shot and about the necessity for the removal of meat from the site of shot wound.

Wild game 6x lead: wild boar – muscle (0,37 – 0,401 - 0,299 – 4,44 – 9,2 and 22,2 ppm)

There were no follow-up investigations as the residues were likely to have been the result of the boars being shot. Owners of wild game plants were warned of the problem of contamination of lead from shot and on necessity for the removal of meat from the site of shot wound.

9x lead: pheasant – muscle (0,329 – 5,836 – 2,22 – 2,85 – 0,85 – 14,6 – 3,04 – 0,32 and 2,3 ppm)

There were no follow-up investigations as the residues were likely to have been the result of the animals being shot. Owners of wild game plants were warned of the problem of contamination of lead from shot and on necessity for the removal of meat from the site of shot wound.

6x lead: wild duck – muscle (0,438 – 4,44 – 1,35 – 1,83 -0,19 and 1,315 ppm)


4x lead: roe deer – muscle (1,09 – 0,39 – 0,805 and 0,25 ppm)

There were no follow-up investigations as the residues were likely to have been the result of the animals being shot. Owners of wild game plants were warned of the problem of contamination of lead from shot and on necessity for the removal of meat from the site

118

of shot wound. 2x lead: fallow deer – muscle (54,8 and 51,9 ppm)


1x dioxins /WHO-PCDD/F-TEQ; WHO PCDD/F-PCB-TEQ: wild boar – muscle (40,4 and 63,4 pg/g)

Wild boar was about 5 years old. Carcass was condemned. Additional samples of meat from the batch were taken (19 wild boards) – compliant. Contaminated wild boar was hunted in the spot of former military area. Additional 3 samples of wild board meat were taken in this area – non-compliant. The investigation is still ongoing.

1x Cesium137 and Cesium134: wild boar – muscle (4.028,73 Bq/kg)

Result of the Chernobyl accident (area contaminated because of the radioactive fallout). Additional 39 samples were taken – 22 out of them non-compliant. Extraordinary veterinary measures were imposed. Investigation is still ongoing.

Honey 1 lead: honey (0,45 ppm) Additional two samples were taken – compliant.

119

DE GERMANY

Group A substances

Modification of national residue plan No changes. Non-compliant results Follow-up actions 1 chloramphenicol – beef cattle – urine – 0,28 µg/kg

The source of the residue could not be identified. On-site investigation at the farm of origin; examination of the records; 5 x additional sampling; ban on transport and delivery of livestock; increased controls in the establishment of origin; criminal proceedings under food law and under drug law; increased controls at the farm of origin pursuant to § 10 Food of Animal Origin Control Regulations – Tier-LMÜV

1 chloramphenicol - fattening pigs – urine – 5,36 µg/kg

Entry via feed. On-site investigation at the farm of origin; examination of the records; 40 additional samples drawn together with the Public Prosecutor from urine, blood, feed, and medicines; ban on transport and delivery of livestock (total of some 500 animals); criminal proceedings by Public Prosecutor; withdrawal of the possibility of receiving or requesting EU subsidies

1 metronidazole - turkey hens – plasma – 3 µg/kg

No further information present. On-site investigation at the farm of origin; examination of the records; additional sampling (48 samples); 2 stables of turkey chicken affected; ban on transport and delivery of livestock (43.000 birds); ban on transport and delivery of livestock; Notification of the Public Prosecutor about the matter. Withdrawal of the possibility of receiving or requesting EU-subsidies

1 metronidazole - turkey hens – plasma – 0,903 µg/kg

Flock from Poland. Suspected illegal use of the substance on the feedlot. Examination of the records. As the whole flock had already been slaughtered, there was no blood left for sampling. Only deep-frozen by-product (tails and stomachs) were left, but muscle or organs from deep-frozen stocks are not suitable for the

120

analytic method. Information to Polish authorities via BVL; order of slaughterhouse self-controls with regards to the feeding establishment concerned, i. e., intensive sampling of the next three feedlot consignments to come; general revision of the slaughterhouse’s self-controls sampling plan for residues

Group B substances

Modification of national residue plan B 1 Anti-bacterial substances, including sulfonamides and chinolones Apramycin, kanamycin, paromomycin, and spectinomycin were included in the range of substances under aminoglycosides. The range of antibiotic substances to be optionally looked for in poultry was also widened, as a result of a publication about use of anitbiotics in poultry. These are the following substances: - ß-Lactam antibiotics: Cloxacillin Dicloxacillin Oxacillin Penicillin V - Lincosamides: Lincomycin - Diaminopyrimidines: Trimethoprim - Macrolides: Acetylisovaleryltylosin (tylvalosin) - Sulfonamides: sulfadimethoxin The following increased sample numbers were defined for 2012, because of positive findings in 2010: Chinolone: 10 % in pigs, Corticosteroids: 10 % in cattle, Gentamycin: 20 % in cattle. B 2 a) Anthelminthics The range of substances of the benzimidazoles group to be looked for in poultry and farmed game is enlarged by the following (for all Länder): albendazole, febantel, fenbendazole, mebendazole, oxfendazole, oxibendazole, thiabendazole, triclabendazole. B 3 d) Mycotoxins As regards tests for zearalenone in the framework of group B3d, tests for the following substances have become obligatory: zeranol, taleranol, zearalanone, α-zearalenol, β-zearalenol. B 3 e) Dyes Given a permanently high level of findings, dyes will remain a matter to be looked for in all aquacultures under the 2012 NRCP. As in 2011, the sampling volume will again be increased by another 5% in 2012.

121


Bovine 1 oxytetracyclin - sum of the mother substance and its 4-epimer – beef cattle – muscle - 222 µg/kg

Source of residue could not be found. On-site investigation at the farm of origin; examination of the records; case handed to Public Prosecutor. Withdrawal of the possibility of receiving or requesting EU-subsidies. Cross Compliance check did not show any non-compliance, because no proof of farmer’s guilt.

1 tetracyclin – cows – muscle - 285 µg/kg – kidney – 1.405 µg/kg

Sold/slaughtered before end of waiting period. On-site investigation at the farm of origin; examination of the records; criminal proceedings; Cross Compliance check

1 phenylbutazone – beef cattle – plasma – 178 µg/kg

Equipalazone and hippopalazone were used in the livestock (pony). It was not clear whether there was cross-contamination to the cattle, or whether the substance was illegally used. On-site investigation at the farm of origin; examination of the records; ban on transport and delivery of livestock; Official injunction and monetary fine. Withdrawal of the possibility of receiving or requesting EU-subsidies; cross check; notification of slaughter.

1 dexamethasone – cows – liver – 5,6 µg/kg

Non-compliance with waiting period. On-site investigation at the farm of origin; examination of the records; criminal proceedings; withdrawal of the possibility of receiving or requesting EU-subsidies

1 lead (Pb) – other cattle – liver – 1,19 mg/kg and kidney 1.69 mg/kg

1 x known soil contamination. Additional sampling; 1; ban on transport and delivery of livestock; increased controls in the establishment of origin; feed samples; animals confiscated in the slaughter house;1; animals and products classified as not suitable for human consumption.

6 cadmium (Cd) – other cattle – kidney - 1.44 to 3.1 mg/kg

2 x no information, 2 x information to competent authority and 2 x on-site investigation at the farm of origin; additional sampling; feed samples; examination of more animals at the next slaughtering.

7 cadmium (Cd) – cows – kidney The degree of contamination with heavy metals

122

- 1.12 to 3.6 mg/kg found is attributable to normal environmental contamination and the age of the animals.

3 cadmium (Cd) – beef cattle – kidney - 1.12 to 1.53 mg/kg

The degree of contamination with heavy metals found is attributable to normal environmental contamination and the age of the animals.

6 copper (Cu) – other calves – liver - 108 to 266 mg/kg

No formal complaint, because copper content was attributed to presence in the environment and feed. 3 x on-site investigation at the farm of origin.

11 copper (Cu) – cows – liver – 47,5 to 268 mg/kg

No formal complaint, because copper content was attributed to presence in the environment and feed. 3 x on-site investigation at the farm of origin. 1 x contamination attributed to intensive use of copper sulphate because of claw diseases until 2 years ago.

4 copper (Cu) – feeder calves – liver – 190 to 248 mg/kg

No formal complaint, because copper content was attributed to presence in the environment and feed. 2 x On-site investigation at the farm of origin.

8 copper (Cu) – beef cattle – liver - 39.4 to 106 mg/kg

No formal complaint, because copper content was attributed to presence in the environment and feed. 2 x On-site investigation at the farm of origin; 1 x animals and products classified as not suitable for human consumption

4 mercury (Hg) – other cattle – kidney – 0,02 to 0,905 mg/kg

1 x cow, 7 years old, pastured in summer --> environmental contamination is suspected. On-site investigation at the farm of origin; examination of the records; 1 x no information. 3 x information to competent authority.

7 mercury (Hg) – cows – kidney – 0,011 to 0,04 mg/kg - 1 x liver – 0,012 mg/kg

3 x no information. 2 x The contamination with heavy metals was attributed to normal environmental contamination and to the animals’ age. 2 x information to competent authority.

19 mercury (Hg) – beef cattle – kidney – 0,0104 to 0,028 mg/kg - 1 x liver – 0,012 mg/kg

1 x the contamination with heavy metals was attributed to normal environmental contamination and to the animals’ age. 1 x repeated use of thiomersal-containing vaccines. 1 x information to competent authority. 16 x no information.

Pigs 1 sulfadimidin sulfamethazin – fattening pigs – muscle - 319 µg/kg

The livestock comprising about ca. 420 fattening pigs is bought and sold always completely. When new stock arrives,

123

sulfadimidin is preventively applied to the stock according to veterinary prescription. The drug pre-mixture is mixed with the feed on the premises. Documents on receipt and use of veterinary drugs are kept correctly. It is assumed that in the present case, drug residues in the premises’ feeding pipe system have resolved long time after the preventive drug application to the new livestock and were then taken up by the animals with the feed. New sampling is not believed to make sense because new livestock (426 pigs) arrived in February 2011. The competent feed control authority was informed about the suspected path of entry of the contamination. On-site investigation at the farm of origin; examination of the records.

1 sulfadiazin sulfapyrimidin – fattening pigs – muscle – 110,4 µg/kg – kidney – 192,6 µg/kg

Source of residue could not be found. On-site investigation at the farm of origin; examination of the records; ban on transport and delivery of livestock; criminal proceedings; Withdrawal of the possibility of receiving or requesting EU-subsidies

1 tetracyclin – fattening pigs – muscle – 113,5 µg/kg

Information to competent authority.

1 azaperon and azaperol (sum) – fattening pigs – kidney – 1,57 µg/kg

No information.

3 cadmium (Cd) – other pigs – kidney – 1,42 to 2,66 mg/kg

1 x known contamination with heavy metals in the region. Sampling of feed cereals. 1 x source unknown. On-site investigation at the farm of origin; examination of the records; additional sampling; elimination of kidneys and livers from the food chain. 1 x the farmer was instructed that he has to include a statement about the animals’ increased level of heavy metals in the producer’s declaration when his sows are sold for slaughter.

5 cadmium (Cd) – fattening pigs – kidney – 1,06 to 2,13 mg/kg – 1 x liver – 0,74 mg/kg

4 x no information; 1 x source unknown. On-site investigation at the farm of origin; examination of the records; additional sampling; follow-up sampling of feed, animals’ toys and chipboard forming part of the stable furniture were without findings when tested for cadmium and other heavy metals

124

16 cadmium (Cd) – breeding pigs – kidney – 1,03 to 3.65 mg/kg

6 x no information; 7 x breeding pigs > 2 years old. 3 x on-site investigation at the farm of origin; examination of the records

33 copper (Cu) – fattening pigs – liver – 34,07 to 370.9 mg/kg – 2x kidney – 37,2 and 60,75 mg/kg

No formal complaint, because copper content was attributed to presence in the environment and feed. 4 x on-site investigation at the farm of origin.

17 mercury (Hg) – other pigs – kidney – 0,02 to 0.103 mg/kg – 2x liver – 0,023 and 0,026 mg/kg

6 x the contamination with heavy metals is attributed to normal environmental contamination and to the animals’ age. 3 x Source could not be identified. 6 x on-site investigation at the farm of origin; examination of the records; additional sampling. Livers and kidneys of pigs aged over 2 years are declared unfit for consumption according to annex I Section II Chapter V No. 1k of Regulation (EC) No. 854/2004. 1 x the only identifiable mercury source was an intensive vaccination regime (10 times) with several thiomersal-containing vaccines. (Haeppovac, Respiporc FLU 3). 2 x no information. 4 x information to competent authority.

60 mercury (Hg) – breeding pigs – kidney – 0,011 to 0,089 mg/kg – 17 x liver – 0,011 to 0,025 mg/kg

35 x the contamination with heavy metals is attributed to normal environmental contamination and to the animals’ age. 26 x no information. 7 x information to competent authority. 8 x on-site investigation at the farm of origin; examination of the records

47 mercury (Hg) – fattening pigs – kidney – 0,011 to 0,069 mg/kg – 16 x liver – 0,011 to 0,026 mg/kg

2 x the contamination with heavy metals is attributed to normal environmental contamination. 35 x No information; 3 x information to competent authority. 17 x on-site investigation at the farm of origin; examination of the records. 7 x the only identifiable mercury source was an intensive vaccination regime with several thiomersal-containing vaccines.

Poultry 1 doxycyclin – laying hens (boiling fowl) – muscle - 32 µg/kg

On-site investigation at the farm of origin; examination of the records

1 metoprolol – laying hens (boiling fowl) – liver - 4 µg/kg

Source unknown. On-site investigation at the farm of origin; examination of the records; additional sampling

1 cadmium (Cd) – laying hens No information.

125

(boiling fowl) – liver – 0,538 mg/kg

Sheep / Goat 1 cadmium (Cd) – other sheep – kidney – 1,78 mg/kg


5 mercury (Hg) – sheep – meat – lambs - kidney – 0,017 to 0,1544 mg/kg – 3 x liver – 0,011 to 0,024 mg/kg

3 x no information. 4 x the contamination with heavy metals is attributed to normal environmental contamination. 1 x information to competent authority.

Horses 5 cadmium (Cd) – other horses – liver – 0,868 to – 8,38 mg/kg – 2 x muscle – 0,317 and 0,405 mg/kg – 6 x kidney – 7,74 to 90,1 mg/kg

No information.

6 mercury (Hg) – other horses – kidney – 0,0280 to 0,4 mg/kg – 2 x liver – 0,018 and 0,03 mg/kg

3 x source unknown. On-site investigation at the farm of origin; examination of the records; 1 x soil-borne heavy metal contamination. 2 x no information.

Milk 1 diclofenac – cows – milk – 0,49 µg/kg

Use of Voltaren gel to treat mastitis or contamination of teats through medically treated staff (no definite information present). On-site investigation at the farm of origin; examination of the records; criminal proceedings; withdrawal of the possibility of receiving or requesting EU subsidies

Eggs 1 lasalocid – Lasalocid A – laying hens (boiling fowl) – eggs – 217 µg/kg


Laying hens (boiling fowl) – eggs – 1 WHO-PCDD/F-TEQ (WHO-TEF 1997) upper bound – 6,2 ng/kg - 1 WHO-PCDD/F-PCB-TEQ (WHO-TEF 1997) upper bound – 7,3 ng/kg

No residues, but non-compliance with maximum contaminant levels. On-site investigation at the farm of origin; examination of the records; additional sampling (5 samples); questionnaire, analysis of farm operations. Self-controls for dioxin (3x feed, 1x eggs, 1x meat) showed compliance with maximum levels. Ban on egg sales.

Laying hens (boiling fowl) – eggs – 1 WHO-PCDD/F-TEQ (WHO-TEF 1997) upper bound – 3,204 ng/kg - 1 WHO-PCDD/F-

First checks on site did not produce any new information. There will be another farm inspection together with an environmental specialist. On-site investigation at the farm of

126

PCB-TEQ (WHO-TEF 1997) upper bound - 12,264 ng/kg

origin; additional sampling

Laying hens (boiling fowl) – eggs – 1 WHO-PCDD/F-TEQ (WHO-TEF 1997) upper bound – 9,3 ng/kg – 1 WHO-PCDD/F-PCB-TEQ (WHO-TEF 1997) upper bound – 9,8 ng/kg


1 WHO-PCDD/F-PCB-TEQ (WHO-TEF 1997) upper bound – laying hens (boiling fowl) – eggs – 7,1 ng/kg

No information.

1 WHO-PCDD/F-PCB-TEQ (WHO-TEF 1997) upper bound – laying hens (boiling fowl) – eggs – 15,4 ng/kg

No information.

Aquacultures 1 leuko-malachite green – trout - muscle of fish – 0,034 and 0.085 mg/kg

2 x follow-up sampling; no new information on source of contamination

Farmed Game 1 mercury (Hg) – ostrich – liver - 0,011 mg/kg – kidney – 0,07 mg/kg

Findings attributable to normal environmental contamination. On-site investigation at the farm of origin; examination of the records; entry via feed unlikely; livestock register used for age determination; Official injunction to condemn organs of birds aged over 2 years Wild Game

1 DDT (sum of DDT, DDE, DDD, calculated as DDT)- wild boar – fat – 1,39 mg/kg

No information.

1 DDT (sum of DDT, DDE, DDD, calculated as DDT)- wild boar – fat – 2,1 mg/kg - 1 pp-DDE - 1,642 mg/kg

Old environmental contamination. On-site investigation at the farm of origin; additional sampling. Wild boars inherent in the forest range.

Wild boar – fat - 1 DDT (sum) - 3,232 mg/kg – 1 pp-DDE – 2,489 mg/kg


1 DDT (sum) – wild boar – fat – 2,74 mg/kg – 1 x pp-DDE – wild boar – fat - 2,49 mg/kg

Source of contamination could not be identified. On-site investigation at the farm of origin; examination of the records; additional sampling (5 samples); animals and products classified as not suitable for human consumption

127

1 oxychlordane – wild boar – fat – 0,07 mg/kg

No information.

2 x hexachlorobenzene (HCB) – wild boar – fat - 0,32 and 1,15 mg/kg

Source of contamination not identified; new sampling in the same forest range

1 mercury (Hg) – fallow deer – kidney – 0,038 mg/kg


3 mercury (Hg) – red deer – kidney – 0,012 to 0,024 mg/kg

No information.

35 mercury (Hg) – wild boar – liver - 0,012 to 1,36 mg/kg – 12 x kidney – 0,04 to 0,275 mg/kg – 1 x muscle – 0,015 mg/kg

30 x no information. 3 x no information because of unclear legal situation. 1 x additional sampling; 1 x information to competent authority.

Honey 5 copper (Cu) – bees – honey – 0,09 to 0.511 mg/kg

5 x no information.

128

DK DENMARK

Group A substances


Non-compliant results Follow-up actions No non-compliant results found in 2011

Group B substances

Modification of national residue plan No changes.

Non-compliant results Follow-up actions Pigs

1 penicillin G-kidney Investigations in the farm of origin: verification of records, carcasses and products declared unfit for human consumption, administrative fines not issued due to problems with tracing of herd number.

Aquaculture 1 malachite green

Five suspect samples from the farm of origin did not show residues of malachite green. There were no signs of abuse of malachite green on the farm.

1 crystal violet Five suspect samples and two feed samples from the farm of origin showed residues of crystal violet in four trouts and one sample of feed for adult fish, while fry and fry feed did not show residues. Additional feed samples taken two weeks later did not show any residues of crystal violet. Wild game

1 lead (Pb) – duck meat 1 mercury (Hg) – duck meat 1 cadmium (Cd) – pigeon meat

No follow up actions, since wild game is a rare diet.

129

EE ESTONIA

Group A substances

Modification of national residue plan The non-compliant results in 2011 (except wild game) have been taken into account regarding the 2012 plan and the number of samples has been increased accordingly.

Non-compliant results Follow-up actions No non-compliant results in 2011 None

Group B substances

Modification of national residue plan The non-compliant results in 2011 (except wild game) have been taken into account regarding the 2012 plan and the number of samples has been increased accordingly.

Non-compliant results Follow-up actions Eggs

Salinomycin sodium – 4,28 µg/kg

The farm of origin and its own feed-mill was investigated immediately. 2 additional egg samples were taken. One of them gave a non-compliant result (salinomycin sodium – 6,82 µg/kg). Also three feed samples for laying hens were taken and analysed - the results were compliant (one sample contained 33,9 µg/kg of salinomycin sodium). The probable cause of contamination was the cross-contamination at feed-mill.

Non-dioxin-like PCB-s in four samples – 21 – 72 – 79 and 103 μg/kg

The samples, that gave positive results originated from different aviaries of one big farm. The farm was investigated immediately. The probable cause of contamination was not found.

Aquaculture Enrofloxacin – 251 µg/kg – Arctic char

The farm of origin was investigated immediately. 2 additional samples were taken. Both of them were non-compliant (146 µg/kg and 340 µg/kg of enfrofloxacin). Also the actions of the veterinarian were investigated. The cause of contamination was

130

the misuse of the veterinary medicinal product (including unsuitable withdrawal period). The veterinarian was ordered to stop the misuse of veterinary medicinal product immediately. Also the bans of movement of fish were imposed and testing of samples at the farmers costs was ordered. For the next 6 months intensified checks were carried out in the farm including sampling for enrofloxacin and ciprofloxacin. Wild game

1 muscle sample from wild boar was positive for lead

Heavy metals are present in the environment as a result of a long-time absorption and may accumulate in animal tissues.

131

ES SPAIN

Group A substances

Modification of national residue plan Inclusión, dentro del grupo A3, del acetato de melengestrol en bovino, porcino, ovino / caprino, aves y conejo. Non-compliant results Follow-up actions 1 cloranfenicol en leche de bovino. Control dirigido 0,3 µg/kg en el análisis inicial. Mas de 2 µg/kg en el análisis contradictorio

Tramitación de expediente administrativo sancionador. Comunicación en el SCIRI Adopción de medidas cautelares sobre la explotación, prohibiéndose la entrada y salida de los animales y de la leche con destino a consumo humano Seguimiento durante los 12 meses posteriores a la detección de cloranfenicol.Se realizaron muestreos oficiales de leche, mensuales durante los primeros cuatro meses y trimestrales durante los 8 siguientes. Las medidas cautelares se vuelven a adoptar tras cada muestreo de seguimiento en la explotación, hasta la llegada de los resultados (todos ellos conformes). Tras los resultados conformes se levantan las medidas cautelares. Se da traslado del expediente a la Brigada Provincial de la Policía Judicial (a solicitud de la misma). El órgano judicial competente comunica que procede causa penal por considerar los hechos constitutivos de infracción penal, por lo cual se suspende el procedimiento administrativo sancionador. Los animales que lleguen al matadero serán muestreados según lo establecido en el Real Decreto 1749/1998.

1 nitrofurazona en músculo de porcino. Control dirigido. Análisis inicial 1,4 µg/kg. Análisis contradictorio 2,8 µg/kg.

Actuaciones de la Agencia de Salud Pública: Expediente incoado y suspendido al enviarse a fiscalía. Comunicación al Departamento de Agricultura y a la Unidad de Consumo de "Mossos d'Esquadra". Comunicación en el

132

SCIRI. Actuaciones del Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio Natural Intervención de 3 explotaciones (2 de ellas por estar vinculadas administrativamente al mismo titular) con un censo de 2.266, 1070 y 4800 animales. Toma de muestras con resultados conformes.

Group B substances

Modification of national residue plan Inclusión, dentro del grupo B2a, del Febendazol en aves. Inclusión, dentro del grupo B2e, de Caprofeno, Diclofenaco, Flunixin y Ketoprofeno en aves Inclusión dentro del grupo B1, del Florfenicol en bovino, porcino, y aves. Miel: Inclusión de la investigación de Dihidroestreptomicina dentro del grupo B1. Non-compliant results Follow-up actions

Bovines 1 dexametasona en hígado de bovino. Control dirigido. Más de 4 µg/kg.

Investigación en las explotaciones de ganado bovino de producción láctea, verificación de registros de la explotación, especialmente de tratamientos veterinarios, procedencia y consumos de pienso y prescripciones de pienso medicamentoso. Confirmados los sacrificios de urgencia en animales con problemas y la cumplimentación correcta de los registros de los tratamientos, se mantiene el control oficial durante 3 meses. Expediente sancionador resuelto, calificado como grave, en una cuantía de 3.500 €.

1 dexametasona en hígado de bovino. Control dirigido. Más de 4 µg/kg.

No han solicitado análisis contradictorio alegando que se trataba de un sacrificio de urgencia y que la canal no iba destinada a consumo humano, aunque en el Certificado Sanitario de Traslado y sus Anexos no mencionaba nada al respecto, y manifestaba que el animal no había sido tratado. La canal fue decomisada. Comunicación a la Comunidad Autónoma de origen de la explotación. Se corrobora por la autoridad sanitaria de la

133

Comunidad Autónoma de origen que la documentación de acompañamiento del animal al matadero estaba incorrectamente cumplimentada, no se consignaron los tratamientos aplicados al animal en los últimos 30 días y ser un animal de sacrificio de urgencia. Inicio de expediente sancionador

1 dexametasona en hígado de bovino. Control dirigido. Más de 4 µg/kg.

Investigación en las explotaciones de ganado bovino de producción láctea, verificación de registros de la explotación, especialmente de tratamientos veterinarios, procedencia y consumos de pienso y prescripciones de pienso medicamentoso. Confirmados los sacrificios de urgencia en animales con problemas y la cumplimentación correcta de los registros de los tratamientos, se mantiene el control oficial durante 3 meses. Expediente sancionador resuelto, calificado como grave, en una cuantía de 3.500 €.

1 doxiciclina en músculo de bovino Control dirigido. 131 µg/kg

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI, Expediente sancionador a explotación de origen ya resuelto con sanción de 3001 € por infracción grave. Actuaciones de la Consejería de Agricultura y Ganadería: Visita a la explotación y revisión documental, del botiquín y del contenedor de residuos. Verificación de la trazabilidad de los animales positivos. Se tomo muestra reglamentaria con resultado conforme. Restricción total de movimientos hasta la obtención del resultado de la muestra, un tiempo no inferior al tiempo de espera del medicamento en cuestión.

2 dexametasona en hígado de toro de lidia. Control dirigido. 21,6 µg/kg. y 14,0 µg/kg

Entrada en listado de sospechosos. Comunicación al interesado para realizar análisis contradictorio. El interesado desiste de llevarlo a cabo. Apertura de expediente sancionador Comunicación a la Autoridad Competente de la Comunidad Autónoma de origen.

134

Actuación en la explotación ganadera de la Comunidad Autónoma de Origen Visita a la explotación y revisión documental, del botiquín y del contenedor de residuos. Verificación de la trazabilidad de los animales positivos.

1 cadmio en riñón de bovino. Control dirigido 1,3 mg/kg.

Comunicación a Autoridades responsables del control en la explotación de origen

1 cadmio en riñón de bovino. Control dirigido.Más de 1,5 mg/kg.

Inicio de expediente sancionado por infracción grave. Comunicación a Autoridades responsables del control en la explotación de origen

1 cadmio en riñón de bovino. Control dirigido. Más de 1,5 mg/kg.

Expediente sancionador resuelto con sanction de 500 €. Comunicación a Autoridades responsables del control en la explotación de origen.

1 cadmio en riñón de bovino. Control dirigido 1,6 mg/kg.

Inicio de expediente sancionado por infracción grave. Comunicación a Autoridades responsables del control en la explotación de origen

Pigs 1 doxiciclina en músculo de porcino. Control dirigido. Más de 150 µg/kg.

Actuaciones de la Agencia de Salud Pública: Expediente incoado y suspendido al enviarse a fiscalía. Comunicación al Departamento de Agricultura y a la Unidad de Consumo de "Mossos d'Esquadra". Comunicación en el SCIRI. Actuaciones del Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio Natural Visita e intervención de la explotación. El posible origen del residuo detectado, es un tratamiento aplicado en el agua de bebida a los animales y quedar parte del medicamento en el depósito, ya que se respetó el tiempo de espera indicado en la receta.

1 narasina en músculo de porcino. Control dirigido. 98 µg/Kg.

Iniciación de expediente en Departamento de Salud y Consumo. Comunicación a Servicio de Seguridad Agroalimentaria. Se procede a la toma de muestra de pienso. Se Inmovilizan todos los animales presentes en la explotación. Resultado conforme de la

135

toma de muestras. Desinmovilización de la explotación

1 narasina en músculo de porcino. Control dirigido. 18 µg/Kg.

Iniciación de expediente en Departamento de Salud y Consumo. Comunicación a Servicio de Seguridad Agroalimentaria. Toma de cuatro muestras de diferentes lotes de pienso. Inmovilización de los reproductores y el cebo presentes en la explotación. Resultados conformes. Desinmovilización de la explotación.

1 enrofloxacina en músculo de porcino. Control dirigido. Más de 150 µg/kg.

Actuaciones de la Agencia de Salud Pública: Comunicación a la Comunidad Autónoma de origen de la explotación. Comunicación en el SCIRI. Actuación en la explotación ganadera de la Comunidad Autónoma de Origen El interesado renuncia al análisis contradictorio. Inicio del expediente sancionador. Comunicación y envío de la documentación solicitada al Cuerpo Nacional de Policía Utilización en un tratamiento de un producto, cuyo principio activo es la enrofloxacina, en un período superior a 30 días estando el medicamento sólo está autorizado para aves y conejos.

1 enrofloxacina en músculo de porcino. Control dirigido. Más de 150 µg/kg, tanto en el análisis inicial, como en el contradictorio.

Actuaciones de la Agencia de Salud Pública: Comunicación a la Comunidad Autónoma de origen de la explotación. Comunicación en el SCIRI. Actuación en la explotación ganadera de la Comunidad Autónoma de Origen Inicio del expediente sancionador. Comunicación y envío de la documentación solicitada al Cuerpo Nacional de Policía Suspensión del procedimiento sancionador por haberse incoado expediente penal. Utilización en un tratamiento de un producto, cuyo principio activo es la enrofloxacina, estando el medicamento sólo está autorizado para aves y conejos.

1 enrofloxacina en músculo de porcino. Control dirigido. Más de

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI.

136

200 µg/kg. Expediente sancionador a explotación de origen en fase de pliego de cargos incoado por infracción grave. Actuaciones de la Consejería de Agricultura y Ganadería: Visita de inspección a la explotación con revisión documental del libro de explotación-hojas de medicamentos y piensos medicamentosos, diligenciando el mismo, comprobar el ganado existente y su correcta identificación. Revisar el botiquín y el contenedor de residuos medicamentosos. Se tomo muestra reglamentaria con resultado conforme. Restricción total de movimientos hasta la obtención del resultado de la muestra, un tiempo no inferior al tiempo de espera del medicamento en cuestión (no inferior a 28 días).

1 lindano en grasa de porcino. Control dirigido. 0,127 mg/Kg

Actuaciones de la Agencia de Salud Pública: Comunicación a la Comunidad Autónoma de origen de la explotación. Actuación en la explotación ganadera de la Comunidad Autónoma de Origen Toma muestras de pienso para la investigación de organoclorados HCH-Gamma lindano. Resultado conforme. Cumplimentación del formulario para determinar el posible origen de la presencia de lindano. No se puede concluir el origen de la presencia de lindano. Explotación en seguimiento durante 3 meses haciendo constar este extremo en las GOSP(guías de origen y sanidad pecuaria)

1 cadmio en riñón de porcino. Control dirigido 1,34 mg/kg.

Actuaciones de la Agencia de Salud Pública: Comunicación al Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio Natural

1 lindano en grasa de porcino. Control dirigido. 0,054 mg/Kg

Actuaciones de la Agencia de Salud Pública: Comunicación al Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio Natural

1 lindano en grasa de porcino. Control dirigido. 134 mg/Kg

Actuaciones de la Agencia de Salud Pública: Comunicación al Departamento de Agricultura,

137

Ganadería, Pesca, Alimentación y Medio Natural

1 diazinon en grasa de porcino. Control dirigido. 0,072 mg/Kg

Comunicación en el SCIRI. Se toman muestras de pienso y de agua en la explotación, siendo las muestras analizadas negativas. La explotación se inmoviliza durante 28 días y se toman las medidas pertinentes, después de la presencia de los Servicios de Control Oficial en la explotación en la que no está presente el titular. Se censa la explotación y se comprueba la identificación animal. Se procede a la inspección del libro de tratamientos medicamentosos y no se verifica la aplicación, de ningún producto que contenga el principio activo DIAZINON y en la explicación física de los animales tienen las características típicas de porcinos precoces y no se observa la aplicación de implantes o la aplicación de otros métodos equivalentes. Finalmente la explotación es excluida del SCIRI

1 tilosina en músculo de porcino. Control dirigido. Más de 150 µg/kg.

Actuaciones de la Agencia de Salud Pública: Expediente incoado y suspendido al enviarse a fiscalía. Comunicación al Departamento de Agricultura y a la Unidad de Consumo de "Mossos d'Esquadra". Comunicación en el SCIRI. Actuaciones del Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio Natural El posible origen del residuo detectado, es un tratamiento aplicado a los animales y no se respetara el tiempo de espera indicado en la receta.

1 doxiciclina en músculo de porcino. Lactante (lechón). Control dirigido. Más de 150 µg/kg.

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI. Expediente sancionador a explotación de origen resuelto con sanction de 3001 €. por infracción grave. Comunicación a la Comunidad Autónoma de origen de la explotación. Actuación en la explotación ganadera de la Comunidad Autónoma de Origen

138

Investigación en la explotación ganadera de porcino, verificación de registros de la explotación, especialmente de tratamientos veterinarios con DOXICICLINA, procedencia y consumos de pienso y prescripciones de pienso medicamentoso. Implantación de medidas cautelares, inmovilización de 2.140 reproductores y 2.220 lechones lactantes. Se confirma el tratamiento de las madres reproductoras. Se recogen muestras de pienso y agua con resultados analíticos negativos.

1 marbofloxacina en músculo de porcino. Control dirigido. Más de 225 µg/kg

Actuaciones de la Agencia de Salud Pública: Expediente incoado y suspendido al enviarse a fiscalía. Comunicación al Departamento de Agricultura y a la Unidad de Consumo de "Mossos d'Esquadra". Comunicación en el SCIRI. Actuaciones del Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio Natural Visita e intervención de la explotación. El posible origen del residuo detectado, es un tratamiento aplicado a 45 animales y no respetar el tiempo de espera.

Poultry 1 enrofloxacina en músculo de pollo broiler. Control dirigido. 122 µg/kg.

Investigación en la explotación ganadera de aves (pollos de engorde), verificación de registros de la explotación, especialmente de tratamientos veterinarios con ENROFLOXACINA, procedencia y consumos de pienso y prescripciones de pienso medicamentoso. Implantación de medidas cautelares, en la explotación que en ese momento esta vacía. Se procede a la inmovilización de la siguiente partida de aves (19.770), procediéndose, previamente a la salida de la explotación con destino a sacrificio a un muestreo analítico de un lote de 21 animales en matadero, resultando todos conformes a la detección de ENROFLOXACINA.Iniciación de expediente sancionador calificado como grave en una cuantía de 3.500 €. No solicita contradictorio.

1 nicarbacina en músculo de Actuaciones de la Agencia de Salud Pública:

139

pollo broiler. Control dirigido. 50,8 µg/kg.

Expediente incoado y suspendido al enviarse a fiscalía. Comunicación al Departamento de Agricultura y a la Unidad de Consumo de "Mossos d'Esquadra". Comunicación en el SCIRI. Actuaciones del Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio Natural Intervención de la explotación 18000 broilers y 900 patos, con toma de muestras.

1 lindano y hexaclorobenceno en grasa de pollo broiler. Control dirigido. El lindano 0,048 mg/kg. El Hexaclorobenceno 0,073 mg/kg

Actuaciones de la Agencia de Salud Pública Comunicación a la Comunidad Autónoma de origen de la explotación. Actuación en la explotación ganadera de la Comunidad Autónoma de Origen Cumplimentación de documentos, no hay animales en el momento de la inspección. Se comprueba que el animal positivo fue trasladado con Certificado Sanitario

1 lindano en grasa de oca. Control dirigido. El lindano 0,037 mg/kg

Comunicación en el SCIRI. La explotación se inmoviliza durante 28 días y se toman las medidas pertinentes, después de la presencia de los Servicios de Control Oficial en la explotación, se censa la explotación y se comprueba la identificación animal. Se procede a la inspección del libro de tratamientos medicamentosos y no se verifica la aplicación, de ningún producto que contenga el principio activo LINDANO. Se comprueban los piensos presentes en la explotación y que están comiendo los animales, se trata de un pienso compuesto de aves para ganaderías ecológicas, de los cuales adjuntan etiqueta, Los animales se encuentran en buen estado aparente en el momento de la observación Finalmente la explotación es excluida del SCIRI

1 doxiciclina en músculo de ave. Control dirigido. Más de 150 µg/kg.

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI, Expediente sancionador a explotación de origen, en fase de pliego de cargos incoado por infracción grave. Actuaciones de la Consejería de Agricultura y

140

Ganadería: Visita a la explotación y revisión documental, del botiquín y del contenedor de residuos de medicamentos.

Sheep and goat 1 sulfadiazina en riñón de ovino. Control dirigido. Más de 150 µg/kg.

Actuaciones en matadero y Departamento de Salud: Comunicación en el SCIRI Comunicaciones a la Autoridad Competente deOrigen en materia de producción ganadera o sanidad animal y vocalía PNIR de la Comunidad Autónoma de origen Solicitud y auditoria del Plan de Residuos del matadero. Inclusión en relación de explotación sospechosa. Actuación en la explotación ganadera de la Comunidad Autónoma de Origen Los Servicios Veterinarios Oficiales realizan visita de inspección a dicha explotación, donde se comunica al titular de la explotación ganadera del resultado de la muestra no conforme de riñón ovino tomadas en el matadero; se procede al censado de la explotación e inmovilización cautelar de los animales presentes en ese momento en la misma hasta la finalización de las investigaciones oportunas, realizando las consiguientes investigaciones pertinentes, referentes al libro de registro de tratamientos, recetas de prescripción veterinaria de medicamentos, así como los controles documentales sobre entradas y salidas de animales, alimentos, piensos y materias primas destinadas a la alimentación animal. No se encuentran incidencias en el libro de registro de la explotación y tampoco en el libro de registro de tratamientos ni recetas. Se comprueba igualmente que en la explotación no se utiliza pienso medicado. Concluida la inspección, se informa al ganadero que durante seis meses la documentación que acompañe a los animales al matadero hará mención expresa de que dicha explotación se encuentra bajo vigilancia por haber detectado Sulfadiazina en uno de los animales de dicha explotación en el ámbito

141

de actuaciones del Plan Nacional de Investigación de Residuos, al objeto de proceder a las medidas contempladas en el artículo 22 del RD 1749/1998.

1 sulfadiazina en riñón de ovino. Control dirigido. 163 µg/kg.

Actuaciones en explotación: Los Servicios Veterinarios Oficiales realizan visita de inspección a dicha explotación, donde se comunica al titular de la explotación ganadera del resultado de la muestra no conforme de riñón ovino tomadas en el matadero; se procede al censado de la explotación e inmovilización cautelar de los animales presentes en ese momento en la misma hasta la finalización de las investigaciones oportunas, realizando las consiguientes investigaciones pertinentes, referentes al libro de registro de tratamientos, recetas de prescripción veterinaria de medicamentos, así como los controles documentales sobre entradas y salidas de animales, alimentos, piensos y materias primas destinadas a la alimentación animal. Se concluye que la causa ha podido estar en error de manejo, existiendo la posibilidad de que los corderos que envió al matadero consumieran pienso medicado destinado a otros animales de la misma explotación. En este sentido se actuará al respecto por parte de los Servicios Provinciales de la Consejería de Agricultura. Concluida la inspección, se informa al ganadero que, durante seis meses la documentación que acompañe a los animales al matadero hará mención expresa de que dicha explotación se encuentra bajo vigilancia por haber detectado Sulfadiazina en uno de los animales de dicha explotación en el ámbito de actuaciones del Plan Nacional de Investigación de Residuos, al objeto de proceder a las medidas contempladas en el artículo 22 del RD 1749/1998. Actuaciones en matadero: Durante el periodo de vigilancia se han

142

tomado 38 muestras, obteniendo todas ellas resultado conforme. Actuaciones administrativas: Expediente en tramitación con una propuesta de sanción de 3100 €.

1 sulfadiazina en riñón de ovino. Control dirigido. Más de 300 µg/kg.

Actuaciones en explotación: Los Servicios Veterinarios Oficiales realizan visita de inspección a dicha explotación, donde se comunica al titular de la explotación ganadera del resultado de la muestra no conforme de RIÑÓN OVINO tomadas en el matadero; se procede al levantamiento de acta de inspección, censado de la explotación e inmovilización cautelar de los animales presentes en ese momento en la misma hasta la finalización de las investigaciones oportunas, realizando las consiguientes investigaciones pertinentes, referentes al libro de registro de tratamientos, recetas de prescripción veterinaria de medicamentos, así como los controles documentales sobre entradas y salidas de animales, alimentos, piensos y materias primas destinadas a la alimentación animal. Concluida la inspección, se informa al ganadero que durante seis meses, la documentación que acompañe a los animales al matadero hará mención expresa de que dicha explotación se encuentra bajo vigilancia por haber detectado Sulfadiazina en uno de los animales de dicha explotación en el ámbito de actuaciones del Plan Nacional de Investigación de Residuos, al objeto de proceder a las medidas contempladas en el artículo 22 del RD 1749/1998. En base a las comprobaciones efectuadas en la explotación donde se detectó la muestra de riñón ovino no conforme, no ha sido posible determinar la causa que provocó la presencia de dichas sustancias. Actuaciones en matadero: Durante el periodo de vigilancia se han tomado 38 muestras, obteniendo todas ellas resultado conforme.

143

Actuaciones administrativas: Expediente en tramitación con una propuesta de sanción de 3.005,07 €.

1 enrofloxacina en músculo de ovino. Control dirigido. 200 µg/kg

Actuaciones en explotación: Los Servicios Veterinarios Oficiales realizan visita de inspección a la explotación, donde se comunica al titular de la explotación ganadera del resultado de la muestra no conforme de MÚSCULO OVINO tomadas en el matadero; se procede al censado de la explotación e inmovilización cautelar de los animales presentes en ese momento en la misma hasta la finalización de las investigaciones oportunas, realizando las consiguientes investigaciones pertinentes, referentes al libro de registro de tratamientos, recetas de prescripción veterinaria de medicamentos, así como los controles documentales sobre entradas y salidas de animales, alimentos, piensos y materias primas destinadas a la alimentación animal. Concluida la inspección, se informa al ganadero que durante seis meses la documentación que acompañe a los animales al matadero hará mención expresa de que dicha explotación se encuentra bajo vigilancia por haber detectado Enrofloxacino y Ciprofloxacino en uno de los animales de dicha explotación en el ámbito de actuaciones del Plan Nacional de Investigación de Residuos, al objeto de proceder a las medidas contempladas en el artículo 22 del RD 1749/1998. En base a las comprobaciones efectuadas en la explotación donde se detectó la muestra de músculo ovino no conforme, no ha sido posible determinar la causa que provocó la presencia de dichas sustancias. Actuaciones en matadero: Durante el periodo de vigilancia se han tomado 5 muestras, obteniendo todas ellas resultado conforme. Actuaciones administrativas: Expediente resuelto con sanción económica de

144

3.100 € 4 enrofloxacina en músculo de ovino. Control dirigido. 3 muestras > 200 μg/kg y 1 muestra 198 μg/kg.

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI. Expediente sancionador a explotación de origen resuelto con sanction de 3001 €. por infracción grave. Actuaciones de la Consejería de Agricultura y Ganadería: Visita a la explotación, revisión documental, del botiquín y del contenedor de residuos de medicamentos. Diligenciado del libro de registro, retirada de talonarios de autoguías. Visita dos veces por semana durante un mes para valorar registro de tratamientos medicamentosos específico, comprobando respeto tiempo espera de medicamentos administrados.

1 oxitetraciclina en músculo de ovino. Control dirigido. 168 μg/kg.

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI. Inicio de expediente sancionador. con propuesta de resolución por infracción grave de 3.001 € Actuaciones de la Consejería de Agricultura y Ganadería: Comprobación del ganado existente y su correcta identificación; cumplimentación del libro de registro de explotación (hojas de medicamentos y piensos medicamentosos); diligenciar dicho libro. Revisar el botiquín y el contenedor de residuos medicamentosos. Restricción total de movimientos de 28 días para el sacrificio de animales por no poder determinar el origen del medicamento. Se retiran las autoguías hasta presentación de un plan de manejo que asegure tiempo de espera de medicamentos empleados.

1 sulfadiazina y clortetraciclina en músculo de ovino. Control dirigido. La sulfadiazina con mas de 150 µg/kg y la clortetraciclina con mas de 150 µg/kg

Actuaciones de la Agencia de Salud Pública: Expediente incoado y suspendido al enviarse a fiscalía. Comunicación al Departamento de Agricultura y a la Unidad de Consumo de "Mossos d'Esquadra". Comunicación en el SCIRI. Actuaciones del Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio

145

Natural Intervención de la explotación con un censo de 825 animales y toma de muestras con resultados conformes.

1 clortetraciclina en músculo de ovino. Control dirigido. 130 µg/kg

Investigación en la explotación de ganado ovino, verificación de registros de la explotación, especialmente de tratamientos veterinarios con CLORTETRACICLINA procedencia y consumos de pienso y prescripciones de pienso medicamentoso. Implantación de medidas cautelares, inmovilización de 3 corderos, recogiendo 1 muestras de agua y 1de pienso con resultados analíticos negativos. Se procede al sacrificio bajo control sanitario de los 3 animales previo muestreo analítico en matadero, resultando todos conformes a la detección de CLORTETRACICLINA. Expediente sancionador resuelto, calificado como grave, en una cuantía de 3.500 €.

1 clortetraciclina en músculo de ovino. Control dirigido. 181 µg/kg

Investigación en la explotación de ganado ovino, verificación de registros de la explotación, especialmente de tratamientos veterinarios con CLORTETRACICLINA procedencia y consumos de pienso y prescripciones de pienso medicamentoso. Implantación de medidas cautelares, inmovilización de 892 corderos, recogiendo 1 muestras de agua y 2 de pienso con resultados analíticos negativos. Se procede al muestreo analítico de un lote de 21 animales en matadero, resultando todos conformes a la detección de CLORTETRACICLINA. Expediente sancionador iniciado, calificado como infracción grave, en una cuantía de 3.500 €.

1 sulfadiazina en músculo de ovino. Control dirigido. > 150 g/kg

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI. Expediente sancionador iniciado, calificado como infracción grave, en una cuantía de 3.500 €. Actuaciones de la Consejería de Agricultura y Ganadería:

146

Visita a la explotación, revisión documental, del botiquín y del contenedor de residuos de medicamentos. Comprobación del ganado existente y su correcta identificación; así como diligenciado del libro de registro. Retirada del talonario de documentos sanitarios de traslado hasta que se garanticen los tiempos de espera de tratamientos medicamentosos (al menos un mes).

1 sulfadiazina en músculo de ovino. Control dirigido. > 300 μg/kg

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI. Expediente sancionador iniciado, posteriormente suspendido el procedimiento administrativo sancionador por estar en vía judicial. Seguimiento de la explotación con inmovilización de canales y muestreo durante 6 meses de los animales sacrificados. 3 positivos en programa de sospechosos con declaración de no aptitud de lotes positivos (véase *). Actuaciones de la Consejería de Agricultura y Ganadería: Visita a la explotación, revisión documental, del botiquín y del contenedor de residuos de medicamentos. Comprobación del ganado existente y su correcta identificación; así como diligenciado del libro de registro. Retirada del talonario de documentos sanitarios de traslado hasta que se garanticen los tiempos de espera de tratamientos medicamentosos.

3 sulfadiazina en músculo de ovino. Control sospechoso. > 300 μg/kg

Actuaciones de la Consejería de Sanidad: Los tres resultados no conformes son consecuencia del citado mas arriba (relación con *). Declaración de no aptitud de lotes positivos.

2 sulfadiazina en músculo de ovino. Control dirigido. 1 muestra 127 μg/kg, 1 muestra > 300 μg/kg

Actuaciones de la Consejería de Sanidad: Comunicación en el SCIRI. Expediente sancionador a explotación de origen por infracción grave en fase de pliego de cargos. Comunicación a la Comunidad Autónoma de origen de la explotación.

147

Actuación en la explotación ganadera de la Comunidad Autónoma de Origen Investigación en la explotación de ganado ovino, verificación de registros de la explotación, especialmente de tratamientos veterinarios, procedencia y consumos de pienso y prescripciones de pienso medicamentoso, con SULFADIAZINA. Implantación de medidas cautelares de restricción de movimientos de animales que hasta el momento se encuentra vacía.

1 sulfadiazina en músculo de ovino. Control dirigido. 131 µg/kg

Comunicaciones a la Autoridad Competente deOrigen en materia de producción ganadera o sanidad animal y vocalía PNIR de la Comunidad Autónoma de origen Actuaciones en explotación de la Comunidad Autónoma de Origen: Incoación expediente sancionador. En el informe Consejería de Agricultura, Pesca y Alimentación se señala, tras la investigación completa, incluyendo el análisis del pienso suministrado a los animales, que ha dado resultado negativo, que no se han obtenido evidencias del uso actual de la sustancia objeto de la investigación, si bien, en el acta de inspección se hace referencia a errores de manejo y contaminación cruzada por uso de sacos de pienso medicamentoso para almacenar materias primas producidas en la propia explotación. Resolución de suspensión de la tramitación del procedimiento sancionador al haberse incoado expediente penal.

1 sulfadiazina en riñón de ovino. Control sospechoso. 224 µg/kg

Actuaciones en explotación: Los Servicios Veterinarios Oficiales realizan visita de inspección a la explotación con las consiguientes investigaciones pertinentes, referentes al libro de registro de tratamientos, recetas de prescripción veterinaria de medicamentos, así como los controles documentales sobre entradas y salidas de animales, alimentos, piensos y materias primas destinadas a la alimentación animal. Se comunica al representante del resultado de

148

las muestras de riñón ovino tomadas en el matadero; se procede al censado de la explotación e inmovilización cautelar de la explotación hasta la finalización de las investigaciones oportunas. De dichas investigaciones, y según la declaración del representante de la explotación, se concluye que el resultado no conforme puede ser debido a un mal manejo, ya que el animal enviado al matadero del que se ha tomado la muestra haya podido consumir pienso medicado sobrante de los comederos de los corderos. Concluida la inspección, se informa al ganadero que, durante seis meses la documentación que acompañe a los animales al matadero hará mención expresa de que dicha explotación se encuentra bajo vigilancia por haber detectado Sulfadiazina en alguno de los animales de dicha explotación en el ámbito de actuaciones del Plan Nacional de Investigación de Residuos, al objeto de proceder a las medidas contempladas en el artículo 22 del RD 1749/1998. Se recomienda al titular de la explotación que tome medidas preventivas para evitar la aparición de futuros casos como éste. Actuaciones en matadero: Durante el periodo de vigilancia se han tomado 36 muestras, obteniendo todas ellas resultado conforme. Actuaciones administrativas: Expediente resuelto con sanción de 3100 €

1 sulfadiazina en músculo de ovino. Control dirigido. 223 µg/kg.

Comunicación en el SCIRI. Comunicaciones a la Autoridad Competente de Origen en materia de producción ganadera El interesado ha renunciado al contradictorio Actuaciones en explotación de la Comunidad Autónoma de Origen: La explotación se inmoviliza durante 28 días y se toman las medidas pertinentes, después de la presencia de los Servicios de Control Oficial en la explotación en la que no está presente el titular. Se censa la explotación y se

149

comprueba la identificación animal. Se toman muestras de agua y se comprueba el libro de registro de entrada y salida de piensos y el de registro de tratamientos veterinarios. Se comprueba que hay una administración de un pienso medicado contra neumonías y procesos entéricos. Finalmente la explotación es excluida del SCIRI

1 cadmio en riñón de ovino. Control dirigido. 1,2 mg/kg

Actuaciones de la Consejería de Sanidad: Comunicado a Autoridades responsables del control en la explotación de origen.

1 cadmio en riñón de ovino. Control dirigido. Mas de 2 mg/kg

Actuaciones de la Consejería de Sanidad: Comunicado a Autoridades responsables del control en la explotación de origen. Iniciado expediente sancionador con propuesta de resolución por infracción grave de 3.001 €.

1 cadmio en riñón de ovino. Control dirigido. 1,4 mg/kg

Actuaciones de la Consejería de Sanidad: Comunicado a Autoridades responsables del control en la explotación de origen. Expediente sancionador sobreseido.

1 sulfadiazina en músculo de caprino.Control dirigido. 181 μg/kg.

Comunicación en el SCIRI. La explotación se inmoviliza durante 28 días y se toman las medidas pertinentes, después de la presencia de los Servicios de Control Oficial en la explotación en la que no está presente el titular. Se censa la explotación y se comprueba la identificación animal. Del resultado de las comprobaciones efectuadas se detecta que los animales menores de cuatro meses, se han tratado con pienso medicado SIN RECETA NI PRESCRIPCIÓN VETERINARIA. La explotación está sometida a una restricción parcial en los movimientos de salida de los animales a matadero, durante un período mínimo de 6 meses y además se hará constar que la explotación esta siendo sometida a controles por presencia de Sulfadiazina, en las correspondientes guías de traslado que amparen los movimientos. Se ha propuesto expediente sancionador por la ausencia de prescripción veterinaria en el tratamiento

150

efectuado con pienso medicado (Ley de Sanidad Animal) Finalmente la explotación es excluida del SCIRI

1 sulfadiazina en músculo de ovino. Control dirigido. 222 μg/kg.

Comunicación en el SCIRI. El análisis contradictorio es rechazado por el ganadero Una vez personados los Servicios Oficiales, y ante la ausencia de libro de registro de tratamientos veterinarios y las recetas justificativas, se dictamina la toma de muestras en matadero de los animales sacrificados en 6 meses sin retención de canales. Se propone un expediente sancionador por incumplimiento de la Ley de Sanidad Animal, por la ausencia de libro de tratamientos veterinarios y recetas justificativas de los tratamientos efectuados Finalmente la explotación es excluida del SCIRI y se levantan las restricciones.

1 sulfadiazina en músculo de ovino. Control dirigido. 167 μg/kg.

Comunicación en el SCIRI. El análisis contradictorio no es realizado por el ganadero Una vez censada la explotación y verificados los registros de entrada-salida de animales, se comprueba que el titular carece de libro de registro de tratamientos veterinarios y de las recetas justificativas de los tratamientos efectuados durante los últimos 5 años. Se establece la restricción parcial de los animales a matadero. También se indica en las GOSP que la explotación está sometida a controles por presencia de residuos .Esta medida se prolongará durante 6 meses. Se propone expediente sancionador por incumplimiento de la Ley de Sanidad Animal, por la ausencia de libro de tratamientos veterinarios y recetas justificativas de los tratamientos efectuados. Se dictamina la toma de muestras en matadero de los animales sacrificados en 6 meses sin retención de canales. Finalmente la explotación es excluida del SCIRI y se levantan las restricciones.

151

Milk 1 doxiciclina en leche de vaca. Control dirigido. 1,9 µg/kg.

Actuaciones del Departamento de Agricultura, Ganadería, Pesca, Alimentación y Medio Natural Iniciado expediente sancionador ya que no se puede usar dicha sustancia en animales que producen leche para el consumo humano.

Horses 1 cadmio y 1 plomo en hígado de caballo. Control dirigido. Cadmio: 1,7 mg/kg y Plomo: 0,87 mg/kg

Actuaciones del Departamento de Salud Comunicación al Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente Actuaciones del Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente Controles documentales sobre entradas y salidas de animales. Controles documentales sobre entradas y salidas de alimentos, así como de piensos y materias primas destinadas a la alimentación animal. Materiales en contacto con piensos y aguas Controles de agua de abastecimiento y otras posibles fuentes de contaminación. Toma de muestra de piensos, agua y forrajes con resultados conformes

1 cadmio en hígado de caballo. Control dirigido. 0,67 mg/kg

Actuaciones del Departamento de Salud Comunicación al Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente Actuaciones del Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente Controles documentales sobre entradas y salidas de animales. Controles documentales sobre entradas y salidas de alimentos, así como de piensos y materias primas destinadas a la alimentación animal. Materiales en contacto con piensos y aguas Controles de agua de abastecimiento y otras posibles fuentes de contaminación. Toma de muestra de piensos, agua y forrajes con resultados conformes


Actuaciones del Departamento de Salud Comunicación al Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente

152

Actuaciones del Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente Controles documentales sobre entradas y salidas de animales. Controles documentales sobre entradas y salidas de alimentos, así como de piensos y materias primas destinadas a la alimentación animal. Materiales en contacto con piensos y aguas Controles de agua de abastecimiento y otras posibles fuentes de contaminación. Toma de muestra de piensos, agua y forrajes con resultados conformes


Actuaciones del Departamento de Salud Comunicación al Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente el cual comunica que el animal solamente estuvo en la explotación de España 3 días. Comunicación y traslado de la información a la Agencia española de Seguridad Alimentaria y Nutrición (AESAN). Actuaciones de AESAN Comunicación a las autoridades competentes de Bélgica ya que la explotación es de dicho país.


Comunicación al Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente el cual comunica que el animal solamente estuvo en un centro de concentración de España 1 día. Comunicación y traslado de la información a la Agencia española de Seguridad Alimentaria y Nutrición (AESAN). Actuaciones de AESAN Comunicación a las autoridades competentes de Francia ya que la explotación es de dicho país.

Rabbit 1 hexaclorobenceno en grasa de conejo. Control dirigido. 251 μg/kg.

Actuaciones de la Consejería de Sanidad: Comunicado a Autoridades responsables del control en la explotación de origen. Actuaciones de la Consejería de Agricultura y Ganadería: Visita a la explotación y revisión documental,

153

Comprobación del ganado existente y toma de muestras en la explotación y en la fábrica de piensos con resultado conforme. Wild game

1 cadmio en hígado de jabalí. Control dirigido. 1,72 mg/kg

Comunicación al Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente

1 plomo en hígado de jabalí. Control dirigido. 0,61 mg/kg

Comunicación al Departamento de Desarrollo Rural, Industria, Empleo y Medio Ambiente

154

FI FINLAND

Group A substances

Modification of national residue plan Modifications 2011 2012: A3: Stanozolol is added to the plan of bovine urine GC-MS/GC-MS. A4: Beta-Zearalanol (Taleranol) is added to the plans when alpha-zearalanol (Zeranol) is analysed. A6: Chloramphenicol is added to the plan of horses (muscle, LC-MS-MS/LC-MS-MS). Nitroimidazoles are added to plan of milk LC-MS/LS-MS-MS. Some changes are made due to changes in production numbers. Some changes or new information on CC-alfa and CC-beta are added to the plans. The number of samples for chloramphenicol in honey are added 10

30. Non-compliant results Follow-up actions None One urine sample of pig was positive for alfa-

zearalenole (4µg/kg). Due to the results, official control actions have been carried out. The farmer had no pigs on the farm anymore.

Group B substances

Modification of national residue plan Modifications 2011 2012: B1: Tetracyclines in milk. HPLC-UV/HPLC-fluo HPLC-DAD/HPLC-DAD. Sulfonamides in milk HPLC-UV/HPLC-DAD HPLC-DAD/HPLC-DAD. B2b, B2c, B3a, B3b: pesticides in aquaculture, horses, wild game are analysed using the methods for pesticides (GC-MS-MS or LC-HRMS). New substances are added to the plans. B2b: Robenidine is added to the plan of poultry and eggs LC-MS-MS/LC-MS-MS. B3c: New heavy metals (As, Cr, Cu, Mn, Ni, Se, Zn) are added to the plans for all animal groups. Lead and cadmium are analysed also in aquaculture. The method used is ICP-MS/ICP-MS in all animal groups. B3d: Zearalenol–alpha and zearalenol-beta are added to the plans when alpha-zearalanol (Zeranol) and beta-zearalanol (Taleranol) are analysed (for pigs, poultry, horses, sheep/goats, farmed game plasma Elisa/GC-MS). Some changes are made due to the changes in production numbers. Some changes or new information on CC-beta and CC-alfa values are added to the plan. The number of sample for tetracycline in eggs are added 70 140. The number of samples for streptomycin in honey are added 10 20. The number of farmed game samples will be at the same level as 2011 (even there were non-compliant reindeer liver and kidney). The number of wild game samples will be at the same level as 2011 (even there were non-compliant elk liver and kidney). Non-compliant results Follow-up actions

155

Bovines None Suspect samples: Three sample of bovine

serum contained small amounts of beta-testosterone (< 12,1 µg/kg) but more than limit of action. Due to the results, official control actions have been carried out. Together 11 samples (“suspect samples”) have been taken. All samples were compliant.

Pigs Ochratoxin A (kidney 2,4 µg/kg) One kidney sample of pig (sow) contained

ochratoxin A (2.4 µg/kg) more than the limit of action. Due to the result, official control actions have been carried out. At the slaughterhouse, three additional kidney samples (“suspect samples”) of sows from the same producer were taken for futher testing and these samples were compliant. Also on the spot control was made by the official veterinarian. It was assumed that the reason for the finding was contaminated feed. Suspect samples: One sample of pig (urine) contained small amount of nandrolone (3,4 µg/kg) more than the limit of action. Due to the result official actions have been carried out on the spot by the local municipal veterinarian. The record (medicinal product) has been checked. One additional urine sample (“suspect sample") taken for futher testing and this sample was compliant. No violation of medication was detected.

Milk Benzylpenicillin (4,2 µg/kg) One milk sample from farm was NC for

benzylpenicillin (4,2 µg/kg). Due to the result, official control actions have been carried out. On the spot control was made by the local municipal veterinarian. The record (medicinal product) has been checked. One additional milk sample (“suspect sample”) was taken for futher testing and this sample was compliant. No violation of medication was detected.

Aflatoxin-M1 (0,08 µg/kg) One milk sample from farm was NC for aflatoxin-M1 (0,08 µg/kg). Due to the result, official control actions have been carried out.

156

On the spot control was made by the local municipal veterinarian and official veterinarian by Regional State Administrative Agency (RSAA).Altogether four milk sample, two ice-cream samples (the ice cream was made on the farm from the milk which might contain residues of aflatoxin –M1) and two feed samples were taken. The feed samples contain residue of aflatoxin –G1 lower the limit. The ice cream samples contain residue of aflatoxin-M1 (0,02 µg/l and 0,14 µg/l). The lot of ice cream containing residues over the limit and also some other ice cream lots which were prepared in certain time period was destroyed and also the farmer was order to withdraw the ice cream from the market. The results of the milk sample were 0,06 µg/l, 0,32 µg/l, 0,07 µg/l and 0,017 µg/l. The reason for the aflatoxin M1 residues was most certain the quality of feed. There have been problems with the strorage conditions of the feed and the preparation of the feed; however, the result of the feed was under the limit.

Aflatoxin-M1 (0,27 µg/kg) One milk sample from farm was NC for aflatoxin-M1 (0,27µg/kg). Due to the non-compliant result, official control actions have been carried out. On the spot control was made by the local municipal veterinarian. The farmer has noticed some problems with the quality of feed and he has changed the batch of feed. One milk sample was taken and it was compliant (0,006 µg/kg). Suspect samples: Three milk samples of route milk / lorry milk and one farm milk sample contained residue of aflatoxin-M1 (0,01 – 0,036 µg/kg). Due to these small amounts of residues more samples (“suspect samples”) were taken; nine route milk samples and three farm milk samples. All samples were compliant.

Farmed game 6/10 liver samples and 7/10

157

kidney samples in reindeer were non-compliant for cadmium

Wild game 14/20 liver samples and 18/20 kidney samples in elks were non-compliant for cadmium. 1/20 kidney sample from elk was non-compliant for lead.

According to Finnish legislation, livers and kidneys of over one-year-old elks are not accepted for human consumption.

158

FR FRANCE

Group A substances

Modification of national residue plan En France, toute mise en évidence de substances interdites par une DD(CS)PP (direction départementale (de la cohésion sociale et) de la protection des populations) doit être transmise à la Brigade Nationale d’Enquêtes Vétérinaires et Phytosanitaires (BNEVP) qui mène les enquêtes et informe les autorités judiciaires. Dans le but de démanteler des trafics de substances interdites, les enquêtes sont longues et les rapports ne parviennent à la DGAL (Direction Générale de l’Alimentation) qu’une fois l’affaire jugée (secret de l’instruction). Tous les élevages et établissements ayant eu des résultats non-conformes au cours des plans de contrôle 2011 seront ciblés prioritairement pour les plans 2012.

Non-compliant results Follow-up actions 1 Estradiol – urine – veau femelle – élevage

L’échantillon a été analysé par GC-C-IRMS (Gas chromatography combustion isotope ratio mass spectrometry) sur les paramètres testostérone et estradiol. Le seuil de non conformité est établi sur la différence entre métabolites (alpha-testostérone, étiocholanolone et alpha estradiol) et précurseurs. Un échantillon est déclaré non-conforme lorsque cette différence excède – 3 delta pour mille. Dans le cas considéré, l’échantillon a été déclaré non conforme sur le paramètre de l'estradiol avec une différence moyenne de – 9 delta pour mille. La BNEVP a été informée de ce résultat non conforme. Une enquête est en cours.

1 clenbutérol – vache – poumon – abattoir – 1,7 µg/kg

La vache a été ciblée en raison de la mention dans ses documents d’un traitement. La BNEVP a été informée de ce résultat non conforme. Une enquête est en cours.

1 chloramphénicol – muscle – bovin

Après examen dans la base de données Sigal, il s’avère que ce résultat est négatif et qu’il y a eu erreur au niveau de la déclaration de non-conformité par le laboratoire.

1 chloramphénicol – muscle – poulet de chair – 1,2 µg/kg

L’animal a été prélevé car issu d’un lot ayant connu de la mortalité en fin de bande. La BNEVP a été informée de ce résultat non conforme. Une enquête est en cours.

1 chloramphénicol – muscle – La BNEVP a été informée de ce résultat non

159

lapin – 0,99 µg/kg conforme. Une enquête et des actions judiciaires sont en cours. Ce cas pourrait être en lien avec celui détecté en 2010 (14,4 µg/kg).

1 17 béta boldénone – chair – truite arc-en-ciel – 2,3 µg/kg

La BNEVP a été informée de ce résultat non-conforme mais les faibles taux détectés et l’impossibilité pour le laboratoire de référence à conclure à une origine non-naturelle ne permettent pas de motiver des poursuites devant un juge.

1 17 béta boldénone – chair – cyprinidé – 3 µg/kg

La BNEVP a été informée de ce résultat non-conforme mais les faibles taux détectés et l’impossibilité pour le laboratoire de référence à conclure à une origine non-naturelle ne permettent pas de motiver des poursuites devant un juge.

1 leucobase de vert de malachite – truite arc-en-ciel – 3,3 µg/kg

La BNEVP a été informée de ce résultat et a ouvert une enquête. L’établissement sera de nouveau prélevé en 2012.

1 cristal violet – truite arc-en-ciel – 2,6 µg/kg

La BNEVP a été informée de ce résultat. La DDPP des côtes d’Armor a réalisé une inspection de l’établissement et réalisé un nouveau prélèvement. Le résultat de la nouvelle analyses était négatif et il n’a pas été découvert de non-conformité majeure pouvant expliquait la présence de cristal violet. L’établissement sera de nouveau prélevé en 2012.

1 leucobase de cristal violet – truite arc-en-ciel – 0,2 µg/kg

La BNEVP a été informée de ce résultat et a ouvert une enquête. L’établissement sera de nouveau prélevé en 2012.

Group B substances

Modification of national residue plan La totalité des élevages ou entreprises ayant fait l’objet d’un résultat non conforme fera l’objet d’un nouveau contrôle par les agents des services déconcentrés pour l’année 2012.

Non-compliant results Follow-up actions Bovines

1 dihydrostreptomycine – muscle de bovin mâle de 17 mois de race allaitante – 14.900 µg/kg

Recherche d’antibiotiques par méthode multirésidus (CL-SM/SM) – ciblé pour infiltration des collets. L’animal a fait l’objet d’une saisie totale. L’élevage concerné sera inspecté en 2012 par les services locaux responsables. Un procès verbal à l’encontre du gérant va également être déposé auprès du procureur de la République pour de multiples infractions

160

(tromperie, présentation d’animaux malades, non-respect des normes de protection animale…).

1 oxytétracycline – muscle de bovin femelle de 34 mois de race allaitante – 238 µg/kg

Recherche d’antibiotiques par méthode multirésidus (CL-SM/SM) – ciblé pour myosite du collier et péritonite congestive. L’animal a fait l’objet d’une saisie totale. L’enquête a révélé un mauvais enregistrement des traitements et délais d’attente dans le registre d’élevage, ainsi qu’un non respect des temps d’attente. Une mise en demeure de mise en conformité a été adressée à l’éleveur.

1 marbofloxacine – muscle de vache de réforme – 4.950 µg/kg

Recherche d’antibiotiques par méthode multirésidus (CL-SM/SM) – ciblé car animal de réforme. Le service concerné a programmé une enquête et un nouveau prélèvement pour 2012. Une relance lui a été toutefois été envoyée par la mission des urgences sanitaires de l’administration centrale.

1 tulathromycine – muscle de bovin mâle de 9 mois

Recherche d’antibiotiques par méthode multirésidus (CL-SM/SM) – ciblé pour état moyen de la carcasse. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 tétracycline – muscle de vache de réforme de 92 mois – 133 µg/kg

Recherche de substances à activité antibiotique – ciblé pour lésion ancienne. Une inspection en élevage a été réalisée et a révélé que les registres sont relativement bien tenus. Toutefois, l’indication des temps d’attente semblait parfois déficiente, ce qui expliquerait le résultat sur l’animal concerné. Un courrier de rappel à la réglementation a été transmis à l’éleveur.

1 oxytétracycline – muscle de bovin mâle de 15 mois de race allaitante – 257 µg/kg

Recherche de substances à activité antibiotique – ciblé pour non-respect du temps d’attente et traces d’injection. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 oxytétracycline – muscle de Recherche de substances à activité antibiotique

161

bovin mâle de 13 mois de race allaitante – 314 µg/kg

– ciblé pour infiltration au niveau des colliers. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 spiramycine + néospiramycine – muscle de vache laitière de 59 mois – 294 µg/kg + 1.430 µg/kg

Recherche de substances à activité antibiotique – ciblé pour coloration anormale des colliers avec nécrose. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 oxytétracycline – muscle de veau mâle de 4 mois de race allaitante – 410 µg/kg

Recherche de substances à activité antibiotique – ciblé pour abcès volumineux. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 pénicilline G – muscle de veau mâle de 5 mois – 66 µg/kg

Recherche de substances à activité antibiotique – ciblé pour péritonite fibrino-congestive. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 sulfadimérazine + tétracycline – muscle de veau de 7 mois de race allaitante – 437 µg/kg + 122 µg/kg

Recherche de substances à activité antibiotique – ciblé pour péritonite fibrineuse. Le service concerné a programmé une enquête et un nouveau prélèvement pour 2012. Une relance lui a été toutefois été envoyée par la mission des urgences sanitaires de l’administration centrale.

1 oxytétracycline – muscle de vache de réforme de 85 mois de race allaitante – 1.905 µg/kg

Recherche de substances à activité antibiotique – ciblé pour myosite localisée. Une inspection pharmacie vétérinaire en élevage a été réalisée. Il en ressort les points suivants : - l'animal n'a pas subi de traitement dans l'élevage ; - l'animal a été vendu à un groupement puis revendu mais aucune notification n'est enregistrée ; - l'animal a été abattu et est entré à l'abattoir au nom de l'exploitant qui avait notifié correctement la sortie de sa bête.

162

En conséquence, il apparaît difficile de relier les différents éléments en raison du nombre d'intermédiaire et du temps écoulé. L'exploitant a reçu un courrier de rappel des règles relatives à la pharmacie vétérinaire et il fera également l'objet d'un contrôle conditionnalité/PSPC en 2012.

1 oxytétracycline – muscle de vache de réforme de 45 mois – 698 µg/kg

Recherche de substances à activité antibiotique – ciblé pour état général moyen de la carcasse, pleurésie fibrineuse, coloration anormale des 2 colliers. La carcasse a été saisie en totalité. L’enquête a révélé un mauvais enregistrement des traitements et délais d’attente dans le registre d’élevage, ainsi qu’un non-respect des temps d’attente. Une mise en demeure de mise en conformité avec délai a été adressée à l’éleveur. Un animal provenant de cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle.


Recherche de substances à activité antibiotique – ciblé pour état général moyen de la carcasse, coloration anormale du collier gauche et péritonite fibrineuse cicatricielle du flanc gauche. Les colliers et flancs ont fait l’objet d’une saisie partielle. L’enquête en élevage a révélé que l’animal a été cédé en vue de son abattage avant expiration du délai d’attente du traitement, sans que l’information soit communiquée. Un courrier de rappel à la réglementation a été envoyé à l’éleveur. Un animal provenant de cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle.

1 oxytétracycline – muscle de bovin mâle de 12 mois – 635 µg/kg

Recherche de substances à activité antibiotique – ciblé pour pleurésie fibrineuse. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 gamithromycine – muscle de bovin mâle de 13 mois – 120 µg/kg

Recherche de substances à activité antibiotique – ciblé pour péricardite congestive + pétéchies rénales. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des

163

intrants et de la santé publique en élevage. 1 oxytétracycline + tétracycline – muscle de bovin mâle de 11 mois de race allaitante – 79.750 µg/kg + 1.405 µg/kg

Recherche de substances à activité antibiotique – ciblé pour pleurésie fibrineuse/myosite localisée. La carcasse a fait l’objet d’une saisie partielle. En raison d’un manque crucial de ressources des services concernés, l’enquête sera conduite en 2012 au cours d’un contrôle conditionnalité complet sur l’élevage en cause.

1 gamithromycine – muscle de bovin femelle de 28 mois de race allaitante – 1.105 µg/kg

Recherche de substances à activité antibiotique – ciblé pour traces d’injection. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 oxytétracycline – muscle de veau femelle de 5 mois de race allaitante – 289 µg/kg

Recherche de substances à activité antibiotique – ciblé pour viande fiévreuse et traces de piqûre collier. La carcasse a fait l’objet d’une saisie partielle. En raison d’un manque crucial de ressources des services concernés, l’enquête sera conduite en 2012 au cours d’un contrôle conditionnalité complet sur l’élevage en cause.

1 oxytétracycline – muscle de jeune bovin mâle de moins de 2 ans – 2.310 µg/kg

Recherche de substances à activité antibiotique – ciblé pour traces d’injection. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 oxytétracycline – muscle de jeune bovin mâle de + de 6 mois et – de 2 ans – 5.375 µg/kg

Recherche de substances à activité antibiotique – ciblé pour traces d’injection au niveau du collier. L’enquête a démontré que l'administration de ce produit a été faite dans le centre de rassemblement dans lequel l'animal a transité avant d'être conduit à l'abattoir. Ce centre de rassemblement administre de manière systématique cet antibiotique aux animaux qui y transitent pour être destinés à l'élevage. Peu de temps après son arrivée dans le centre, l'animal s'est blessé et a été envoyé à l'abattoir par le responsable du centre de rassemblement ayant oublié qu'un produit pharmaceutique avait été administré. Un rappel à la réglementation a été adressé au centre de rassemblement.

164

1 oxytétracycline – muscle de jeune bovin mâle de moins de 2 ans – 3.100 µg/kg

Recherche de tétracyclines – ciblé pour traces d’injection. L’enquête a révélé un mauvais enregistrement des traitements et délais d’attente dans le registre d’élevage, ainsi qu’un non respect des temps d’attente. Une mise en demeure de mise en conformité avec délai a été adressée à l’éleveur. Un animal provenant de cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle.

1 chlortétracycline – muscle de vache de réforme de 70 mois de race allaitante – 376 µg/kg

Recherche de tétracyclines – ciblé pour pleurésie. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.


Recherche de tétracyclines – ciblé pour « carcasse légère », péritonite fibrineuse et coloration anormal des colliers. La carcasse a fait l’objet d’une saisie partielle. Le service concerné a programmé une enquête et un nouveau prélèvement pour 2012. Une relance lui a été toutefois été envoyée par la mission des urgences sanitaires de l’administration centrale.

1 tétracycline + oxytétracycline – muscle de bovin mâle de 12 mois – 172 µg/kg + 250 µg/kg

Recherche de tétracyclines – ciblé pour pleurésie fibrineuse. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 ivermectine – foie de vache de 35 mois de race allaitante – 120 µg/kg

Recherche d’avermectines – ciblé pour abcès au thorax gauche. L’enquête a montré que l’éleveur ne réalise d’enregistrement des traitements et des soins apportés aux animaux. Toutefois, d’après l’éleveur, le traitement antiparasitaire a été réalisé en début d’engraissement. Il aurait constaté un abcès au point d’injection. L’injection, mal réalisée, aurait engendré une collection intradermique permettant un relargage lent de la substance active, ce qui expliquerait la présence de résidu malgré le respect du temps d’attente. Un rappel à la réglementation a été adressé à l’éleveur et au vétérinaire traitant, qui sera contrôlé au titre du contrôle des ayant droits de

165

la pharmacie vétérinaire. Un animal provenant de cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle.

1 meloxicam + acide tolfénamique – muscle de vache de réforme de 91 mois de race allaitante – 42 µg/kg + 6.190 µg/kg

Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

1 meloxicam – muscle de vache de 26 mois de race laitière – 47 µg/kg

Ciblé pour fracture du postérieur et pleurésie fibrineuse. La carcasse a été saisie en totalité. L’enquête a révélé que le traitement de l’animal n’a pas été correctement enregistré et que le temps d’attente n’a pas été respecté. Un courrier de rappel à la réglementation a été envoyé à l’éleveur. Un animal provenant de cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle.

Pigs 1 oxytétracycline – muscle de porc charcutier femelle – 317 µg/kg

Recherche de tétracycline – Abcès multiples et traces d’injection. L’animal a fait l’objet d’une saisie totale. Le service concerné a programmé une enquête et un nouveau prélèvement pour 2012. Une relance lui a été toutefois été envoyée par la mission des urgences sanitaires de l’administration centrale.

1 oxytétracycline – muscle de porc charcutier femelle – 616 µg/kg

Recherche de substances à activité antibiotique – erreur du service préleveur: il s’agit du même animal que le cas précédent.

1 sulfadimétoxine – muscle de truie de réforme – 2.064 µg/kg

Recherche de sulfamides – ciblé car animal de réforme, péritonite purulente. La carcasse et abats ont fait l’objet d’une saisie totale. Une enquête a été faite dans l'élevage. L'aliment a été mis hors de cause. L'hypothèse d’une injection directe de la molécule serait plausible, mais celle-ci n'a pas pu être mise en évidence sur l'élevage et n'est pas utilisée par le vétérinaire traitant. La cause de cette positivité est inconnue mais l’élevage sera ciblé pour les contrôles conditionnalité (chapitre pharmacie vétérinaire) en 2012.

1 sulfadiazine – muscle de truie de réforme – 290 µg/kg

Recherche de sulfamides - ciblé car animal de réforme et infiltration à coloration anormale. Deux inspections ont révélé un mauvais

166

enregistrement des traitements et délais d’attente dans le registre d’élevage, ainsi qu’un non respect des temps d’attente, et présence de médicaments périmés. Une mise en demeure de mise en conformité avec délai a été adressée à l’éleveur. Un animal provenant de cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle.

1 marbofloxacine – muscle de porc charcutier mâle – 329 µg/kg

Recherche de substances à activité antibiotique – ciblé pour arthrite multiple. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

Sheep and goat 1 sulfadiméthoxine – muscle d’ovin – 6.300 µg/kg

Recherche de sulfamides – ciblé pour arthritis. La carcasse a fait l’objet d’une saisie totale pour arthrites multiples. Une inspection en élevage n’a pas révélé de non-conformité dans la tenue des documents d’élevage et le temps d’attente du traitement correspondant à cette non-conformité semble avoir été respecté. Une hypothèse envisageable serait le prélèvement d’un point d’injection contenant un micro-abcès, contenant la molécule. Cet élevage a fait l’objet d’un nouveau prélèvement transmis fin juin 2012 au laboratoire d’analyse..

1 sulfadiazine – muscle d’ovin mâle de moins de 3 mois – 163 µg/kg

Recherche de substance à activité antibiotique. Le service concerné a programmé une enquête et un nouveau prélèvement pour 2012. Une relance lui a été toutefois été envoyée par la mission des urgences sanitaires de l’administration centrale.

1 sulfadiméthoxine – muscle de brebis de réforme – 130 µg/kg

Recherche de sulfamides – Ciblé car animal de réforme. L’enquête en élevage a permis d’identifier les faits suivants :

- l’éleveur ne traite jamais les brebis aux antibiotiques mais traitent les agneaux, qui restent plus longtemps sur l'exploitation.

- une mauvaise pratique existe sur l'exploitation: en fin journée les mangeoires des agneaux sont nettoyées

167

et les restes des aliments (y compris ceux contenant des médicaments) sont donnés aux brebis de réforme.

Cela peut expliquer la présence de sulfadiméthoxine constatée. L'éleveur affirme ne jamais avoir pensé à l'éventualité de l'ingestion croisée de médicaments. Un courrier de rappel à la réglementation a été envoyé à l’éleveur. Un animal provenant de cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle.

1 sulfadimétoxine + sulfaquinoxaline – muscle de brebis - sulfadimétoxine 1.081 µg/kg + sulfaquinoxaline 97 µg/kg

Recherche de sulfamides – prélevée en raison d’un constat de pleurésie. Suite à la découverte de cette non-conformité, l’éleveur a été destinataire d’un courrier de demande des documents concernant l’animal mis en cause et de rappel à la réglementation.

Rabbit 1 sulfadiméthoxine – muscle lapin – 218 µg/kg

Le lapin non-conforme a été prélevé en raison de l’aspect anormal des rognons. Le service concerné n’a pas remonté de suites à l’administration centrale. Une relance lui a été communiquée par le bureau des intrants et de la santé publique en élevage.

Wild game 1 Cadmium – muscle foie – Sanglier – muscle 0,05 mg/kg et foie 1,5 mg/kg

Une enquête a été menée mais n’a pas permis d’identifier la source d’une éventuelle pollution (décharge, ancienne implantation de structure industrielle). Le secteur où a été réalisé ce prélèvement sera de nouveau ciblé dans le cadre du plan de contrôle 2012.

1 Cadmium – muscle foie – sanglier – muscle - 0,017 mg/kg et foie 2,2 mg/kg

Une enquête a été menée mais n’a pas permis d’identifier la source d’une éventuelle pollution (décharge, ancienne implantation de structure industrielle). Le secteur où a été réalisé ce prélèvement sera de nouveau ciblé dans le cadre du plan de contrôle 2012. Aquaculture

1 fluméquine – chair – 7.125 µg/kg


168

Milk 1 fenbendazole – lait de vache – 60 µg/kg

Le service concerné a programmé une enquête et un nouveau prélèvement pour 2012. Une relance lui a été toutefois été envoyée par la mission des urgences sanitaires de l’administration centrale.

1 HCH-β – lait de vache – 6,1 µg/kg

La BNEVP a été informée de ce résultat et suspecte l’usage de lindane dans l’exploitation. Une enquête a été programmée avec l’assistance de la DDPP de l’Orne. L’élevage sera prélevé de nouveau, en procédure contradictoire (triple exemplaire) dans les semaines futures.

Eggs 1 lasalocid – œufs de caille – 998 µg/kg

L'enquête menée n'a pas permis de définir la ou les raisons de la présence de Lasalocid dans les oeufs de caille. Toutefois, la procédure mise en place pour les successions de fabrication aliments blancs-médicamenteux laisse entrevoir un gros risque de contamination croisée. Par contre, dans le cas présent, cela ne peut expliquer un tel dépassement de la LMR. Des investigations complémentaires sur d’autres échantillons d’aliment ont été réalisée mais n’apporte pas d’information supplémentaire. Cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle 2012.

1 lasalocid – œufs de poule – 160 µg/kg

Ce cas est en lien avec le précédent (lasalocid 998 µg/kg dans des œufs de caille): même élevage et même fournisseur d’aliment. Aucun élément probant ne permet d'aboutir à une explication pertinente. Il a toutefois été relevé une insuffisance du fabricant dans la gestion des interdictions de succession de fabrication (entreprise fabricant à la fois des aliments blancs et des aliments médicamenteux). Suite à l’intervention de la direction départementale, des mesures ont été prises pour sécuriser le process et les enchaînements. Cet élevage sera de nouveau prélevé dans le cadre des plans de contrôle 2012.

1 maduramycine – œufs de poule – 2,3 µg/kg

Le taux très faiblement au-dessus de la limite de tolérance fixé par le règlement 124/2009 (2 µg/kg) incite à penser à une contamination croisée de l’aliment des poules pondeuses. Le centre concerné a été ciblé en 2012 pour un

169

prélèvement en vue d’une recherche de nitrofuranes et sera reprélevé en septembre 2012 pour recherche de coccidiostatiques.

1 maduramycine – œufs de poule – 2,6 µg/kg

Le taux très faiblement au-dessus de la limite de tolérance fixé par le règlement 124/2009 (2 µg/kg) incite à penser à une contamination croisée de l’aliment des poules pondeuses. Le centre concerné a été ciblé en 2012 pour un contrôle et sera reprélevé en août - septembre 2012 pour recherche de coccidiostatiques.

1 semduramycine – œufs de poule – 100 µg/kg


Honey 1 vinclozoline – miel – 382 µg/kg

Une enquête a été menée mais n’a pas permis d’identifier la source d’une éventuelle contamination. L’apiculteur concerné sera prélevé dans le cadre du plan de contrôle 2012.

1 tétracyclines – miel – 29,4 µg/kg

L’usage de tétracycline en apiculture est considéré comme interdit en France. La BNEVP a donc été informée de cette non-conformité et l’apiculteur concerné sera prélevé dans le cadre du plan de contrôle 2012.

1 plomb – miel – 200 µg/kg Une enquête a été menée mais n’a pas permis d’identifier la source d’une éventuelle pollution. L’apiculteur concerné sera prélevé dans le cadre du plan de contrôle 2012.

170

EL GREECE

Group A substances

Modification of national residue plan Due to non-compliant results in 2011, extra samples have been added in the NRCP 2012 in the group substances and the species/products where non-compliant results were found.


Group B substances

Modification of national residue plan Due to non-compliant results in 2011, extra samples have been added in the NRCP 2012 in the group substances and the species/products where non-compliant results were found.The number of wild game samples remains the same as in 2011 regardless the fact of non-compliant results.


1 oxytetracycline – kidney Suspect sample – investigation in the farm of origin and controls on the farm records. The farm was placed under surveillance. Additional sampling was carried out.

Pigs 1 sulfamerazine – kidney Investigation in the farm of origin and controls

on the farm records. The farm was placed under surveillance. Additional sampling was carried out.

Sheep and goat 2 dihydrostreptomycine – sheep – kidney 1 chlortetracycline – sheep – muscle 2 lead – sheep – muscle 3 cadmium – sheep – liver 4 cadmium – goat – liver

Investigation in the farm of origin and controls on the farm records. The farm was placed under surveillance. Additional sampling was carried out.

Milk 5 aflatoxin M1 – sheep 2 aflatoxin M1 – cow

Investigation in the farms. Checks were carried out on the feed storage at the farm. Additional samples have been taken and the official

171

controls have been intensified. Wild game

1 cadmium – liver Free range animal. The local hunting club was informed.

1 lead – muscle Contamination due to the bullet used for killing. Honey

5 chlortetracycline – honey Investigation in the farm of origin. Additional sampling was carried out. Administrative measures were undertaken.

172

HU HUNGARY

Group A substances

Modification of national residue plan According to the FVO recommendations and CRL comments, we have modified the annual 2012 plan. Non-compliant results Follow-up actions Chicken liver: chloramphenicol 1 pc

- official closure of the consignment - recall from the market - modifications of the NRCP of 2012: increased sample number from the originally planned 42 to 50

Group B substances

Modification of national residue plan According to the FVO recommendations and CRL comments, we have modified the annual 2012 plan. Non-compliant results Follow-up actions

Bovines Bovine liver: amoxicillin 1 pc. Bovine kidney: cadmium 1 pc. Bovine urine: alpha-zearalenol 1pc, beta-zearalenol 1pc, zearalenone (mycotoxin F) 1pc

- additional sampling - administrative measures, - modifications of the NRCP of 2012: increased sample numbers. B1 penicillins from 8 to 10. B3c from 5 to 7. B3d (urine, slaughterhouse) from 19 to 22.

Pigs Pig liver: Enrofloxacin 1 pc. Pig kidney: Oxytetracycline 1 pc. Pig urine: alpha-zearalenol 8 pcs, alpha-zearalenol 8 pcs, zearalenone (mycotoxin F) 8 pcs.

- additional sampling - administrative measures, - modifications of the NRCP of 2012: increased sample numbers. B1 quinolones from 20 to 23. B1 tetracyclines from 80 to 88. B3d from 148 to 165.

Horses Horse liver: cadmium 1 pc. Horse kidney: cadmium 1 pc.

- additional sampling - administrative measures, - modifications of the NRCP of 2012: increased sample number from 2 to 5.

Milk Goat milk: lead 1 pc. - additional sampling

173

- administrative measures, - modifications of the NRCP of 2012: increased sample number from 2 to 4 (together with sheep milk from 5 to 7).

Honey Sulphadimethoxin 2 pcs. Tetracyclines 6pcs.

- Additional sampling - modifications of the NRCP of 2012 - increased sample numbers: B1 sulphonamides from 10 to 20. B1 tetracyclines from 15 to 40.

174

IE IRELAND

Group A substances

Modification of national residue plan Agriculture: an LCMSMS method has been validated to confirm chloramphenicol in milk and honey. An LCMSMS method has been validated and accredited to screen and confirm Beta Agonists in urine. Taleranol analysis has been added to the plan. Aquaculture: No non-compliant results for 2011 Non-compliant results Follow-up actions

Bovines Thyrostats – thiouracil – urine 11 non-compliant results

11 target samples confirmed non-compliant for thiouracil at the following levels: 12,9 – 16,6 – 23,6 – 22,5 – 9,0 – 15,2 – 13,7 – 8,8 – 11,6 – 10,3 and 10,7 µg/kg. Follow-up investigations were initiated at farm level in all cases and no evidence of illegal use was identified. In line with scientific evidence, the Competent Authority has concluded that the residues resulted from dietary factors.

Beta-agonists – urine – 2 non-compliant results* (same herd)

Following notification of a positive result from an Irish animal tested in Northern Ireland, 2 target samples confirmed non-compliant for clenbuterol at 5,2 and 0,7 µg/kg. A follow up investigation was initiated at farm level and restrictions were imposed in accordance with Article 16 & 17 of Directive 96/23/EC. Criminal prosecution was initiated and is still ongoing.

Nitrofurans – nitrofurazone as SEM – plasma - 1 non-compliant result

1 target sample confirmed non-compliant for nitrofurazone as SEM at 0,189µg/kg. A follow up investigation was initiated at the farm of origin and no evidence of illegal use was identified. In line with scientific evidence, the Competent Authority has concluded that the residues resulted from extraneous factors.

Poultry Beta-agonists – liver – 1 non-compliant result

1 target sample confirmed non-compliant for Isoxsuprine at 0,16µg/kg. A follow up investigation was initiated at the plant and associated rearing units and did not reveal any evidence of illegal administration.

Ovine Nitrofurans – nitrofurazone as SEM – liver – 4 non-compliant result.

4 target samples confirmed non-compliant for Nitrofurazone as SEM at 0,115 – 0,139 – 0,159 and 0,171 µg/kg. A follow up investigation was initiated at the farm of origin and no evidence of

175

illegal use was identified. In line with scientific evidence, the Competent Authority has concluded that the residues resulted from extraneous factors.

Thyrostats – thiouracil – urine – 1 non-compliant result

1 target sample confirmed non-compliant for Thiouracil at 38.2 µg/kg. Follow up investigation was initiated at farm level and no evidence of illegal use was identified. In line with scientific evidence, the Competent Authority has concluded that the residues resulted from dietary factors.

Group B substances

Modification of national residue plan Agriculture: An LCMSMS method has been validated and accredited to confirm Anticoccidials in avian muscle. An LCMSMS method to confirm Anticoccidials in egg has been accredited. An LCMSMS method to confirm Anticoccidials in non-broiler muscle has been validated. An LCMSMS method has been validated to confirm sedatives in kidney. An LCMSMS method has been validated and accredited to confirm NSAID’s in kidney. Mycotoxin analysis has been added to the Plan in the bovine/porcine/ovine/caprine/poultry & equine sectors. Non-compliant results Follow-up actions

Bovines Antimicrobials – muscle - 5 non-compliant results*

5 suspect samples confirmed non-compliant for antibiotics: (1) 131,5µg/kg oxytetracycline (2) > 300 µg/kg Marbofloxacin (3) > 200µg/kg sulfamethazine (4) 360 µg/kg oxytetracycline (5) 150 µg/kg oxytetracycline

Anthelmintics – liver - 3 non-compliant results*

3 target samples confirmed non-compliant for anthelmintics: (1) 3.591 µg/kg triclabendazole (2) 816,5 µg/kg ivermectin (3) 302 µg/kg ivermectin. All suspect carcases declared unfit for human consumption and destroyed. Full on farm investigations including examination of medicines on farm and animal remedies record were carried out in each case. As appropriate, advice was given to the farmer and follow-up visits took place.

Pigs Antibiotics – muscle – 2 non-compliant results*

2 target samples confirmed non-compliant for antibiotics as follows: (1) Sulfadiazine > 200 µg/kg (2) Sulfadimidine 1.250 µg/kg. Full on farm investigations including examination of medicines on farm and animal remedies record

176

were carried out in each case. As appropriate, advice was given to the farmer and follow-up visits took place.

Ovine Anthelmintics – liver – 4 non-compliant results*

3 target samples confirmed non-compliant for closantel: (1) 2.860,3 µg/kg (2) 5.284 µg/kg (3) 2.566 µg/kg. 1 target sample confirmed non-compliant for hydroxy-flubendazole & amino-flubendazole at 3,95 µg/kg & 2,65 µg/kg. Full on farm investigations including examination of medicines on farm and animal remedies record were carried out in each case. As appropriate, advice was given to the farmer and follow-up visits were scheduled.

Honey Chemical elements – honey – 3 non-compliant results

2 target samples confirmed non-compliant for lead: (1) 87,381 µg/kg (2) 199,99 µg/kg. 1 suspect sample confirmed non-compliant for lead (1) 90,492 µg/kg. Targeted sample (1) was 2011 honey taken directly from hives on an apiary operated by the beekeeper that had a non-compliance associated with lead in honey in late 2010. This sample was taken as part of the follow-up investigation. Honey produced on this apiary in 2011 was detained in the hives and was not extracted for human consumption. Targeted sample (2) relates to a separate case where lead was detected in a different producer’s honey. The suspect sample outlined above was taken as part of the follow-up activity arising from this non-compliant result. This beekeeper’s honey has been removed from the market and restrictions placed on his hives and future honey. Due to the seasonal nature of honey production, the follow-up investigation in this case is on-going.

Eggs Anticoccidials – eggs – 1 non-compliant result

1 target sample confirmed non-compliant for monensin 20,7 µg/kg. A full on farm investigation including examination of animal remedies record carried out.

Milk Anthelmintics – bovine milk - 2 2 target samples taken from milk tanks at farm

177

non-compliant results* level confirmed non-compliant as follows: (1) ivermectin at 1,2 µg/kg (2) Nitroxynil at 8,8 µg/kg. Follow up farm investigations were carried out in all cases. Risk assessment concluded that at the very low levels found, it was not necessary to withdraw milk from the market. Restrictions on movement of milk/treated animals; additional sampling and on-going monitoring were implemented as appropriate, advice was given to the farmer and follow-up visits took place.

*Non-compliant results as appropriate have been reported to the relevant Services of the CA for the purposes of implementation of Commission Regulation (EC) No 796/2004.

178

IT ITALY

Group A substances

Modification of national residue plan Corticosteroids migrate from group A3 to B2f: this changes follow a request of the EU Commission. However, we would like to underline that “use of corticosteroids for purpose different from the ones allowed to the current law, as example without a receipt, without a registration on the treatment register, the lack of the registration of the treatment by the official veterinarian on the official register is foreseen as an illicit treatment”. Resorcycil acid lactones including zeranol: the confirmation methods used as research of substances of group A4 – resorcycil acid lactones including zeranol – in urine, must be detect the following substances: alpha-zearalanol, beta-zearalanol, zearalanone, zearalenol-alpha, zearalenol-beta and zearalenone (mycotoxin F). Prednisolone: values below 5 ppb come from the possible origin (semi) endogenous of prednisolone.

Non-compliant results Follow-up actions Dexamethasone – cow – liver – 44 ppb

Target sample. Investigations in the farm: the record checks allowed to identify the source in the withdrawal period not observed. No additional sample has been taken, intensified checks in the farm.

Dexamethasone - veal calves – liver – 4,36 ppb

Target sample. Investigations in the farm. No additional sample has been taken but intensified checks. At the slaughterhouse, 478 kg of carcasses have been declared unfit for the human consumption.

Dexamethasone – urine – veal – calves – 0,69 ppb.

Target samples. Investigation in the farm. record checks and additional samples; the source was a treatment.

12 dexamethasone – liver – cows: 1. 1,65 ppb – 2. 15,3 ppb – 3. 26,5 ppb – 4. 42,7 ppb – 5. 13,3 ppb – 6. 9,64 ppb – 7. 5,38 ppb – 8. 98,0 ppb – 9. 6,33 ppb – 10. 41,5 ppb – 11. 12,4 ppb – 12. 13,0 ppb

Target, other and suspect samples. 2 animals have been put under seizure. At the slaughterhouses, 10 carcasses put under temporary seizure and 10 have been declared unfit for the human consumption. Administrative measures and criminal penalties. (6) (8) (9) (10): denial EC aids in progress. (8) n. 11 additional samples, intensified checks in 11 farm. Investigations in the farms still in progress.

179

2 dexamethasone – liver – veal – calves: 1. 16,5 ppb – 2. 123 ppb.

Suspect samples. (1) Investigation in the farm. Record checks but no additional samples; 1 animal has been put under seizure and declared unfit for the human consumption. The source has not been established. Investigations in the farms still in progress.

8 dexamethasone – liver – young bovines: 1. 21,1 ppb – 2. 0,98 ppb – 3. 13,70 ppb – 4. 1,64 ppb – 5. 27,11 ppb – 6. 61,36 ppb – 7. 859 ppb – 8. 5,3 ppb.

Target, other and suspect samples. Investigation in the farm: record checks and 25 additional samples. 590 animals have been put under seizure and one declared unfit for the human consumption. The source was established in the treatment 7 days before the slaughter. Investigations in the farms still in progress (7). Administrative measures and criminal penalties.

1 dexamethasone – urine – young bovines - 0,59 ppb.

Suspect sample. Investigation in the farm: record checks. No additional samples have been taken. 1 animal put under temporary seizure and have been declared unfit for the human consumption. Administrative measures. The source was an illegal (anabolic) treatment.

3 dexamethasone – urine – cow:1. 1,43 ppb – 2. 1,55 ppb – 3. 5.02 ppb and 1 prednisolone – urine – cow 0,64 ppb.

Target sample. Investigation in the farm and intensified the checks. 38 additional samples have been taken. In one case, the animal has been sampled by mistake because it was been undergone treatment; in another case the source has not been established. 307 animals under seizure and intensified checks in 2 farms.

3 prednisolone – urine – calves: 1. 0,93 ppb – 2. 35,8 ppb – 3. 3,61 ppb

Target and suspect samples. Investigation in the farm: record checks. 3 animals have been put under seizure and 1 animal has been put under temporary seizure until the end of the investigation. (2): as “Suspected” “anatomohistopathological” samples. (3): Investigation in the farm: record checks. 21 additional samples have been taken; the source was a recorded treatment (Desacin).

3 prednisolone and 2 prednisone – urine – young bovines: 1. 0,73 ppb

Target and suspect samples. (1) (2): Investigation in the farm (records). 11 additional samples and intensified checks in

180

2. 0,86 ppb – 0,96 ppb 3. 0,59 ppb – 0,59 ppb.

the farm. Administrative measures, criminal penalties and denial EC aids in progress. 12 animals has been put under temporary seizure. Investigations in the farms still in progress. (3): as “Suspected” “anatomo-histopathological” samples). Investigation in the farm: record checks but no additional samples. The source has not been established. 1 carcass has been put under temporary seizure and declared unfit for human consumption. Administrative measures. Investigations in the farms still in progress.

3 prednisolone and 3 prednisone – cow – urine: 1. 79,7 ppb – 16,8 ppb 2. 53,4 ppb – 7,71 ppb 3. 118 ppb – 17,8 ppb

Suspect samples. Investigation in the farms of origin with checks of the record. No additional samples have been taken. Administrative measures. Denial EC aid. The source has been a not recorded treatment.

1 prednisolone and 1 prednisone – cow – liver – 261,29 ppb and 21,19 ppb

Target samples. (1): Investigation in the farm (records). 11 additional samples and intensified checks in the farm. 60 animals have been put under seizure. The source has not been established. Administrative measures, criminal penalties and denial EC aids.

1 stanozolol – urine – veal calves – 50,8 ppb

Target sample. Investigation in the farm with checks of the record. 1 carcass declared unfit for the human consumption. No source determined. Criminal penalties.

2 chloramphenicol – muscle: 1. rabbit – 2,49 ppb 2. euryhaline (sea bream) – 0,14 ppb

Target sample. At the farm, there was an investigation with record checks and 31 additional samples, 4 of which feed. The source has not been established. 1600 animals have been put under seizure. Intensified checks in other 2 farms. Investigations are still in progress. Administrative measures and denial EC aids.

1 beta-zearalenol – urine – cows – 1,41 ppb

Target samples. At the slaughterhouse, 1 carcass has been put under temporary seizure. Investigations in the farm: record checks, no additional samples.

1 beta-zearalenol – urine – veal – calves – 1,45 ppb

Target samples. No information.

181

2 beta-zearalenol – urine – young bovines: 1. 1,16 ppb 2. 0,7 ppb

Target samples. (1) Investigations in the farm: no record checks, 21 additional samples have been taken. 1 carcass has been put under temporary seizure. Investigations are still in progress.

1 alpha- and 1 beta-zearalenol – urine – young bovines - 1,33 ppb and 2,87 ppb

Target samples. (1) Investigation in the farm (record checks), no additional samples. The source probably has been the feed.

5 clenbuterol – hair – veal calves: 1. 2.29 ppb – 2. 2,48 ppb – 3. 2,62 ppb – 4. 2,65 ppb – 5. 2,45 ppb

Suspect sample. 196 animals put under temporary seizure. Investigation in the farm and record checks. 42 samples taken in linked farms. Intensified checks in other 10 farms. Investigations are still in progress.

11 SEM (semicarbazide) – muscle – veal calves: 1. 2,29 ppb – 2. 1,17 ppb – 3. 1,12 ppb – 4. 1,84 ppb – 5. 1,59 ppb – 6. 1,56 ppb – 7. 1,48 ppb – 8. 1,49 ppb – 9. 1,95 ppb – 10. 1,07 ppb – 11. 1,85 ppb

Suspect samples. At the farm there was an investigation with record checks and 21 additional samples; the source has not been established. 21 carcasses have been put under temporary seizure and 11 declared unfit for the human consumption. Intensified checks in 1 farm. Administrative measures and criminal penalties. Denial EC aids.

2 SEM (semicarbazide) 2 AMOZ – muscle – veal calves: 1. 1,01 ppb – 1,08 ppb 2. 1,01 ppb – 1,09 ppb 3. 1,32 ppb – 2,76 ppb 4. 8,16 ppb – 3,48 ppb

Suspect (1) (2) and Target (3) (4) samples. At the farm, there was an investigation with record checks and 7 additional samples; 428 animals have been put under temporary seizure in the farm. The source has not been established. 21 carcasses have been put under temporary seizure and 11 declared unfit for the human consumption. Administrative measures and criminal penalties.

1 AMOZ – muscle – veal calves - 1,03 ppb

Target samples. At the farm, there was an investigation with record checks and additional samples. 21 carcasses have been put under temporary seizure and 1 declared unfit for the human consumption. Administrative measures and criminal penalties. Denial EC aids.

1 clenbuterol – urine – young bovines – 5,9 ppb

Target sample. One animal has been put under temporary seizure in the farm. Checks of the record and 23 additional samples has been taken. The checks have been intensified in 2 farms because the source has not been established.

182

1 clenbuterol – liver – young bovines – 5,8 ppb

Target sample. At the farm, there was an investigation with record checks; 17 animals have been put under temporary seizure in the farm. 13 additional samples (hair and feed) have been taken. The source has not been established. 1 carcass has been put under temporary seizure and declared unfit for human consumption. The checks have been intensified in 2 farms. Investigations are still in progress. Criminal penalties.

Group B substances

Modification of national residue plan NSAIDs in muscle for bovine, swine, equine, ovine, goats and rabbit species: the following research has been inserted. Dioxins and dioxin-like PCBs in muscle for ovine, goats and poultry – animal “hen”: this research is particularly important according to a high risk of contamination in ovine grazing and in hen bred on ground. Non-dioxin-like PCBs in honey: because in honey the research of substances soluble in fat is not sensible, this research was eliminated. This valuation was confirmed by absence of MLR for this matrix in the published law. Eggs: sampling activity is divided into farm and packing centres according to EU decision 97/747/EC saying “at least 30% of samples must be collected from packing centre which represent the most significant percentage of eggs for human consumption”. Aquaculture: sampling must cover “a minimum of 10% of registered sites of production”. We invite each Region and Autonomous Province to implement its programs according to the previous information. At national level, the assessment of this requirement will take into account the information coming from aquaculture registry office. Non-compliant results Follow-up actions

Bovines 4 (beta HCH) – feed Other samples. Investigation in the farm. 9

additional samples (3 of witch not have been compliant). Intensified checks. In one case, the field was put under seizure, prohibiting the collection and use. In two cases, the source of contamination was found in the overflowing of the river Sacco. Administrative measures. Investigations in the farms still in progress.

6 benzylpenicillin (penicillin G) Other and suspect samples. Investigation in

183

– muscle the farm: record checks. No additional samples. Intensified checks. 4 carcasses have been put under temporary seizure and 5 carcasses have been declared unfit for the human consumption. The source was mistakenly performed treatment on another animal. In one case the source was the treatment. Investigations in the farms still in progress. Administrative measures. Denial EC aid.

2 ampicillin – muscle Other and suspect samples. Investigation in the farm: record checks. No additional samples. Intensified checks. 1 carcass has been declared unfit for the human consumption. Administrative measures and criminal penalties. Denial EC aids in progress.

1 dicloxacillin – muscle Suspect samples. Investigation in the farm: record checks. No additional samples. The source has not been established. Administrative measures and criminal penalties. Denial EC aids in progress.

11 oxytetracycline – muscle Target and suspect samples. Investigation in the farm, no additional samples Intensified checks. 6 carcasses have been put under temporary seizure and declared unfit for the human consumption. In one case the source was mistakenly replaced by another with an animal ear tag like, while in another two cases the source was no record of treatment by the veterinarian. Investigations are still in progress. Administrative measures and criminal penalties. Denial EC aids.

1 oxytetracycline – liver Suspect samples. Investigation in the farm, no additional samples Intensified checks. 1 carcasses have been put under temporary seizure and declared unfit for the human consumption. The source has not been established. Investigations are still in progress. Administrative measures.

3 chlortetracycline – muscle Target samples. Record checks; no additional sample. The source has not been established. 1 carcass has been declared

184

unfit for the human consumption. Administrative measures.

1 amoxycillin – muscle Suspect sample. At the slaughterhouse, 1 carcass put under temporary seizure and declared unfit for the human consumption. No additional samples in the farm because the investigation showed that the treatment was not recorded. Denial EC aid.

4 sulfadimethoxine – muscle Target samples. Investigation in the farm: record checks. No additional samples The source has not been established. 3 carcasses has been declared unfit for the human consumption. In one case, the source was a therapeutic treatment.Administrative measures. Denial EC aid in progress.

1 sulfadimidine and 1 sulfamerazine – muscle – young bovines

Other samples. 1 carcass has been put under temporary seizure and declared unfit for human consumption. Investigations in the farm but no additional samples have been taken, intensified checks at the farm. Administrative measures.

3 sulfadiazine, 2 sulfamerazine and 2 sulfadimidine – muscle

Target and suspect samples. Investigation in the farm: record checks; 3 carcass has been put under temporary seizure and then declared unfit to the human consumption. In one case, the source was the treatment was not recorded. Administrative measure and criminal penalties.

2 sulfathiazole – muscle Suspect samples. Investigation in the farm: record checks; the source has not been established. 1 carcass has been put under temporary seizure and then declared unfit to the human consumption. Investigations are still in progress

Dioxins – muscle Other samples. Investigation in the farm: record checks; 3 additional samples have been taken. Intensified checks in 16 farm. Investigation are still in progress. Administrative measure.

Pigs 7 sulfadimethoxine – muscle Target and other samples. 23 carcasses

have been put under seizure at the slaughterhouse and the declared unfit for the

185

human consumption. Investigation in the farm of origin. No additional sample taken but the checks on the farms have been intensified. In one case, the source was a management error. Administrative measures and criminal penalties.

2 sulfadimidine – muscle Target sample. Investigation in the farm: record checks; in one case, the source was a management error. Investigations are still in progress. Administrative measure and criminal penalties.

1 sulfadiazine – muscle Target sample. Investigation in the farm of origin.

2 doxycycline – muscle Target sample. 148 carcasses put under temporary seizure at the slaughterhouse and declared unfit for the human consumption. Investigation in the farms of the origin: check of the record. No additional samples. Criminal penalties.

1 tetracycline – liver Other sample. 1 carcass has been put under seizure at the slaughterhouse and declared unfit for the human consumption. The animal came from a collecting centre. Administrative measures.

1 chlortetracycline – liver Other sample. The value was below MRL. The investigation on the farm has showed the use of this drug on other animals. Poultry

1 sulfadimethoxine – drinking water – turkey

Other sample. Investigation in the farm: record checks. Administrative measures.

1 sulfadimethoxine – muscle Target samples. Investigation in the farms: record checks, but no additional samples, the source has not been established. Investigation are still in progress.

4 doxycycline – muscle – broiler

Target samples and other samples. Investigation in the farms: record checks, but no additional samples, the source has not been established.

1 oxytetracycline – muscle – broiler

Target sample. Investigation on the farm. Administrative measures and criminal penalties.

4 dioxins – muscle – hens Other samples. 140 animals declared unfit for the human consumption and destroyed.

186

Intensified checks in the farm. Further samples have been taken. Administrative measures. The source can be identified with Bad Agricultural Practices, i.e. bad handling of polluting material.

1 flumequine – drinking water – broiler

Other sample. The investigation in the farm, especially the checks of the record have showed one treatment not recorded. Administrative measures.

1 lead (Pb) – muscle Target samples. Investigation in the farm and 1 additional sample has been taken (drinking water). The source of contamination was not found.

1 lasalocid – muscle – quail Target sample. Recall of product. Investigation on the farm of origin: record checks and 1 additional sample have been taken. Intensified checks on one farm. The source has been identified in improper use of the drug. Denial EC aids.

Sheep and goats 2 lead (Pb) – muscle Target samples. Investigation in the farm

and 2 additional samples have been taken. Intensified checks in the farm. The source of contamination was not found. Investigations are still in progress.

1 HCH-beta – fat Other samples. At the slaughterhouse, 1 carcass hase been put under seizure and declared unfit to the human consumption. At the farm of origin, 1 additional sample of milk has been taken. Horses

3 cadmium (Cd) – muscle 1 aflatoxin B1 – feed

Target sample. Investigation in the farm of origin: checks of the treatment register. 3 additional (for Aflatoxin B1) samples have been taken. No intensified check on the farm. Administrative measures.

Milk 17 M1 – bovine Target, other and suspect samples. 13

additional samples of milk and 2 of feed have been taken. Intensified checks on the farms. 6.911,7 l of milk and 79 round have been declared unfit for the human consumption. Verification of the results of

187

self-checking system implemented by the FBO. Administrative measures and criminal penalties. In three cases, the source has been the feed. Additional sample after change of animal’s diet. The result has been compliant. Checks of the washing cycle of the bin.

1 aflatoxin M1 – sheep Other samples. No additional information 2 alpha- and 4 beta-HCH – bovine

Target and other samples. 11 additional samples have been taken and have been intensified the checks. The source of contamination was not found. Investigations are still in progress. In one case, 274 animals put under seizure and 400 litres of milk were declared unfit for the human and animal consumption has been destroyed. Intensified checks in 1 farm. In one case, the source has been the feed and drinking water

1 beta-HCH – sheep and goats Other samples. Investigation and have been intensified the checks. 2 additional samples have been taken The source of contamination was not found. Investigations are still in progress.

1 beta-HCH in sheep Target sample. Investigation at the farm. Intensified checks in the farms and 2 additional samples of feed have been taken. The source of contamination was not found. Investigations are still in progress.

3 beta-HCH in buffalo Other and suspect sample. Intensified checks in the farms and 4 additional sample have been taken; 46 animals put under seizure, 1.000 litres of milk and 43 rounds first declared unfit for the human and animal consumption then destroyed. In one case, the source has been the feed. Investigations are still in progress.

1 ampicillin – bovine Suspect sample. 2,5 q of milk declared unfit for the human and animal consumption. Investigation in the farm: record checks. Administrative measures.

Eggs 6 dioxins Other samples. Have been intensified the

188

checks on the farms. 11 hens have been put under temporary seizure. No 2 additional samples have been taken. In one case, the waste has been easy to get to. In one case, the source was environmental contamination In another case, the hens can scratch around on the road and ingest pieces of asphalt. Not eating eggs and not access to the road.

Aquaculture 2 malachite green-leuco – eurialine (trout)

Target and suspect samples. An order of the mayor has put the whole farm under temporary seizure. 1 additional sample has been taken and the result has been non-compliant. Another order of the mayor has imposed the culling of the whole farm. Office of the Public Prosecutor c/o Criminal Court in Salerno has been informed. Denial EC aids. Honey

1 sulfamethoxazole Other samples. Investigation in the farm: record checks. One batch of honey has been put under seizure and the declared unfit to human consumption. The source has not been identified. Investigations are still in progress.

3 tetracycline Target samples. 800 kg of honey 10 hives put under temporary seizure. Investigation in the farms and intensified checks. 3 additional samples have been taken. 14 hives have been put under seizure. Administrative measures and criminal penalties. Investigations are still in progress.

4 chlortetracycline Other samples. 2.566 kg of honey put under temporary seizure. Investigation in the farms and intensified checks. 48 additional samples have been taken. Administrative measures. Investigations are still in progress.

3 cypermethrin Other samples. Investigation on the farm: record checks and no 2 additional samples have been taken. Intensified checks. 1.153 kg of honey have declared unfit to human consumption. The source has not been identified.

1 tylosin Other samples. Investigation on the farm:

189

record checks and 5 additional samples have been taken. Intensified checks. Administrative measures and criminal penalties.

190

LT LITHUANIA

Group A substances

Modification of national residue plan Number of pigs and honey samples is increased whereas there is increase in the number of slaughtered pigs and honey production in Lithuania. Official laboratories involved in analyses of residues of veterinary medicinal products are accredited in accordance with EN ISO/IEC 17025 on ‘General requirements for the competence of testing and calibration laboratories’ standard and they use validated methods according to Commission Decision 2002/657/EC. Considering the results of residue monitoring in EU and RASFF notifications, testing of nitrofurans is introduced into residue monitoring plan for bovine animals. Testing of dapsone is introduced into residue monitoring plan for sheep/goats, horses, rabbits and farmed game.


17β-oestradiol – plasma Investigation was carried out, farm and animal were identified. The probable cause is of natural origin. Farm was classified to higher risk group in order to increase frequency of official control.

Swine 2-thiouracil – urine Investigation was carried out, farm and animal

were identified. Non-compliances regarding record of use of veterinary medicinal products were found. Restriction on animal moving was applied; additional samples were taken (negative results). Administrative sanctions have been applied; official control on farm was strengthened. The cause of origin was not identified.

Group B substances

Modification of national residue plan Number of pig samples for testing of dioxins and ochratoxin is increased according to EFSA Scientific Opinion on the public health hazards to be covered by inspection of meat (swine). UPLC-MS/MS method was introduced for testing of sulfonamides in muscle samples of bovines, pigs, poultry, sheep/goats, horses, rabbits and farmed game. LC-MS/MS (screening/post screening) broad spectrum method is used for testing of antimicrobials in muscle samples of sheep/goats, horses, rabbits and farmed game. According to EURL recommendations and

191

RASFF notifications, testing of crystal violet, leuco crystal violet, brilliant green and methylene blue is introduced into the monitoring plan for aquaculture. According to FVO recommendation, testing of tylosin is introduced into the monitoring plan for honey.


1 oxytetracycline – muscle Investigation was carried out, farm and animal were identified. Carcass was disposed. Restriction measures were applied; additional samples were taken for investigation (negative results).

1 dihydrostreptomycin – muscle

Investigation was carried out, farm and animal were identified. Carcass was sold before the investigation. The cause of origin was not identified.

1 diclofenac – muscle Investigation was carried out, farm and animal were identified. Carcass was sold before the investigation. Non-compliances regarding record of use of veterinary medicinal products were found. Official control on farm was strengthened.

1 cadmium – kidney Investigation was carried out, farm and animal were identified. Cow (13 years old) was pastured on the grassland. Carcass was sold before the investigation. Restriction measures were applied for the farm.

Swine 1 benzylpenicillin – muscle Investigation was carried out, farm and animal

were identified. Non-compliance regarding use of veterinary medicinal product (containing benzylpenicillin) was found. Administrative sanctions have been applied.

1 oxytetracycline – muscle Investigation was carried out, farm and animal were identified. Non-compliance regarding use of veterinary medicinal products was found. Additional samples were taken (negative results). Administrative sanctions have been applied.

Horses 1 cadmium – kidney Investigation was carried out, farm and animal

were identified. Horse was pastured near highway. Carcass was sold before the investigation. Subproducts were processed in

192

category 1 processing plant. Poultry

1 diclofenac – muscle Investigation was carried out, farm was identified. Additional samples were taken (negative results). The cause of origin was not identified.

Milk 1 benzylpenicillin Investigation was carried out, farm was

identified. Non-compliances regarding use of veterinary medicinal products and record of use of veterinary medicinal products were found. Additional samples have been taken (negative results). Administrative sanctions have been applied, official control on farm was strengthened.

Honey 1 sulfathiazole Investigation was carried out, apiary was

identified. Honey was sold before the investigation. Additional samples were taken (negative results). Restriction measures were applied. The cause of origin was not identified.

1 tetracycline Investigation was carried out, apiary was identified. Non-compliances regarding use of veterinary medicinal products were found. Restriction measures were applied for the apiary. Remaining stock of contaminated honey was processed in category 1 processing plant. Additional samples of honey from further harvest were taken. Administrative sanctions have been applied

193

LU LUXEMBURG

Group A substances



Group B substances


Non-compliant results Follow-up actions Wild game

1 sample – fat – wild boar – alpha-HCH 0,484 mg/kg - beta-HCH 0,248 mg/kg – HCB 0,442 mg/kg

Increasing sampling for B3c in 2012

1 sample Cd – liver – roe – 0,554 mg/kg

Increasing sampling for B3c in 2012

194

LV LATVIA

Group A substances



Group B substances



Spiramycin – 1,4 µg/kg – bovine kidney

1 farm (1.025 cows held in the farm) was investigated. Origin of spiramycin was not identified.

Trimethoprim – 6,2 µg/kg – bovine kidney

1 farm was investigated. The time of drugs separation was not considered. The slaughtered cow was last in this farm. The penalty was imposed.

Eggs Enrofloxacin – 30 µg/kg. 1 farm (1,5 millions birds held in the farm) was

investigated. The infringements were found regarding to cleaning of drinking water tanks. Additional sampling – 4 eggs samples. The testing of all the samples were negative.

Wild game Cadmium – 16 liver samples (0,476 to 7,2 mg/kg) – 13 kidney samples (1,27 to 20,8 mg/kg) – 7 muscle samples (0,053 to 0,286 mg/kg). Lead – 2 muscle samples (0,119 and 0,357 mg/kg) – 1 liver sample (0,514 mg/kg) – 1 kidney sample (0,671 mg/kg).

Honey

195

AOZ – 7 µg/kg. The product was withdrawn from the market. 25 kg were destroyed.

Lead – 3 samples – 0,035, 0,022 and 0,011 mg/kg.

Origin of lead was not identified.

196

MT MALTA

Group A substances



Group B substances


Non-compliant results Follow-up actions Poultry (Target and Suspects)

1 liver sample non-compliant for salinomycin: liver – 10 µg/kg (target). 1 feed sample (broiler finisher) from a 2011 follow-up sample found non-compliant for salinomycin: >1.400 ug/kg (suspect)

During the investigation carried out on the farm on the targeted poultry liver sample, the farmer stated that during that period, the slaughterhouse had requested animals prior to full withdrawal period. A suspect broiler finisher feed sample was taken on farm which resulted non compliant for salinomycin levels in feed but the liver sample taken from the flock fed the above mentioned feed was found compliant for ionophores. The finisher broiler feed sample taken from the supplying feedmill was compliant to MRL levels. A warning letter was issued to farmer. Suspect liver samples during every flock slaughter have been taken and analysed and have all resulted compliant. Finisher feed samples on farm will still be taken to monitor compliance.

1 liver sample non-compliant for salinomycin: liver – 10 µg/kg (suspect). 1 liver sample non-compliant for salinomycin: liver – 24 µg/kg (suspect)

Two suspect poultry liver samples belonging to the same farmer were once again found non-compliant as in previous years. The food business operator is being targeted at every slaughter and samples are sent immediately for analysis. Three consecutive samples were taken from the three different slaughterings. The first two were found positive but the most recent one was found negative. On farm

197

investigation was also carried out and the food business operator was warned by an official letter. Feed sample was also taken from the supplying feedmill and found compliant. Farm is still being targeted during every slaughter and all liver samples analysed for ionophores have resulted compliant.

1 feed sample from a 2011 follow-up sample found non-compliant for salinomycin: > 2.000 µg/kg (suspect)

This is a follow-up from a 2011 positive sample. In 2011, a poultry target liver sample was found positive and following an investigation, feed used by feed business operator was taken from feedmill. The finished product was sampled and resulted negative to coccidiostats but the concentrate was also sampled and was found to be positive to salinomycin even though the label did not state any salinomycin added. The owner had to contact company (imported product) to lodge complaint.

Eggs 1 sample non-compliant for maduramycin; 6 µg/kg (target). 1 sample non-compliant for maduramycin; 5 µg/kg (target).

Two positives for maduramycin from different farms sampled in the same month. Farm investigations revealed that both farms use feed from same feedmill. Feed from both farms and from feedmills were sampled during investigation and resulted compliant for ionophores. One farm has closed down in the meantime. The other farm is being targeted for egg samples.

1 sample non-compliant for diclazuril; 8 µg/kg (target)

The sample found non-compliant for diclazuril was received recently. Investigation is still underway. The sample originates from a farm with less than 300 birds of over thirty (30) months. This farm rears birds using natural light and therefore egg production is scarce during certain periods of the year. Eggs were also sampled during 2012 for ionophores and resulted compliant. The farm will be targeted during egg-production season.

198

NL THE NETHERLANDS

Group A substances


Non-compliant results Follow-up actions 9 non-compliant results for testosterone in bovine (calves)

In all cases the gender of the calves was male. Testosterone is endogenous in male calves. Investigation closed.

1 non-compliant result for clencyclohexerol in bovine (calves)

Investigation was carried out. A probable cause was not observed. The result of a verification test was compliant. Investigation closed.

3 non-compliant results for alfa-boldenon in bovine (calves)

No investigation was carried out. Alfa-boldenon could be endogenous.

5 non-compliant results for thiouracil in bovine (calves)

Investigation was carried out. Additional sampling carried out but no further non-compliant samples were found. A probable cause was not observed. Perhaps the feed is the source. Investigation closed.

2 non-compliant results for isoxsuprine in bovine (calves)

Investigation was carried out. In one case the calve had already been slaughtered and there were no others calves at the holding. In the other case the use of Duphaspasmin was observed. Maternal transfer is a possible explanation. Investigation closed.

2 non-compliant results for beta-nortestosterone in pig.

Investigation was carried out. In both cases the administration records were inspected and additional sampling was carried out which did not reveal further indications of the abuse of beta-nortestosterone. Investigations are closed.

2 non-compliant results for oestradiol in poultry (spent hens)

No investigation was carried out. Oestradiol is endogenous in spent hens.

1 non-compliant result for nitrofurazon in broiler chicken

Investigation was carried out. No probable cause found. Investigation closed.

Group B substances



199

Bovine animals 1 non-compliant result for dihydrostreptomycin in bovine (cows)

Investigation was carried out. Treatment with dihydrostreptomycin was carried out routinely, but not recorded. Official warning issued.

3 non-compliant results for neomycin in bovine (cows)

Investigation was carried out. In 2 cases, the use of neomycine was not recorded in the food chain information and the withdrawal period was not respected. Penalties applied. In one case no records of the use of neomycine were found. Official warning issued.

3 non-compliant results for gentamycin in bovine (1 calf, 2 cows)

In 2 cases, investigation was carried out. The use of neomycine was not documented. Investigation closed.

25 non-compliant results for cadmium in bovine kidney

No investigation was carried out because all the bovine were older than 2 years. In the Netherlands, kidneys from bovines older than 2 years are excluded from human consumption.

Pigs 1 non-compliant result for dihydrostreptomycin in pig

Investigation was carried out. The records of VMP use were improperly kept. Penalty applied.

4 non-compliant results for oxytetracycline in pig

Investigation was carried out. In 3 cases the records of VMP use were improperly kept. The use of OTC was also not recorded in the food chain information. Withdrawal period was not respected. Penalties applied. In one case, no cause found. Investigation closed.

2 non-compliant results for doxycycline in pig

Investigation was carried out. In both cases, the withdrawal period was not respected. In one case the records of VMP use were also improperly kept. Penalties applied.

1 non-compliant result for diclofenac in pig

No investigation was carried out. The person who took the sample, used a unguent that contained diclofenac. The instructions for sampling were modified to avoid similar contamination of samples in future. The modified procedure is in place since 01-04-2012.

Poultry 2 non-compliant results for doxycycline in broiler chicken

Investigation was carried out. In both cases, the use of doxycycline was confirmed. Records of the VMP use were kept properly and the withdrawal period was respected. Investigation closed.

1 non-compliant result for Investigation was carried out. Poultry farmer

200

salicylic acid in broiler chicken did not apply salicylic acid. The veterinarian did not deliver a veterinary medicine containing salicylic acid to that poultry farmer. No cause found and investigation closed.

Sheep and goat 2 non-compliant results for dihydrostreptomycin in sheep

Investigation was carried out. In one case the records of VMP use were improperly kept. Warning applied. The holding will be checked again soon. In the other case, no cause found. Investigation closed.

2 non-compliant results for oxytetracycline in goat.

No investigation carried out.

2 non-compliant results for cadmium in sheep

Investigation was carried out. No cause found. Investigation closed. Wild game

2 non-compliant results for lead in rabbit. 6 non-compliant results for lead in roe deer. 4 non-compliant results for lead in deer. 1 non-compliant result for lead in hare. 4 non-compliant results for lead in wild boar. 1 non-compliant result for lead in wild pigeon. 6 non-compliant results for lead in wild duck

Free range animals. No investigation carried out.

201

PL POLAND

Group A substances

Modification of national residue plan Increased number of samples of pigs, poulty (chickens) and bovines for many substances from group A. Samples of farm game included to the plan. Updating of action levels (MRLs, MLs, national levels) and validation data (CCα and CCβ).

Non-compliant results Follow-up actions A2 – thiouracil (target) – pigs – urine – 16,6 ppb

Investigation on the farm of origin, verification of records; additional sampling (urine, feed); all results compliant; origin of thiouracil was not identified; small farm – no medical treatment registration was kept; 1 administrative measure.

A3 – 4 x nandrolone (target) – pigs – urine (1) 514,7 ppb (2) 6,8 ppb (3) 2,5 ppb (4) 1,3 ppb

Investigation on the farm of origin; modest infringements concerning feed storage on the farm established during the control; no proof of illegal used of nandrolone was found; additional sampling – all results compliant;4 administrative measures; 2. Investigation on the farm of orgin; no VMPs nor illegal sustance was found on the spot; medical treatment registration kept correct; additional sampling (water, feed, urine) – all complient (animals held until the results);1 administrative measure; origin of nandrolone was not identified 3. Investigation in the slaughterhouse and on the farm of origin; meat and meat products thereof, was already eaten after result; additional sampling on the farm (urine) – complient; the reason for presence of nandrolone was not established;1 administrative measure; 4. Investigation in the slaughterhouse and on the farm of origin.verification of records – kept correct; additional sampling (urine and water- animals held untli sampling results) – results complient; 1 administrative measure; origin of nandrolone was not identified;

A6 – SEM (semicarbazide) Investigation on the farm;verification of

202

(target) – bovines – urine – 1,3 ppb

records; no fndings, no illegal substance found on the spot; additional sampling (water, serum, urine) – all complient; 1 administrative measure; no reason of presence of SEM was found

Group B substances

Modification of national residue plan Increased number of samples of pigs, poulty (chickens) and bovines for many substances from group B. Samples of farm game included to the plan. New compound/matrix included to the plan: B1 – Antibacterial substances: Sulfonamides (Sulfamethazine, Sulfamerazine, Sulfadimethoxine, Sulfadiazine, Sulfamethoxazole, Sulfamethoxypyridazine, Sulfathiazole, Sulfaguanidine, Sulfamonomethoxine, Sulfadoxine, Sulfaquinoxaline), Fluoroquinolones (Enrofloxacin, Ciprofloxacin, Marbofloxacin, Norfloxacin, Danofloxacin, Sarafloxacin, Difloxacin, Flumequine, Oxolinic acid, Nalidixic acid), Tetracyclines (Chlortetracycline, Doxycycline, Oxytetracycline, Tetracycline), Aminoglycosides (Spectinomycin, Streptomycin, Dihydrostreptomycin, Kanamycin, Paromomycin, Gentamicin, Neomycin), Penicillins (Amoxycillin, Ampicillin, Penicillin G, Penicillin V, Oxacillin, Cloxacillin, Nafcillin, Dicloxacillin), Cephalosporins (Cefapirin, Ceftiofur, Cefquinom, Cefalonium, Cefazolin, Cefalexin, Cefoperazon), Macrolides (Spiramycin, Tilmicosin, Tylosin, Erythromycin, Josamycin), Lincomycin in muscle of pigs, bovines and poultry, eggs and milk. B2c – Pyrethroids (Bifenthrin, Cyfluthrin, Cyhalothrin, Cypermethrin, Deltamethrin, Fenvalerate, Permethrin) in milk. B 2e – NSAIDs (Antipyrin-4-Methylamino, Antipyrin-4-Amino, Antipyrin-4-Formylamino, Antipyrin-4-Acetylamino) in animal muscles. B 2e – NSAIDs (Firocoxib, Celecoxib, Rofecoxib) in milk. Updating of action levels (MRLs, MLs, national levels), validation data (CCα and CCβ) and methods.


B1 – 4 penicillin G B1 – 5 dihydrostreptomycin B1 – gentamicin B1 – neomycin – muscle/kidney (target)

6 investigations (6 cases) in the establishments and on the farms as well; verification of records, additional sampling – compliant;in one case additional control of the private practicionner who was in charge of the farm – animals weren’t treated; no reason found; in one case carcass was rendered due to cahexia;in case of treatment of animals, withdrawal period kept

203

correct;in one case RASFF procedure initiated – meat exported to Turkey; no reason for B1 presence was established

B2f – dexamethasone – liver (target)

Investigation in the slaughterhouse and on the farm of orign, verification of records – meat and meat poducts therof already eaten; during the control on the farm appeared that it was shut down – additional sampling impossible; medical treatment documentation has shown, that withdrawal periods was kept; no reason for presence of dexamethaone was found

Pigs B1 – 3 penicillin G B1 – chlortetracyclin B1 – 3 dihydrostreptomycin B1 – 4 doxycycline B1 – 2 oxytetracycline – muscle/kidney (target)

9 investigations in establishments and on the farms of origin; verification of records; additional sampling (feed on the farm and muscle/kidneys in slaughterhouses) – all results compliant; in all cases meat and products therof were already eaten; infringments established during the controls on farms weren’t link in many cases directly to usage of VMP's – proper marking of animals intending for slaughter; proper filling out of FCI; in three cases withdrawal period wasn’t kept (fines were imposed);in all cases farms subjected to intensified checks.

B3c – 2 lead – muscle (target)

Investigations in the esablishment and on the farms of origin; verification of records; farms suspected; feed given to the animals from the farm; source of contaminaton wasn’t idenfied.

B3d – Ochratoxin A – kidney (target)

Investigation on the farm of orgin; verification of records; feed bought from the feeding mill – storage of feed correct; additional sampling (kidney and feed – all compliant); 1 adminstrative measure.

Poultry B1 – enrofloxacin (target) B1 – 3 doxycycline (target) – muscle/liver (target)

4 investigations in the establishment and on the farms of origin; verification of records; additional sampling (in the slaughterhouse) – compliant results; in all cases farms subjected to intensified checks; in one case foodstuff was still in the establishment – 5.637 kg of meat rendered; in 2 cases reason of presence of antibacterials was established; it was withdrawal period that wasn’t kept; 2 infringements – in medical treatment

204

documentation as well (2 fines about 15.000 PLN).

B2b – 2 lasalocid – liver (target) B2b – Monensin – liver (target)

3 investigations on the farms; verification of records; additional sampling of feed – compliant; no reason for presence of coccidiostats was found; farms subjected to intensified checks; 3 administrative measures. Sheep and goat

B3c – 7 Cadmium – liver (target)

7 investigations on the farm of origin; 6 cases from the same region; feed from the farm; no industry in the area; in one case animals were grazing near the main road; farms suspected;7 administrative measures.

Horses B3c – 1 Cadmium – muscle (target)

Investigation on the farm of origin; additional sampling of feed – results compliant; no reason was found; meat intended to Italian market – RASFF procedure initiated; farm subjected to intensified checks.

Milk B1 – 2 tetracycline (target) 2 investigations on the farms; in both cases cows

were treated for mastitis with VMP’s including tetracycline; according to medical treatment documentation withdrawal period (5 days) was kept; in second case some neglects during rinsing milking equipment could be the reason;farms suspected.

Eggs B1 – enrofloxacin (target) B1 – doxycycline (target)

2 investigations on the farm performed; verification of records; additional sampling (water, feed, eggs) – all compliant; eggs were held (35.000) till obtaining the results; additional pharmaceutical control – no infringements concerning private vets who were in charge of the farm; farm subjected to intensified checks; origin of antimicrobials was not identified.

B2b – decoquinate (target) B2b – decoquinate – feed (suspect)

Investigation on the farm; verification of records; hens weren’t treated; additional sampling (water, feed, eggs) – eggs held till the results – all compliant. Suspect sample taken during intensified check after the non-compliant result in eggs.

B2b – diclazuril (target) Investigation on the farm; additional sampling;

205

at the end it turned out, that it had been mistake in sampling; samples were taking from the young hens during grow period.

B2b – 4 maduramicin (2 target + 2 suspect)

Investigation on the farm; verification of records, additional sampling (8 samples of water, eggs, feed). 2 egg samples non-compliant (maduramicin); cross contamination in feed mill was excluded as a reason of NC in eggs. Eggs held and withdraw from the market – 91.033 were rendered; origin of antimicrobials was not identified; farm suspected.

B2b – salinomycin (target) Investigation on the farm; additional sampling (feed for lying hens) – compliant results; it was established that feed for broilers (with salinomycin) was given to hens; 1 administrative measure; ban on putting meat and eggs on the market – 240 hens and 700 eggs were rendered; owner suspended activity.

Aquaculture B1 – doxycycline B1 – sufadiazine – muscle (target)

Investigation on the farm (trout); additional sampling; fish were held until results – compliant; origin of antimicrobials was not identified.

B3e – 10 malachite green (6 target + 4 suspect) – muscle (fish)

6 investigations on the farm were performed (5 carps, 1 trout); verification of records; additional sampling where possible (1 NC result); fish held on the farm until compliant results received; farms suspected.

B3c – 1 Arsenic (import) – muscle (fish)

3 non-compliant suspect samples taken during intensified checks.

Wild game B3c – 7 Lead – muscle (target)

7 investigation performed (5 boars, 2 deer); verification of records; carcasses or/and offals declared unfit for human consumption; 7 administrative measures.

Honey B1 – 8 sulfonamides (4 target + 4 suspect)

4 investigations on the farms; additional sampling (product held till obtaining results); 98 kg of honey in total was rendered (according to data given) using of VMP’s was not established in any case; farms subjected to intensified checks.

206

PT PORTUGAL

Group A substances

Modification of national residue plan Bovine, ovine, goat, horses, pigs: Subgroup A5 reinforced, due to positive cases in bovine and pig. Subgroup A2 has recently (2010-2011) presented some positive cases, so there has been a reinforcement (using the balance) of samples to analyze. Poultry: The application of the balance was focused on substances of subgroup A6. The positive results in the European Union and the need for Portugal to be vigilant especially with nitrofurans.

Non-compliant results Follow-up actions Thiouracil – 1 non-compliant result in thyroid – 16 µg/kg.

Investigation in the farm origin. There were no animals in the farm. Inquiry in the farm especially concerning data about the feed. The operator was notified in order to communicate to the competent authorities when the farm will have animals again. The inquiry was not conclusive. The bovines were feed with soya but not with cruciferous plants.

Clenbuterol – 1 non-compliant results in bovine liver.

Investigation in the farm origin. Inquiry of possible reasons for the presence of the substance. Additional sampling of urine. All animals held in the farm origin until results were available. Additional urine samples in the related farms. The animals: all results were negative. Sanctions will be applied accordingly with the results of the investigation.

Clenbuterol – 2 non-compliant results in water for bovines.

Investigation in the farm origin. Inquiry of possible reasons for the presence of the substance. Additional sampling of urine. All animals held in the farm origin until results were available. Additional urine samples in the related farms. The animals: all results were negative. Sanctions will be applied accordingly with the results of the investigation.

Group B substances

Modification of national residue plan Bovine, ovine, goat, horses, pigs: Group B: Continues strengthening in subgroup B1 (antimicrobial) that still has the largest number of non-compliant in all species

207

in the European Union. Similar to the previous year, B2f (quinoxalines) will be surveyed in piglets besides poultry and rabbit, which had positive cases, recently. In horses the total number of samples was maintained. The number of slaughtered horses is reducing each year, 907 (2009) and 774 (2010), and the fact that there isn’t a minimum required samples for this species, together with the non-compliant results that have emerged only in heavy metals in liver that are systematically rejected in animals older than two years ensures the effectiveness of the checks. Poultry: Group B: Despite of non-compliant results for subgroup B2b (anticoccidials) has been reduced, the highest number of non-compliant in poultry, is still reported in this subgroup in Portugal and in the European Union. So there will be reinforcement in the number of samples to be collected for this subgroup using the balance samples. Other species and products: Rabbits: Allocation of balance samples in the reinforcement of B2f – quinoxalines due to a positive result in Portugal. Milk: Allocation of balance samples in the reinforcement of B2a – anthelmintics due to the raise of non-compliant results in the European Union. Eggs: Distribution of balance samples in the reinforcement of B3a, especially in dioxins due to a non-compliant result in chicken. Honey: Due to positive results in the European Union and despite that it is not a requisite for searching, there are some planned samples for nitrofurans and chloramphenicol.


Sulfametazine – 2 non-compliant results in muscle – > 5 mg/kg; 0,190 mg/kg.

Investigations in the farm of origin: inquiry of possible reasons for the presence of the substance. Verification of records. Sanctions will be applied accordingly with the results of the investigation.

Sulfadimetoxine – 1 non-compliant result in muscle – 0,71 mg/kg.


Poultry Maduramicin – 1 non-compliant result in broiler liver – 887,4 µg/kg.

Investigations in the farm of origin: inquiry of possible reasons for the presence of the substance. Verification of records. Sanctions in order to pay a fine.

Robenidine – 1 non-compliant result in broiler liver – 916,1 µg/kg.

Investigations in the farm of origin: inquiry of possible reasons for the presence of the substance. Verification of records. Sanctions will be applied accordingly with the results of the investigation. Sheep and goat

208

Sulfadiazine – 1 non-compliant result in sheep muscle: > 5 mg/kg.


Sulfadimethoxine / Sulfadoxine – 0,32 mg/kg; 1,40 mg/kg – 1 non-compliant result in sheep muscle.


Lead – 1 non-compliant result in goat liver – 1,9 mg/kg.

Investigations in the farm of origin: inquiry of possible reasons for the presence of the substance but it was no conclusive. Data information was sent to the feed department.

Horses Cadmium – 5 non-compliant result in liver – 2,9 mg/kg; 1,0 mg/kg; 4,2 mg/kg; 12,2 mg/kg; 0,9 mg/kg.

Horses with more than two years old have their livers rejected for human consumption.

Rabbit Olaquindox – 1 non-compliant result in rabbit liver – 0,008 mg/kg.

Investigations in the farm of origin, animals held in the farm, new samples in liver 7 (all positive), water 7 (1 positive) and 8 feed (all negative). We slaughtered 1.937 rabbits, which were destroyed as category 1 by-products in accordance with Regulation (EC) No 1069/2009. Inquiry of possible reasons for the presence of the substance. Sanctions will be applied accordingly with the results of the investigation.

Farmed game Diclazuril – 1 non-compliant result in liver in quail - 594,5 µg/kg.


Wild game Lead – 1 non-compliant result in veal liver – 0,6 mg/kg. 6 non-compliant results in wild boar liver – 0,8 mg/kg; 5,8 mg/kg; 1,5 mg/kg; 1,4 mg/kg; 0,7 mg/kg; 0,8 mg/kg.

Inquiries of possible reasons for the presence of the substance were not conclusive. Contamination by bullet could be a possibility.

209

RO ROMANIA

Group A substances

Modification of national residue plan A.1. No changes. A.2. Was added 6-Propyl-2-thyouracil. A.3. Were added Stanozolol, stanozolol 16-beta-hydroxi, CLAD, boldenon. A.4. Was added alfa and beta-zearalenol and zearalenone on LC-MS/MS. A. 5. Were added Salbutamol and Zilpaterol. A.6. No changes.

Non-compliant results Follow-up actions 1 sample from farm (bovine urine) reported non-compliant for alfa-estradiol (3,46 ng/mL) – BA 23314/17.10.2011

Interdiction of movement of animal (RO 013000120313) from farm for 60 days. There was found no evidence of illegal treatment in the investigation performed on site. Follow the investigation was established an increased number of controls for the next 12 months.

1 sample from slaughter house (bovine urine) reported non-compliant for alfa-nor testosterone (0,50 ng/mL) – BA 20589/24.03.2011

Animal number (RO 264000002906). There was found no evidence of illegal treatment in the investigation performed on site. Follow the investigation was established an increased number of controls for the next 12 months.

1 sample from farm (bovine urine) reported non-compliant for alfa-estradiol (2,16 ng/mL) – BA 23314/17.10.2011

Interdiction of movement of animal (RO 294001036788) ) from farm for 60 days. There was found no evidence of illegal treatment in the investigation performed on site. Follow the investigation was established an increased number of controls for the next 12 months.

Group B substances

Modification of national residue plan B.1. – No changes. B.2.a – inclusion of new compounds: eprinomectin and emamectin. For benzimidazoles were added triclabendazol, levamisol, clorsulon, flubendazole, oxibendazol and new matrices – egg and poultry. B.2.b. - were added diclazuril, robenidin, maduramicin and a new matrix was added – egg. B.2.c. – No changes. B.2.d. – Screening method is LC-MS/MS. Haloperidol, azaperol, azaperone, chlorpromazine were included. B.2.e. – Vedaprofen was excluded. New compounds were added: 5-hydroxi flunixin, diclofenac, flunixin, carprofen and tolfenamic acid. B.2.f. – For corticosteroids was included muscle as new matrix. For amitraz was included new matrices: kidney and liver. B.3.a. – PCB 118 was excluded. Were added quintozene, tecnazene. B.3.b. – No changes. B.3.c. – No changes. B.3.d. – No changes. B.3.e – No changes.

210

Non-compliant results Follow-up actions Bovines, Pigs, Sheep and Goats, Horses, Poultry, Aquaculture Animals,

Farmed Game, Milk, Eggs and Honey None None

211

SE SWEDEN

Group A substances

Modification of national residue plan A new multi method for group A1, A3 and A4 is introduced for bovine, pigs and sheep. The method will be validated for other matrix such as horse, farmed game etc during the year. Honey will be controlled for nitrofurans and the number of samples for control of CAP is increased. The sampling of CAP and antibiotics will be focused on calves and cows. One more beta-agonist is introduced in the multi method for beta-agonists.

Non-compliant results Follow-up actions Chloramphenicol – Honey Verification of records, investigation at the farm.

Follow-up sampling was done at a tap station and positive samples were found. 256 kg from the primary farm was condemned. Case left to the police.

Group B substances



Cadmium Investigation at the farm, follow up sampling at the slaughterhouse from the same farm at two occasions. Sampling of feed. Investigation still ongoing.

212

SI SLOVENIA

Group A substances

Modification of national residue plan in 2012 No changes


Group B substances

Modification of national residue plan in 2012 None

Non-compliant results Follow-up actions Eggs

1x lasalocid – eggs – hen > 250 µg/kg

Inquiry on the farm of origin including official sampling of the eggs. Prohibition of placing eggs on the market till the results of analyses showed compliance with the relevant legislation.

3x maduramicin – eggs – hen – 3,1 – 3,1 and 4,7 µg/kg

Inquiry on the farms of origin including official sampling of the eggs. Prohibition of placing eggs on the market till the results of analyses showed compliance with the relevant legislation. Official samples of feed on respective farms were taken and official controls in respective feed mills were conducted

Horses 2x cadmium (Cd) – kidney – horse – twice >1,5 mg/kg

Both of the kidneys were sampled. Data on heavy metals are collected separately and they will be processed with specialised web application (GIS – geographical information system), which will provide us with an exact geographical overview of the situation regarding contamination with heavy metals in our country.

Bovines 1x cadmium (Cd) – kidney – cow – 1,23 mg/kg

Official check has been carried out in respective slaughterhouses. Result of those check revealed that the remaining kidney of respective animal was not destined for human consumption. Data on heavy metals are collected separately and they will be processed with specialised web

213

application (GIS – geographical information system), which will provide us with an exact geographical overview of the situation regarding contamination with heavy metals in our country.

214

SK SLOVAK REPUBLIC

Group A substances


Non-compliant results Follow-up actions 17–alfa-19-nortestosterone – urine – young bovine 25 months – 12 ppb

The action on the ban of the movement and removal of the animal in question was issued by the competent veterinary inspector from the DVFA. Subsequently, the repeated urine collection was performed from the same animal for analysis of nortestosterone with a negative result and imposed measures were lifted. By an official control carried out by the competent veterinary inspector also drug handling, administration and drug storage were checked without identified shortcomings and the possibility of parenteral administration of prohibited substance – steroids was excluded.

Group B substances



Residues of inhibitory substances (b.1.) – liver – pig

The pig liver sample was taken at the slaughterhouse under the NRCP (National Residue Control Plan). By the screening method, the positive finding of residues of inhibitory substances was detected. The DVFA under competence of which the controlled slaughterhouse belongs, immediately reported the positive finding to the DVFA, under competence of which is the pig farm, from which the pig in question originated. The veterinary inspector carried out the official control in the pig holding and imposed immediate measures in respect of the ban on movement of pigs intended for breeding, production and slaughtering of animals until

215

recalled. The confirmatory analysis did not confirm the occurrence of residues of antibiotics. The veterinary inspector drew the attention of the breeder to the fact that each delivery of pigs to the slaughterhouse /also outside the Slovak Republic / shall be accompanied by the accompanying document for slaughter and a copy of this document shall be submitted by the breeder to the DVFA. The evidence of applied drugs together with indicated withdrawal period and signature of the responsible person shall be submitted to every so issued document.

Sheep and goat Cadmium – sheep – kidney The taking of suspect samples of drinking water

and feeedingstuffs in the holding was ordered by the competent veterinary inspector. The analyses results of these samples were negative. On the farm, the investigation of stable premises, water supply, feedingstuffs was carried by which the source of contamination was not detected and subsequently a positive finding of Cd in kidney was not detected. Aquaculture

Leucomalachite green – fish – 1x common carp – farm fish

Under the NRCP, the sample in fish breeder was taken, in which the positive finding of leucomalachite green was detected. The official control by the competent DVFA was subsequently performed in fish breeder. The DVFA immediately ordered ban on movement, transport and placing on the market of fish in question on the said farm. The DVFA orded to the breeder the killing and safe disposal of carps in the number of 27 pieces weighing 26,7 kg in compliance with the valid legislation and also consistent observance of working practices of cleaning and disinfection to avoid fish contamination. The suspect sample was taken by the veterinary inspector on the farm in question with a negative result for malachite and leucomalachite green. Feedingstuff

Deoxynivalenol In the sample of complete feeding stuff for

216

laying hens, taken under the NRCP the presence of positive finding of deoxynivalenol was detected. The veterinary inspector of the competent DVFA detected, that the said compound feeding stuff was already not on the farm. The case was conveyed to the competent authority in the field of feeedingstuff production, to the Central Control and Testing Institute of Agriculture (CCTIA) in Bratislava. The competent inspector of CCTIA detected, based on the tracing back of individual raw materials entering the production of the said complete feeding stuff and sample analysis that the maize contains the positive finding of deoxynivalenol. The maize in question was ceased for incorporation into compound feeedingstuffs and at the same time an order for removal of the whole harmful amount to the biogas station was issued. The attention of the producer was drawn to perform an increased entry control in incorporated feed materials into compound feedingstuffs.

217

UK UNITED KINGDOM

Group A substances



Six cases of zeranol found in cattle urine samples at (1,1 – 1,3 – 1,7 – 2,6 – 3,0 – 5,2 – 11,1 and 13,7)

The follow up investigations established that all residues found were due to the cattle ingesting feed contaminated with Zeranol due to mould caused by damp storage conditions.

31 cases of thiouracil found in cattle urine samples at (4,2 – 5,2 – 5,3 – 5,8 – 6,5 – 7,0 – 7,2 – 7,3 – 7,5 – 8,2 – 8,3 – 8,6 – 9,2 – 10 – 11 – 11 – 11 – 11 – 12 – 12 – 18 – 18 – 20 – 20 – 23 – 28 – 31 – 31 and 77)

In some samples the source of non-compliance could not be established but it is considered that the animals were fed on a diet rich in brassica. The farmers have been informed.

Pigs Three cases of thiouracil were found in pig urine samples at (5,2 – 9,9 and 17)

It is considered that the animals were fed on a diet rich in brassica. The farmers have been informed. Sheep/Goats

Eight cases of thiouracil were found in sheep urine samples at (5,1 – 5,3 – 5,6 – 5,8 – 8 – 10 – 17 and 27)

It is considered that the animals were fed on a diet rich in brassica. The farmers have been informed

Group B substances



Four Dihydrostreptomycin in calves kidney (1.400 - 4.000 - 19.000 and 21.000)

In three of these cases concerning concentrations of 1.400 µg/kg, 4.000 µg/kg and 19.000 µg/kg, the product Pen & Strep was found to have been used and treated animals were submitted for slaughter within the withdrawal period, either due to using an

218

incorrect withdrawal period or because of incomplete medicines records. The owner of the animal in the other case, concerning a concentration of 21.000 µg/kg, rented a few buildings where he kept poor quality calves, raised them for sometimes only a few days, then sells them again at market. A part-used bottle of Pen & Strep was found and further investigation was attempted, but the owner and his animals were evicted from the farm by the land owner and subsequently Investigating Officers were unable to locate him.

One penicillin G in cattle kidney (1.100)

Penicillin G was found in this heifer at a concentration of 1.100 µg/kg. The investigation established that the animal was treated by the vet with depocillin, however, no records of treatments were being kept and it was likely that the heifer sent to slaughter within the withdrawal period.

One neomycin in cattle kidney (8.600)

The investigation discovered that the medicines records were incomplete. The cow had suffered from E.coli mastitis and was withdrawn from the herd and treated by the vet with fluids. The cow was given framomycin, engemycin and metacam, which were not recorded, and sent toslaughter within the withdrawal period of 135 days. The prescribing vet has been informed of the deficiencies of record keeping and the failure to comply with the withdrawal period.

One oxytetracycline in cattle kidney (21.000)

This heifer was suffering from Johne's Disease. The medicines records recorded four cattle as being treated with Engemycin LA. On veterinary advice, the owner decided to have the heifer destroyed and passed it to a dealer assuming that the animal would not be submitted for human consumption. The investigation established that the dealer submittedthis animal for slaughter, which was within the withdrawal period. The carcass was subsequently destroyed and did not enter the food chain.

One ivermectin in cattle liver (240)

A follow up investigation was carried out and it was established that the animal was within the

219

withdrawal period at the time of slaughter. This case has been referred to the Rural Payments Agency.

One florfenicol in calf kidney (14.000)

The on farm investigation found that the medicines record for the treatment of calves was incomplete. The animal had been treated with Resflor and it was determined that the animal had been treated by mistake. The calf was sent to slaughter within the withdrawal period.

One cadmium (Cd) in cattle kidney (1.300)

The originating farm has a series of footpaths through it which are well used and in the past the farmer has found mobile phones on several occasions, one of which was found melted in what had been a camp fire. It was therefore determined that the most likely cause of this residue concentration of 1.300 µg/kg is from environmental contamination from batteries.

One phenylbutazone in cattle kidney (3,6)

The on farm investigation reported that the medicines storage and records were satisfactory and that there was no record of phenylbutazone use. The animal had been sold at market, and remained under the control of the market until it was slaughtered 10 days later. It was not possible to determine the cause of this residue.

One ibuprofen in cattle kidney (11)

There was no evidence of any medicines containing this substance on farm.

Pigs One sulphadiazine at 937 µg/kg

Sulphadiazine detected above the MRL in one pig kidney. Three batches of follow-up samples were collected. All were found to be compliant

Poultry One oxfendazole sulfone in hen liver (71)

No medication was administered this birdhouse on the farm. The feed mill does produce feed medicated with Panacur, although has a protocol to prevent carryover of medication. Therefore, this investigation could not definitively establish the cause of the residue.

Sheep and goat One oxfendazole, fenbendazole and oxfendazole sulfone in sheep liver (6.800 – 2.100 – 640)

The investigation established that this animal was treated with Panacur, 20 days prior to slaughter which complies with the withdrawal period of 15 days. The most likely cause of this

220

residue is due to an accidental overdose of Panacur.

One oxfendazole and fenbendazole in sheep liver (2.000 – 390)

The investigation established that the most likely cause of this residue was due to accidental overdosing of Panacur.

One cypermethrin in sheep kidney fat (850)

The investigation established that the likely cause of this residue was due to the animal being treated with a product containing cypermethrin and subsequently sent to slaughter whilst still within the withdrawal period.

Two lead in sheep kidney (630 and 1.500)

The investigation established the most likely cause of the residue of 630 µg/kgwas due to environmental pollution. For the residues of 1.500 µg/kg, no evidence of any lead source was noted in the environment; therefore, the source of this residue could not be established.

One cadmium in sheep kidney (2.400)

The sheep on this farm are grazed on grass and there were no obvious signs of environmental pollution or otherwise, therefore the source of this residue concentration of 2.400 µg/kg could not be established.

Horses One phenylbutazone in cattle kidney (6,5)

The investigation was carried out and the previous owner could not be traced, however, the most likely cause of the residue was that phenylbutazone had been administered prior to sale.

Milk One ivermectin in cows milk (5,2)

The farmer had been mistakenly using Bimectin plus. A follow-up milk sample was collected which was found to be compliant.

Four nitroxynil in cows milk (3,8 – 12 – 13 and 144)

The investigation established that the cause of this residue concentration of 3,8 – 12 – 13 – 144 µg/l was due to the owners, who routinely used Trodax to treat fluke, mistakenly thinking that it is permissible to use it on dry cows resulting in the treated animals being milked during the withdrawal period. The farmers have received notices to stop using this medication. No further action was deemed necessary Aquaculture

One oxytetracycline in trout The fish which contained a concentration of

221

muscle (230) 230 µg/kg was sampled in error whilst within a withdrawal period due to a miscommunication between the site manager and the collection officer.

Honey One naphthalene in honey (15) The mostly likely cause of this residue

concentration of 15 µg/kg was due to contamination due to the incorrect storage of honeycombs over winter. The Bee Inspector has advised the owner of better working practises to avoid this type of residue in the future.

One 1-4-dichlorobenzene in honey (7,8)

The mostly likely cause of this residue concentration of 7,8 µg/kg was contamination due to the incorrect storage of honeycombs over winter. The Bee Inspector has advised the owner of better working practises to avoid this type of residue in the future.